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Background: Pregnancy and the period around birth are critical for the development and improvement of
population health as well as the health of mothers and babies, with outcomes such as birthweight
influencing adult health.
Objectives: We evaluated the clinical effectiveness and cost-effectiveness of the Health in Pregnancy (HiP)
grants in Scotland, looking for differential outcomes when the scheme was in place, as well as before its
implementation and after its withdrawal.
Design: The HiP grants were evaluated as a natural experiment using interrupted time series analysis.
We had comparison groups of women who delivered before the grants were introduced and after the
grants were withdrawn.
Setting: Scotland, UK.
Participants: A total of 525,400 singleton births delivered between 24 and 44 weeks in hospitals across
Scotland between 1 January 2004 and 31 December 2014.
Intervention: The HiP grant was a universal, unconditional cash transfer of £190 for women in Great
Britain and Northern Ireland reaching 25 weeks of pregnancy if they had sought health advice from a
doctor or midwife. The grant was introduced for women with a due date on or after 6 April 2009 and
subsequently withdrawn for women reaching the 25th week of pregnancy on or after 1 January 2011.
The programme was paid for by Her Majesty’s Treasury.
Main outcome measures: Our primary outcome measure was birthweight. Secondary outcome measures
included maternal behaviour, measures of size, measures of stage and birth outcomes.
Data sources: The data came from the Scottish maternity and neonatal database held by the Information
and Services Division at the NHS National Services Scotland.
Results: There was no statistically significant effect on birthweight, with births during the intervention
period being, on average, 2.3 g [95% confidence interval (CI) –1.9 to 6.6 g] lighter than would have
been expected had the pre-intervention trend continued. Mean gestational age at booking (i.e. the
first antenatal appointment with a health-care professional) decreased by 0.35 weeks (95% CI 0.29 to
0.41 weeks) and the odds of booking before 25 weeks increased by 10% [odds ratio (OR) 1.10, 95% CI
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1.02 to 1.18] during the intervention but decreased again post intervention (OR 0.91, 95% CI 0.83 to
1.00). The odds of neonatal death increased by 84% (OR 1.84, 95% CI 1.22 to 2.78) and the odds of
having an emergency caesarean section increased by 7% (OR 1.07, 95% CI 1.03 to 1.10) during the
intervention period.
Conclusions: The decrease in the odds of booking before 25 weeks following withdrawal of the intervention
makes it likely that the HiP grants influenced maternal health-care-seeking behaviour. It is unclear why neonatal
mortality and emergency caesarean section rates increased, but plausible explanations include the effects of
the swine flu outbreak in 2009 and the global financial crisis. The study is limited by its non-randomised design.
Future research could assess an eligibility threshold for payment earlier than the 25th week of pregnancy.
Funding: The National Institute for Health Research Public Health Research programme. The Social and
Public Health Sciences Unit is core funded by the Medical Research Council (MC_UU_12017/13) and the
Scottish Government Chief Scientist Office (SPHSU13).
ABSTRACT
NIHR Journals Library www.journalslibrary.nihr.ac.uk
vi
Contents
List of tables xv
List of figures xxi
List of abbreviations xxiii
Plain English summary xxv
Scientific summary xxvii
Chapter 1 Introduction 1
Background 1
The intervention 2
Rationale for the study 2
Socioeconomic position and inequalities 3
Research objectives 4
Chapter 2 Methods 5
Outcomes and causal pathway 5
Research design 6
Natural experiment using interrupted time series analysis 6
Study population including definitions of subgroups 8
Data 10
Ethics and information governance 10
Structure of the data 10
Power calculation 10
Outcome measures 10
Covariates 10
Removing outliers 11
Imputation methods 11
Numbers of observations used in analyses 12
Statistical analysis 12
Fitting interaction models 20
Subgroup analyses 21
Ethnicity 21
Economic analysis 21
Model overview 21
Parameter sources 22
Health outcomes 22
Cost parameters 23
Analysis 24
Strengthening the inference 24
Models fitted and interpretation 26
Models fitted 26
Interpretation 26
Changes from the protocol 26
Not adjusting for maternal smoking or gestational age at booking 26
Not using health board and data zone clustering in the imputation model 26
DOI: 10.3310/phr05060 PUBLIC HEALTH RESEARCH 2017 VOL. 5 NO. 6
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Leyland et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
vii
Spontaneous delivery 27
Ethnicity breakdown into further ethnic groups 27
Fitting interactions between subgroup and intervention 27
Combinations of subgroups 27
Not adjusting for gestational age at delivery in models with caesarean section
as outcomes 27
Chapter 3 Results 29
Description of outcomes and covariates 29
Results for the main analysis 29
Results for the primary outcome 29
Results for the secondary outcomes 29
Results of the subgroup analysis 43
The primary outcome 43
The secondary outcomes 43
Results of sensitivity analysis 50
Subgroup of nulliparous mothers 50
Impact of restricting the pre-intervention period to the period following the
introduction of the smoking ban in public places 50
Impact of moving the Health in Pregnancy grant period 50
Impact of moving the intervention period to 1 year before the real Health in
Pregnancy grant period 50
Impact of moving the intervention period to 6 months before the real Health in
Pregnancy grant period 51
Impact of moving the intervention period to 6 months after the real Health in
Pregnancy grant period 51
Impact of moving the intervention period to 1 year after the real Health in Pregnancy
grant period 51
Summary of results for the main analysis and moving windows 51
Economic analysis results 51
Chapter 4 Discussion 59
Principal findings 59
Impact on inequalities 60
Robustness and generalisability 61
Interpretation 63
Strengths and weaknesses 64
Patient and public involvement 65
Chapter 5 Conclusions 67
Implications for health care 67
Recommendations for research 68
Acknowledgements 71
References 73
Appendix 1 Models specification (adjusted on gestational age at booking and
maternal smoking) 79
Appendix 2 Results of the analysis for the secondary outcomes using the
complete cases unadjusted for gestational age at booking and maternal
smoking: maternal behaviour 87
CONTENTS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
viii
Appendix 3 The results of analysis for the secondary outcomes using the
complete cases unadjusted for gestational age at booking and maternal
smoking: measures of size 89
Appendix 4 The results of analysis for the secondary outcomes using the
complete cases unadjusted for gestational age at booking and maternal
smoking: measures of stage 91
Appendix 5 The results of analysis for the secondary outcomes using the
complete cases unadjusted for gestational age at booking and maternal
smoking: birth outcomes 93
Appendix 6 The results of analysis for the secondary outcomes using the
complete cases and adjusting the model for gestational age at booking and
maternal smoking: maternal behaviour 95
Appendix 7 The results of analysis for the secondary outcomes using the
complete cases and adjusting the model for gestational age at booking and
maternal smoking: measures of size 97
Appendix 8 The results of analysis for the secondary outcomes using the
complete cases and adjusting the model for gestational age at booking and
maternal smoking: measures of stage 99
Appendix 9 The results of analysis for the secondary outcomes using the
complete cases and adjusting the model for gestational age at booking and
maternal smoking: birth outcomes 101
Appendix 10 Other parameter estimates for the primary and secondary
outcomes using the imputed data and unadjusted for gestational age at booking
and maternal smoking: maternal behaviour 103
Appendix 11 Other parameter estimates for the primary and secondary
outcomes using the imputed data and unadjusted for gestational age at booking
and maternal smoking: measures of size 105
Appendix 12 Other parameter estimates for the primary and secondary
outcomes using the imputed data and unadjusted for gestational age at booking
and maternal smoking: measures of stage 111
Appendix 13 Other parameter estimates for the primary and secondary
outcomes using the imputed data and unadjusted for gestational age at booking
and maternal smoking: birth outcomes 117
Appendix 14 Variances and standard errors for the final models for each outcome 123
Appendix 15 Results of the analysis for the secondary outcomes using the
imputed data: subgroup of mothers living in the most deprived areas (SIMD1) –
maternal behaviour 125
Appendix 16 Results of analysis for the secondary outcomes using the imputed
data: subgroup of mothers living in the most deprived areas (SIMD1) – measures
of size 127
DOI: 10.3310/phr05060 PUBLIC HEALTH RESEARCH 2017 VOL. 5 NO. 6
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Leyland et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
ix
Appendix 17 Results of analysis for the secondary outcomes using the imputed
data: subgroup of mothers living in the most deprived areas (SIMD1) – measures
of stage 129
Appendix 18 Results of analysis for the secondary outcomes using the imputed
data: subgroup of mothers living in the most deprived areas (SIMD1) –
birth outcomes 131
Appendix 19 Results of analysis for the secondary outcomes using the imputed
data: subgroup of mothers living in SIMD2 areas – maternal behaviour 133
Appendix 20 Results of analysis for the secondary outcomes using the imputed
data: subgroup of mothers living in SIMD2 areas – measures of size 135
Appendix 21 Results of analysis for the secondary outcomes using the imputed
data: subgroup of mothers living in SIMD2 areas – measures of stage 137
Appendix 22 Results of analysis for the secondary outcomes using the imputed
data: subgroup of mothers living in SIMD2 areas – birth outcomes 139
Appendix 23 Results of analysis for the secondary outcomes using the imputed
data: subgroup of mothers living in SIMD3 areas – maternal behaviour 141
Appendix 24 Results of analysis for the secondary outcomes using the imputed
data: subgroup of mothers living in SIMD3 areas – measures of size 143
Appendix 25 Results of analysis for the secondary outcomes using the imputed
data: subgroup of mothers living in SIMD3 areas – measures of stage 145
Appendix 26 Results of analysis for the secondary outcomes using the imputed
data: subgroup of mothers living in SIMD3 areas – birth outcomes 147
Appendix 27 Results of analysis for the secondary outcomes using the imputed
data: subgroup of mothers living in SIMD4 areas – maternal behaviour 149
Appendix 28 Results of analysis for the secondary outcomes using the imputed
data: subgroup of mothers living in SIMD4 areas – measures of size 151
Appendix 29 Results of analysis for the secondary outcomes using the imputed
data: subgroup of mothers living in SIMD4 areas – measures of stage 153
Appendix 30 Results of analysis for the secondary outcomes using the imputed
data: subgroup of mothers living in SIMD4 areas – birth outcomes 155
Appendix 31 Results of analysis for the secondary outcomes using the imputed
data: subgroup of mothers living in the least deprived areas – maternal behaviour 157
Appendix 32 Results of analysis for the secondary outcomes using the imputed
data: subgroup of mothers living in the least deprived areas – measures of size 159
Appendix 33 Results of analysis for the secondary outcomes using the imputed
data: subgroup of mothers living in the least deprived areas – measures of stage 161
CONTENTS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
x
Appendix 34 Results of analysis for the secondary outcomes using the imputed
data: subgroup of mothers living in the least deprived areas – birth outcomes 163
Appendix 35 Results of analysis for the secondary outcomes using the imputed
data: subgroup of mothers with diabetes mellitus (before or during pregnancy) –
maternal behaviour 165
Appendix 36 Results of analysis for the secondary outcomes using the imputed
data: subgroup of mothers with diabetes mellitus (before or during pregnancy) –
measures of size 167
Appendix 37 Results of analysis for the secondary outcomes using the imputed
data: subgroup of mothers with diabetes mellitus (before or during pregnancy) –
measures of stage 169
Appendix 38 Results of analysis for the secondary outcomes using the imputed
data: subgroup of mothers with diabetes mellitus (before or during pregnancy) –
birth outcomes 171
Appendix 39 Results of analysis for the secondary outcomes using the imputed
data: subgroup of obese mothers (BMI ≥ 35 kg/m2) – maternal behaviour 173
Appendix 40 Results of analysis for the secondary outcomes using the imputed
data: subgroup of obese mothers (BMI ≥ 35 kg/m2) – measures of size 175
Appendix 41 Results of analysis for the secondary outcomes using the imputed
data: subgroup of obese mothers (BMI ≥ 35 kg/m2) – measures of stage 177
Appendix 42 Results of analysis for the secondary outcomes using the imputed
data: subgroup of obese mothers (BMI ≥ 35 kg/m2) – birth outcomes 179
Appendix 43 Results of analysis for the secondary outcomes using the imputed
data: subgroup of lone mothers – maternal behaviour 181
Appendix 44 Results of analysis for the secondary outcomes using the imputed
data: subgroup of lone mothers – measures of size 183
Appendix 45 Results of analysis for the secondary outcomes using the imputed
data: subgroup of lone mothers – measures of stage 185
Appendix 46 Results of analysis for the secondary outcomes using the imputed
data: subgroup of lone mothers – birth outcomes 187
Appendix 47 Results of analysis for the secondary outcomes using the imputed
data: subgroup of mothers living in households where the head is in the group
of working-class people – maternal behaviour 189
Appendix 48 Results of analysis for the secondary outcomes using the imputed
data: subgroup of mothers living in households where the head is in the group
of working-class people – measures of size 191
DOI: 10.3310/phr05060 PUBLIC HEALTH RESEARCH 2017 VOL. 5 NO. 6
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Leyland et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
xi
Appendix 49 Results of analysis for the secondary outcomes using the imputed
data: subgroup of mothers living in households where the head is in the group
of working-class people – measures of stage 193
Appendix 50 Results of analysis for the secondary outcomes using the imputed
data: subgroup of mothers living in households where the head is in the group
of working-class people – birth outcomes 195
Appendix 51 Results of analysis for the secondary outcomes using the imputed
data: subgroup of mothers living in households where the head is in the group
of people who have never worked – maternal behaviour 197
Appendix 52 Results of analysis for the secondary outcomes using the imputed
data: subgroup of mothers living in households where the head is in the group
of people who have never worked – measures of size 199
Appendix 53 Results of analysis for the secondary outcomes using the imputed
data: subgroup of mothers living in households where the head is in the group
of people who have never worked – measures of stage 201
Appendix 54 Results of analysis for the secondary outcomes using the imputed
data: subgroup of mothers living in households where the head is in the group
of people who have never worked – birth outcomes 203
Appendix 55 Results of analysis for the secondary outcomes using the imputed
data: subgroup of teen mothers (< 20 years old) – maternal behaviour 205
Appendix 56 Results of analysis for the secondary outcomes using the imputed
data: subgroup of teen mothers (< 20 years old) – measures of size 207
Appendix 57 Results of analysis for the secondary outcomes using the imputed
data: subgroup of teen mothers (< 20 years old) – measures of stage 209
Appendix 58 Results of analysis for the secondary outcomes using the imputed
data: subgroup of teen mothers (< 20 years old) – birth outcomes 211
Appendix 59 Results of analysis for the secondary outcomes using the imputed
data: subgroup of non-white mothers – maternal behaviour 213
Appendix 60 Results of analysis for the secondary outcomes using the imputed
data: subgroup of non-white mothers – measures of size 215
Appendix 61 Results of analysis for the secondary outcomes using the imputed
data: subgroup of non-white mothers – measures of stage 217
Appendix 62 Results of analysis for the secondary outcomes using the imputed
data: subgroup of non-white mothers – birth outcomes 219
Appendix 63 Results of the main analysis for the secondary outcomes adjusted
for ethnicity and using the complete cases: maternal behaviour 221
Appendix 64 Results of the main analysis for the primary and secondary
outcomes adjusted for ethnicity and using the complete cases: measures of size 223
CONTENTS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
xii
Appendix 65 Results of the main analysis for the secondary outcomes adjusted
for ethnicity and using the complete cases: measures of stage 225
Appendix 66 Results of the main analysis for the secondary outcomes adjusted
for ethnicity and using the complete cases: birth outcomes 227
Appendix 67 Results of analysis for the secondary outcomes using the imputed
data: subgroup of nulliparous mothers – maternal behaviour 229
Appendix 68 Results of analysis for the primary and secondary outcomes using
the imputed data: subgroup of nulliparous mothers – measures of size 231
Appendix 69 Results of analysis for the secondary outcomes using the imputed
data: subgroup of nulliparous mothers – measures of stage 233
Appendix 70 Results of analysis for the secondary outcomes using the imputed
data: subgroup of nulliparous mothers – birth outcomes 235
Appendix 71 Impact of restricting the pre-intervention period to the period after
the smoking ban: maternal behaviour 237
Appendix 72 Impact of restricting the pre-intervention period to the period after
the smoking ban: measures of size 239
Appendix 73 Impact of restricting the pre-intervention period to the period after
the smoking ban: measures of stage 241
Appendix 74 Impact of restricting the pre-intervention period to the period after
the smoking ban: birth outcomes 243
Appendix 75 Impact of moving the real Health in Pregnancy grant period:
restriction to 18 months 245
Appendix 76 Impact of moving the real Health in Pregnancy grant period:
extension to 30 months 247
Appendix 77 Impact of moving the real Health in Pregnancy grant period:
exclusion of births that occurred during the 2009 swine flu outbreak 249
Appendix 78 Impact of moving the start of the intervention period to one year
before the real Health in Pregnancy grant period: 24-month intervention period 251
Appendix 79 Impact of moving the start of the intervention period to 1 year
before the real Health in Pregnancy grant period: 18-month intervention period 253
Appendix 80 Impact of moving the start of the intervention period to 1 year
before the real Health in Pregnancy grant period: 30-month intervention period 255
Appendix 81 Impact of moving the start of the intervention period to 6 months
before the real Health in Pregnancy grant period: 24-month intervention period 257
Appendix 82 Impact of moving the start of the intervention period to 6 months
before the real Health in Pregnancy grant period: 18-month intervention period 259
DOI: 10.3310/phr05060 PUBLIC HEALTH RESEARCH 2017 VOL. 5 NO. 6
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Leyland et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
xiii
Appendix 83 Impact of moving the start of the intervention period to 6 months
before the real Health in Pregnancy grant period: 30-month intervention period 261
Appendix 84 Impact of moving the start of the intervention period to 6 months
after the real Health in Pregnancy grant period: 24-month intervention period 263
Appendix 85 Impact of moving the start of the intervention period to 6 months
after the real Health in Pregnancy grant period: 18-month intervention period 265
Appendix 86 Impact of moving the start of the intervention period to 6 months
after the real Health in Pregnancy grant period: 30-month intervention period 267
Appendix 87 Impact of moving the start of the intervention period to 1 year
after the real Health in Pregnancy grant period: 24-month intervention period 269
Appendix 88 Impact of moving the start of the intervention period to 1 year
after the real Health in Pregnancy grant period: 18-month intervention period 271
Appendix 89 Impact of moving the start of the intervention period to 1 year
after the real Health in Pregnancy grant period: 30-month intervention period 273
Appendix 90 STrengthening the Reporting of OBservational studies in
Epidemiology statement for reporting of observational studies 275
CONTENTS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
xiv
List of tables
TABLE 1 Dates for the study periods and washout periods 8
TABLE 2 Sample sizes for subgroup analyses 12
TABLE 3 Sample sizes for subgroup analyses 13
TABLE 4 Main models specification (unadjusted for gestational age at booking
and maternal smoking) 15
TABLE 5 Parameters used in the model 22
TABLE 6 Cost of index hospitalisation by gestational age 23
TABLE 7 Cost of index hospitalisation by birthweight 23
TABLE 8 Start and end dates for moving window periods 25
TABLE 9 Proportion of preterm (< 37 weeks’ gestation) births by mode of delivery 27
TABLE 10 Description of the outcomes over time: measures of size 30
TABLE 11 Description of the outcomes over time: measures of stage 31
TABLE 12 Description of the outcomes over time: birth outcomes 32
TABLE 13 Description of the outcomes over time: maternal behaviour 33
TABLE 14 Description of the covariates over time 34
TABLE 15 Results of analysis for the primary outcome using the complete cases
and the imputed data both unadjusted and adjusted for gestational age at
booking and maternal smoking 40
TABLE 16 Results of analysis for the secondary outcomes using the imputed data
unadjusted for gestational age at booking and maternal smoking: maternal
behaviour 40
TABLE 17 Results of analysis for the secondary outcomes using the imputed data
unadjusted for gestational age at booking and maternal smoking: measures of size 41
TABLE 18 Results of analysis for the secondary outcomes using the imputed data
unadjusted for gestational age at booking and maternal smoking: measures of stage 42
TABLE 19 Results of analysis for the secondary outcomes using the imputed data
unadjusted for gestational age at booking and maternal smoking: birth outcomes 42
TABLE 20 Results of analysis for the secondary outcomes using the imputed data
and adjusting for gestational age at booking and maternal smoking: maternal
behaviour 44
DOI: 10.3310/phr05060 PUBLIC HEALTH RESEARCH 2017 VOL. 5 NO. 6
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Leyland et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
xv
TABLE 21 Results of analysis for the secondary outcomes using the imputed data
and adjusting for gestational age at booking and maternal smoking: measures
of size 44
TABLE 22 Results of analysis for the secondary outcomes using the imputed data
and adjusting for gestational age at booking and maternal smoking: measures
of stage 45
TABLE 23 Results of analysis for the secondary outcomes using the imputed data
and adjusting for gestational age at booking and maternal smoking: birth outcomes 46
TABLE 24 Results of subgroup analysis for the primary outcome using the
imputed data unadjusted for gestational age at booking and maternal smoking:
subgroups related to the socioeconomic position of the area of residence
(SIMD2009 version 2) 47
TABLE 25 Results of subgroup analysis for the primary outcome using the
imputed data unadjusted for gestational age at booking and maternal smoking:
other subgroups 49
TABLE 26 Incremental outcomes and costs attributable to HiP grant intervention 58
TABLE 27 Models specification (adjusted on gestational age at booking and
maternal smoking) 80
TABLE 28 Complete cases unadjusted for gestational age at booking and
maternal smoking: maternal behaviour 87
TABLE 29 Complete cases unadjusted for gestational age at booking and
maternal smoking: measures of size 89
TABLE 30 Complete cases unadjusted for gestational age at booking and
maternal smoking: measures of stage 91
TABLE 31 Complete cases unadjusted for gestational age at booking and
maternal smoking: birth outcomes 93
TABLE 32 Complete cases and adjusting the model for gestational age at
booking and maternal smoking: maternal behaviour 95
TABLE 33 Complete cases and adjusting the model for gestational age at
booking and maternal smoking: measures of size 97
TABLE 34 Complete cases and adjusting the model for gestational age at
booking and maternal smoking: measures of stage 99
TABLE 35 Complete cases and adjusting the model for gestational age at
booking and maternal smoking: birth outcomes 101
TABLE 36 Other parameter estimates for the primary and secondary outcomes
using the imputed data and unadjusted for gestational age at booking and
maternal smoking: maternal behaviour 103
LIST OF TABLES
NIHR Journals Library www.journalslibrary.nihr.ac.uk
xvi
TABLE 37 Other parameter estimates for the primary and secondary outcomes
using the imputed data and unadjusted for gestational age at booking and
maternal smoking: measures of size 106
TABLE 38 Other parameter estimates for the primary and secondary outcomes
using the imputed data and unadjusted for gestational age at booking and
maternal smoking: measures of stage 112
TABLE 39 Other parameter estimates for the primary and secondary outcomes
using the imputed data and unadjusted for gestational age at booking and
maternal smoking: birth outcomes 118
TABLE 40 Variances and standard errors for the final models for each outcome 123
TABLE 41 Subgroup of mothers living in the most deprived areas (SIMD1):
maternal behaviour 125
TABLE 42 Subgroup of mothers living in the most deprived areas (SIMD1):
measures of size 127
TABLE 43 Subgroup of mothers living in the most deprived areas (SIMD1):
measures of stage 129
TABLE 44 Subgroup of mothers living in the most deprived areas (SIMD1):
birth outcomes 131
TABLE 45 Subgroup of mothers living in SIMD2 areas: maternal behaviour 133
TABLE 46 Subgroup of mothers living in SIMD2 areas: measures of size 135
TABLE 47 Subgroup of mothers living in SIMD2 areas: measures of stage 137
TABLE 48 Subgroup of mothers living in SIMD2 areas: birth outcomes 139
TABLE 49 Subgroup of mothers living in SIMD3 areas: maternal behaviour 141
TABLE 50 Subgroup of mothers living in SIMD3 areas: measures of size 143
TABLE 51 Subgroup of mothers living in SIMD3 areas: measures of stage 145
TABLE 52 Subgroup of mothers living in SIMD3 areas: birth outcomes 147
TABLE 53 Subgroup of mothers living in SIMD4 areas: maternal behaviour 149
TABLE 54 Subgroup of mothers living in SIMD4 areas: measures of size 151
TABLE 55 Subgroup of mothers living in SIMD4 areas: measures of stage 153
TABLE 56 Subgroup of mothers living in SIMD4 areas: birth outcomes 155
TABLE 57 Subgroup of mothers living in the least deprived areas: maternal
behaviour 157
DOI: 10.3310/phr05060 PUBLIC HEALTH RESEARCH 2017 VOL. 5 NO. 6
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Leyland et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
xvii
TABLE 58 Subgroup of mothers living in the least deprived areas: measures of size 159
TABLE 59 Subgroup of mothers living in the least deprived areas: measures of stage 161
TABLE 60 Subgroup of mothers living in the least deprived areas: birth outcomes 163
TABLE 61 Subgroup of mothers with diabetes mellitus (before or during
pregnancy): maternal behaviour 165
TABLE 62 Subgroup of mothers with diabetes mellitus (before or during
pregnancy): measures of size 167
TABLE 63 Subgroup of mothers with diabetes mellitus (before or during
pregnancy): measures of stage 169
TABLE 64 Subgroup of mothers with diabetes mellitus (before or during
pregnancy): birth outcomes 171
TABLE 65 Subgroup of obese mothers (BMI ≥ 35 kg/m2): maternal behaviour 173
TABLE 66 Subgroup of obese mothers (BMI ≥ 35 kg/m2): measures of size 175
TABLE 67 Subgroup of obese mothers (BMI ≥ 35 kg/m2): measures of stage 177
TABLE 68 Subgroup of obese mothers (BMI ≥ 35 kg/m2): birth outcomes 179
TABLE 69 Subgroup of lone mothers: maternal behaviour 181
TABLE 70 Subgroup of lone mothers: measures of size 183
TABLE 71 Subgroup of lone mothers: measures of stage 185
TABLE 72 Subgroup of lone mothers: birth outcomes 187
TABLE 73 Subgroup of mothers living in households where the head is in the
group of working-class people: maternal behaviour 189
TABLE 74 Subgroup of mothers living in households where the head is in the
group of working-class people: measures of size 191
TABLE 75 Subgroup of mothers living in households where the head is in the
group of working-class people: measures of stage 193
TABLE 76 Subgroup of mothers living in households where the head is in the
group of working-class people: birth outcomes 195
TABLE 77 Subgroup of mothers living in households where the head is in the
group of people who have never worked: maternal behaviour 197
TABLE 78 Subgroup of mothers living in households where the head is in the
group of people who have never worked: measures of size 199
LIST OF TABLES
NIHR Journals Library www.journalslibrary.nihr.ac.uk
xviii
TABLE 79 Subgroup of mothers living in households where the head is in the
group of people who have never worked: measures of stage 201
TABLE 80 Subgroup of mothers living in households where the head is in the
group of people who have never worked: birth outcomes 203
TABLE 81 Subgroup of teen mothers (< 20 years old): maternal behaviour 205
TABLE 82 Subgroup of teen mothers (< 20 years old): measures of size 207
TABLE 83 Subgroup of teen mothers (< 20 years old): measures of stage 209
TABLE 84 Subgroup of teen mothers (< 20 years old): birth outcomes 211
TABLE 85 Subgroup of non-white mothers: maternal behaviour 213
TABLE 86 Subgroup of non-white mothers: measures of size 215
TABLE 87 Subgroup of non-white mothers: measures of stage 217
TABLE 88 Subgroup of non-white mothers: birth outcomes 219
TABLE 89 Secondary outcomes adjusted for ethnicity and using the complete
cases: maternal behaviour 221
TABLE 90 Primary and secondary outcomes adjusted for ethnicity and using the
complete cases: measures of size 223
TABLE 91 Secondary outcomes adjusted for ethnicity and using the complete
cases: measures of stage 225
TABLE 92 Secondary outcomes adjusted for ethnicity and using the complete
cases: birth outcomes 227
TABLE 93 Subgroup of nulliparous mothers: maternal behaviour 229
TABLE 94 Subgroup of nulliparous mothers: measures of size 231
TABLE 95 Subgroup of nulliparous mothers: measures of stage 233
TABLE 96 Subgroup of nulliparous mothers: birth outcomes 235
TABLE 97 Impact of restricting the pre-intervention period to the period after
the smoking ban: maternal behaviour 237
TABLE 98 Impact of restricting the pre-intervention period to the period after
the smoking ban: measures of size 239
TABLE 99 Impact of restricting the pre-intervention period to the period after
the smoking ban: measures of stage 241
TABLE 100 Impact of restricting the pre-intervention period to the period after
the smoking ban: birth outcomes 243
DOI: 10.3310/phr05060 PUBLIC HEALTH RESEARCH 2017 VOL. 5 NO. 6
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Leyland et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
xix
TABLE 101 Impact of moving the real HiP grant period: restriction to 18 months 245
TABLE 102 Impact of moving the real HiP grant period: extension to 30 months 247
TABLE 103 Impact of moving the real HiP grant period: exclusion of births that
occurred during the 2009 swine flu outbreak 249
TABLE 104 Impact of moving the start of the intervention period to 1 year
before the real HiP grant period: 24-month intervention period 251
TABLE 105 Impact of moving the start of the intervention period to 1 year
before the real HiP grant period: 18-month intervention period 253
TABLE 106 Impact of moving the start of the intervention period to 1 year
before the real HiP grant period: 30-month intervention period 255
TABLE 107 Impact of moving the start of the intervention period to 6 months
before the real HiP grant period: 24-month intervention period 257
TABLE 108 Impact of moving the start of the intervention period to 6 months
before the real HiP grant period: 18-month intervention period 259
TABLE 109 Impact of moving the start of the intervention period to 6 months
before the real HiP grant period: 30-month intervention period 261
TABLE 110 Impact of moving the start of the intervention period to 6 months
after the real HiP grant period: 24-month intervention period 263
TABLE 111 Impact of moving the start of the intervention period to 6 months
after the real HiP grant period: 18-month intervention period 265
TABLE 112 Impact of moving the start of the intervention period to 6 months
after the real HiP grant period: 30-month intervention period 267
TABLE 113 Impact of moving the start of the intervention period to 1 year after
the real HiP grant period: 24-month intervention period 269
TABLE 114 Impact of moving the start of the intervention period to 1 year after
the real HiP grant period: 18-month intervention period 271
TABLE 115 Impact of moving the start of the intervention period to 1 year after
the real HiP grant period: 30-month intervention period 273
TABLE 116 STrengthening the Reporting of OBservational studies in
Epidemiology statement for reporting of observational studies 275
LIST OF TABLES
NIHR Journals Library www.journalslibrary.nihr.ac.uk
xx
List of figures
FIGURE 1 Flow chart showing observations received from the Information and
Services Division, removal of outliers and final sample size for analyses 7
FIGURE 2 Conceptual analysis approach 22
FIGURE 3 Coefficient and 95% CI for birthweight during the HiP grant period
and moving windows 52
FIGURE 4 Coefficient and 95% CI for gestational age at booking during the HiP
grant period and moving windows 53
FIGURE 5 Odds ratio and 95% CI for booking before 25 weeks during the HiP
grant period and moving windows 54
FIGURE 6 Odds ratio and 95% CI for preterm delivery during the HiP grant
period and moving windows 55
FIGURE 7 Odds ratio and 95% CI for very preterm delivery during the HiP grant
period and moving windows 56
FIGURE 8 Odds ratio and 95% CI for neonatal death during the HiP grant period
and moving windows 57
DOI: 10.3310/phr05060 PUBLIC HEALTH RESEARCH 2017 VOL. 5 NO. 6
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Leyland et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
xxi

List of abbreviations
BMI body mass index
CHD coronary heart disease
CI confidence interval
CSO Chief Scientist Office
HEAT Health improvement, Efficiency and
governance improvements, Access
to services, Treatment appropriate
to individuals
HiP Health in Pregnancy
HMRC Her Majesty’s Revenue and
Customs
IQR interquartile range
ISD Information and Services Division
LGA large for gestational age
MICE multiple imputation by chained
equations
MRC Medical Research Council
NRS National Records of Scotland
NS-SEC National Statistics Socioeconomic
Classification
OR odds ratio
PPROM preterm premature rupture of
membranes
SBR Scottish Birth Records
SES socioeconomic status
SGA small for gestational age
SIMD Scottish Index of Multiple
Deprivation
SMR Scottish Morbidity Records
DOI: 10.3310/phr05060 PUBLIC HEALTH RESEARCH 2017 VOL. 5 NO. 6
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Leyland et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
xxiii

Plain English summary
Several studies have reported that improving the health and nutrition of women during pregnancy couldimprove the health of their babies. From April 2009, for a 2-year period, a programme called Health in
Pregnancy grants was implemented by the government across the UK. A cash sum of £190 was given to
women reaching the 25th week of their pregnancy if they had been in contact with a doctor or midwife.
The intention was to encourage pregnant women to visit a health professional earlier in their pregnancy,
and to get advice related to a healthy lifestyle and diet. We investigated whether or not there was a
difference in birthweight between babies born to mothers who were eligible for the grant and babies born
either before the grant was introduced or after the programme had ended.
We used data relating to all single births in Scotland from 2004 to 2013. For our main analysis, this was
525,400 births. We found no evidence that the programme improved birthweight or babies’ health.
However, we found that, on average, women visited a doctor or midwife half a week earlier when the
grant was in place than before the grant was introduced. Results were similar for all women, including
those who might potentially have benefited most from the grant, such as single mothers or those living in
disadvantaged areas. In terms of the overall cost of the programme, we found negligible financial savings
compared with the existing costs of health care for babies and mothers.
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Scientific summary
Background
Pregnancy and the perinatal period are critical stages for the development and improvement of population
health. Lower birthweight babies have a higher risk of adverse perinatal outcomes and, although mean
birthweight has increased in the UK, the social patterning of birthweight has become more pronounced.
Low birthweight also has an impact on adult health; it is associated with a higher risk of coronary heart
disease death and diabetes mellitus. An improvement in fetal nutrition may, therefore, have far-reaching
consequences in terms of the prevention of disease. Antenatal care is widely considered to be an effective
method of improving pregnancy and birth outcomes, through its ability to offer advice and help regarding
the modification of health behaviours. For such care to be effective, it should be offered in a timely
manner, that is, early in the pregnancy.
This study evaluates the clinical effectiveness and cost-effectiveness of the Health in Pregnancy (HiP) grant.
This was a universal, unconditional cash transfer of £190 for women in Great Britain and Northern Ireland
reaching 25 weeks of pregnancy if they had sought health advice from a doctor or midwife. The grant
was introduced for women with a due date on or after 6 April 2009 and was subsequently withdrawn for
women reaching the 25th week of pregnancy on or after 1 January 2011. It was intended to provide
additional financial support in the last months of pregnancy to contribute towards a healthy lifestyle
(e.g. in terms of diet), and it was suggested that the link to the requirement for pregnant women to seek
health advice from a health professional may provide an incentive for expectant mothers to seek the
recommended health advice at the appropriate time. The grant was paid by Her Majesty’s Revenue and
Customs to pregnant women on receipt of a claim form partly completed by a doctor or midwife, and the
programme was paid for by Her Majesty’s Treasury.
Our evaluation was restricted to Scotland and used the high-quality and complete maternal hospital
discharge forms linked to the birth registration system (Scottish Birth Records).
Objectives
Our objective was to evaluate the clinical effectiveness and cost-effectiveness of the HiP grants in Scotland.
We did this by assessing the difference in birthweight between babies born to those mothers who were
eligible for the HiP grant, and babies born either before the HiP grants were introduced or after they were
withdrawn. Specific questions that we address include the following:
l Did the HiP grant result in a change in birthweight (our primary outcome measure) or any of a number
of secondary outcomes grouped as measures of maternal behaviour [gestation at booking (i.e. the first
antenatal appointment with a health-care professional), booking before 25 weeks and maternal
smoking during this pregnancy], measures of size [very low birthweight (< 1500 g), low birthweight
(< 2500 g), high birthweight (> 4000 g), crown-to-heel length and head circumference], measures of
stage [gestational age at delivery, preterm (< 37 weeks), very preterm (< 32 weeks), weight for dates
(standardised, small and large for gestational age)] and birth outcomes (elective caesarean section,
emergency caesarean section, stillbirths, neonatal deaths and 5-minute Apgar score)?
l Were there differential impacts of the intervention for particular subgroups defined by socioeconomic
(both area deprivation and individual occupational social class), demographic (marital status, age,
ethnicity) or obstetric (parity, maternal obesity, maternal diabetes mellitus) factors?
l Were the HiP grants cost-effective? What were their total aggregate health and cost consequences?
How did cost-effectiveness vary across important subgroups identified as having differential outcomes?
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Methods
The HiP intervention was evaluated as a natural experiment using interrupted time series analysis. The
interrupted time series approach allowed us to compare an intervention group that received the HiP grant
both with a comparison group of pregnant women who delivered before the HiP grant was introduced
and with a post-intervention group of women who delivered after the HiP grant was withdrawn.
The data came from the Scottish maternity and neonatal database held by the Information and Services
Division at the NHS National Services Scotland. These data are routinely collected information from
maternal and birth records from all hospitals in Scotland. Individual birth records were available for analysis
in this study. The data covered 10 years from 1 January 2004 to 31 December 2013. During this time,
some mothers gave birth more than once. Therefore, the structure of the data was multilevel; births were
nested within mothers and mothers were nested within small geographic areas (data zones).
Our primary outcome measure, birthweight, had a completion rate of 99.9%. There was a high completion
rate for all outcome variables (< 1.5% missing), with the exception of crown-to-heel length (46.4% missing),
head circumference (26.3% missing), gestational age at booking (15.4% missing) and maternal smoking
(8.9% missing). Birthweight can be affected by many factors; we were able to adjust for a range of routinely
collected obstetric and maternal characteristics such as sociodemographic classifications and medical risks of
the current and previous pregnancies, as well as environmental and behavioural characteristics of the
mother. In addition, we adjusted for time trends and seasonality in the data.
Extreme data values (implausible observations and outliers) were excluded. A total of 18,276 (3.4%)
singleton births delivered between 24 and 44 weeks were excluded, leaving 525,400 births for the main
analysis. Item non-response values were imputed using multiple imputation by chained equations. A total
of 30 imputed data sets were created and analysed identically, and the results were combined to obtain
estimates and standard errors for the multiply imputed data. Multilevel models were used to determine
whether or not the outcomes changed during the intervention period in which the HiP grants were in
effect. Multilevel linear regression was used for continuous outcomes, and multilevel logistic regression
was used when the outcome was dichotomous. Results from imputed data were compared with those
from complete cases, but the results from the imputed data were favoured because these take into
account the non-random pattern in data missingness.
Subgroup analyses were conducted for those groups seen as having the greatest potential to benefit from
the payments, namely those living in the most deprived areas, those in the ‘never worked’ social class
group, those in the ‘manual worker’ social class group, lone mothers and teen mothers, and for mothers
for whom an increase in mean birthweight was not desirable, namely obese mothers and mothers with
diabetes mellitus. For each group the main analysis was replicated and the results from the combined
analysis of the 30 imputed data sets are reported.
Ethnicity was poorly recorded in the routine data set, with 56.5% of data missing over the 10-year period.
Missingness varied across the years: 83.3% of data were missing in 2004 and 23.6% of data were missing
in 2013. Ethnicity was not imputed and was not included in the main analyses. In order to gauge the
effect of ethnicity on the HiP grant intervention, analyses were carried out on the subgroup of non-white
mothers identified in the data set. In addition, the models for the complete cases were fitted to include
ethnicity along with other covariates.
Different forms of sensitivity analysis were conducted in an attempt to ascertain whether or not any effects
were attributable to the HiP grant. The exact window in which the intervention was in place was defined
by two parameters, namely the start date (a due date of delivery on or after 6 April 2009) and the duration
of the intervention (2 years). We allowed both the start date and duration to vary; five different start dates
and three different durations were chosen, giving 15 different windows tested. In all cases in which this
window differed from the real intervention period, a dilution of any effects of the HiP grant was expected.
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The introduction of the smoking ban in public places in Scotland in March 2006 may have had an effect
on the level of smoking in pregnant women and, therefore, may have affected the rate of change of
birthweight of babies born after this time, as well as other outcomes examined. We carried out a further
analysis, restricting the pre-intervention period to 1 January 2007 to 1 April 2009, to ensure that
pregnancies included in the pre-intervention period were all after the smoking ban had come into effect.
The effect of the HiP grant on birthweight and other secondary outcomes might have had a carryover
effect after the withdrawal of the programme. In other words, the trend in birthweight post intervention
might not return to the same rate as pre intervention. This contamination could be attributable to women
who gave birth during the intervention subsequently having a birth post intervention but still heeding
the health advice given during their first pregnancy. An additional analysis using only the subgroup of
primiparous women was carried out to avoid such contamination.
In 2009 there was an outbreak of swine flu (influenza virus A/H1N1pdm09) in Scotland (and the rest of
the UK). Pregnant women were adversely affected by this virus, resulting in poorer perinatal outcomes.
There were two outbreak periods, in July 2009 and October–November 2009. To try to take this into
account, a further analysis removing births from 1 July 2009 to 30 November 2009 in the intervention
period was carried out.
Health and cost consequences were mediated through either a birthweight or gestational age at birth
perspective, in addition to smoking during pregnancy. All costs were presented in 2015 Great British
pounds using the Hospital and Community Health Services index to adjust. Health and cost changes during
the intervention period were presented relative to the pre-intervention period. The model used was based
on the incremental numbers of cases (of preterm, low birthweight or poor maternal outcomes) attributable
to the HiP grant. Unit costs by outcomes were based on published results.
Results
The mean birthweight for live singleton births during the study period was 3418 g. There was no
statistically significant effect of the intervention on birthweight, with birthweight during the intervention
period being, on average, 2.3 g [95% confidence interval (CI) –1.9 to 6.6 g] lighter than would have been
expected had the pre-intervention trend continued. [The general trend was one of birthweight increasing
by 3.3 g per year (95% CI 2.4 to 4.2 g).]
There was no statistically significant effect of the HiP grants on most of the measures of stage and size.
However, compared with the pre-intervention period, maternal booking behaviour changed during
the intervention period. The mean gestational age at booking decreased by 0.35 weeks (95% CI 0.29
to 0.41 weeks) during the period when the grant was in place, and the odds of booking before
25 weeks increased by 10% [odds ratio (OR) 1.10, 95% CI 1.02 to 1.18]. However, the odds of neonatal
death increased by 84% (OR 1.84, 95% CI 1.22 to 2.78), and the odds of having an emergency caesarean
section also increased by 7% (OR 1.07, 95% CI 1.03 to 1.10) during the intervention period.
The decrease in mean gestational age at booking seen during the intervention period was extended post
intervention; relative to the pre-intervention period, mean gestational age at booking was 1.10 weeks
(95% CI 1.02 to 1.20 weeks) lower post intervention. However, following the withdrawal of the HiP grants
there was a small decrease in the odds of booking before 25 weeks (OR 0.91, 95% CI 0.83 to 1.00).
These findings were largely replicated across subgroups. For example, looking at fifths of the population
defined by area deprivation, there was a small decrease in mean birthweight during the intervention period
in the most deprived areas [12.2 g (95% CI 3.6 to 20.8 g)] but no significant difference in the other groups.
Mean gestational age at booking decreased in all deprivation groups, but slightly more so in the more
deprived area groups; there was a reduction of 0.5 weeks (95% CI 0.4 to 0.6 weeks) in the most deprived
20% of areas and a reduction of 0.2 weeks (95% CI 0.1 to 0.4 weeks) in the least deprived 20% of areas.
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The HiP grants were not associated with any significant changes in birthweight, gestational age or
maternal outcomes. As a result, their impact on costs was negligible. The total estimated grant cost
was £20.4M.
Conclusions
There was no impact of the HiP grants on birthweight, our primary outcome measure. In fact, most
measures of stage or size appeared to be little changed by the intervention. There was, however, some
influence on health-care-seeking behaviour, namely gestational age at booking and the likelihood of
booking before 25 weeks. Other studies have similarly shown that behaviour can be changed through
relatively modest financial incentives.
It is likely that the decrease in mean gestational age reflects the introduction and pursuit of a Health
improvement, Efficiency and governance improvements, Access to services, Treatment appropriate to
individuals (HEAT) target related to earlier booking for antenatal care. The same is not true, however, for
the increase in the odds of booking before 25 weeks. The target of 25 weeks was related to the eligibility
for the HiP grants and not to the HEAT targets, and the decrease in the odds of booking before 25 weeks
following withdrawal of the intervention appears to be a response to the withdrawal of the incentive.
Those failing to book before 25 weeks were notably disadvantaged compared with those booking earlier,
particularly in terms of lone parenthood, worklessness and the mother being under 20 years of age.
It is unclear why increases were seen for the probability of neonatal mortality and caesarean sections.
Both remained high following withdrawal of the intervention. It is possible that both were affected by
wider environmental factors that coincided with the intervention period, such as the global financial crisis
and the swine flu pandemic of 2009.
Our study was limited by the implementation of the HiP grants in a way that neither was randomised nor
facilitated their evaluation.
Our recommended priorities for future research are as follows:
1. Test whether an eligibility threshold earlier than 25 weeks would lead to increased exposure to
antenatal care and advice (increased frequency of antenatal visits) and whether any accompanying
change in health behaviour (such as smoking or diet) occurring earlier in the pregnancy would lead to
improvements in maternal and infant health outcomes. Evaluate the economic benefit that can be
achieved through such a modified threshold and any consequent improvement in results.
2. Evaluate whether or not this intervention has greater impact, and higher cost-effectiveness, when
delivered as a targeted intervention or as a universal intervention.
3. Test if outcomes differ depending on whether or not the payment is conditional or unconditional.
4. Investigate the relationship between the size of the payment and subsequent outcomes.
Funding
Funding for this study was provided by the Public Health Research programme of the National Institute for
Health Research. The Social and Public Health Sciences Unit is core funded by the Medical Research
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Chapter 1 Introduction
Background
Pregnancy and the perinatal period are critical stages for the development and improvement of population
health. Deaths in infancy have considerable impact on population life expectancy, and the long-term
consequences of problems arising during pregnancy, including very preterm birth, track through childhood
and into adult life.
Babies of lower birthweight, whether as a result of preterm birth or of an intra-uterine growth restriction,
which can lead to a neonate being small for gestational age (SGA), have a higher risk of adverse perinatal
outcomes. Low birthweight is an important factor in neonatal deaths1 and poorer development.2 Although
mean birthweight has been increasing in the UK, inequalities in birthweight have increased. The UK has an
incidence of low birthweight (< 2500 g) and very low birthweight (< 1500 g) in the top third compared
with other western European countries.3 The proportion of preterm births (< 37 weeks) is also high in the
UK compared with other western European countries.
Low birthweight also has an impact on adult disease, being associated with a higher risk of coronary heart
disease (CHD) death and diabetes mellitus. The developmental model of the origins of chronic disease
proposes the causal influence of undernutrition in utero on CHD and stroke in adult life,4 and longer-term
consequences have been demonstrated for many diseases.5–14 The association between maternal nutrition
and birth outcome is complex and is influenced by many biological, socioeconomic and demographic
factors, which vary widely in different populations.15,16 However, it has been reported that favourable
prenatal nutrition associated with adequate prenatal care can have a positive impact on birth outcomes
and morbidity in adult life.17,18 In addition to poor maternal nutrition being associated with adverse birth
outcomes, a review of maternal nutrition and birth outcomes identified improving maternal nutrition as
contributing to the prevention of adverse birth outcomes in lower social class groups.15 An improvement in
fetal nutrition may, therefore, have far-reaching consequences in terms of the prevention of disease.
Low birthweight is not the only adverse perinatal outcome associated with poor infant outcomes and
poorer long-term health. Across Europe, approximately 75% of neonatal deaths and 60% of all infant
deaths occur among those births classified as preterm (births before 37 weeks of gestation), despite
preterm births constituting only a small proportion of all births; the preterm birth rate ranges between
5.2% and 10.4% across countries, and is 7.0% in the UK.19 A low Apgar score20 – a commonly used
indicator of health in the immediate neonatal period – has been shown to be associated with increased
neonatal and infant mortality21 and additional educational support needs in later life.22
Considerable attention has been focused on the causal determinants of low birthweight in order to identify
potentially modifiable factors. A substantial proportion of low birthweight is attributable to the mother’s
cultural and socioeconomic circumstances, such as socioeconomic status (SES), harmful behaviours (smoking
and excessive alcohol consumption) and poor nutrition during pregnancy.14,23–25 Any social impact may vary
with maternal factors such as age and smoking status. Smoking during pregnancy reduces birthweight by
162–377 g, depending on daily consumption (there is a greater reduction for heavy smokers) and the
trimester in which exposure occurs (a greater reduction is seen during the third trimester).24,26,27
A number of interventions have been developed to improve pregnancy outcomes,28 but evidence of the
success of any interventions is, in most cases, still limited. An analysis of the potential to reduce preterm birth
rates in high-income countries focused solely on five interventions for which there were high levels of evidence:
(1) smoking cessation; (2) progesterone; (3) cervical cerclage; (4) decrease in non-medically indicated caesarean
delivery and induction; and (5) a limit on multiple embryo transfer in assisted reproductive technology.29
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Although there is uncertainty over how to intervene to improve birth outcomes, many outcomes show
strong patterning by measures of socioeconomic position. For example, in Scotland between 1995 and
2000, the odds of preterm birth were 56% higher in social class V (unskilled manual workers) than in
social class I (professional workers; prevalence 5.7% vs. 3.7%).30 Comparing these two groups, the odds
were 107% higher for low birthweight (5.8% vs. 3.8%) and 128% higher for SGA (i.e. babies falling
on or below the fifth centile of the appropriate age and sex distribution in Scotland; 5.1% vs. 3.1%).
A systematic review and meta-analysis of social inequality and infant health in the UK found an odds ratio
(OR) for low birthweight of 1.79 in the lowest compared with the highest social class.31 It is, therefore,
no surprise that many attempts to improve outcomes have concentrated on the most disadvantaged
populations. For example, the Healthy Baby programme in Manitoba, Canada, which was designed to
promote prenatal and perinatal health, comprised a targeted income supplement for low-income women
and educational and supportive groups for all mothers up to the infant’s first birthday. Evaluation of this
complex programme found that receipt of the prenatal benefit was associated with a reduction in
incidence of both low birthweight babies and preterm births.32
A recent systematic review of the effectiveness of antenatal care programmes for socially disadvantaged
and vulnerable women noted that antenatal care was generally thought to be an effective method of
improving pregnancy and birth outcomes, although the authors noted that many antenatal care practices
had not been subjected to rigorous evaluation.33 If receiving antenatal care is beneficial, then it is
reasonable to think that earlier uptake of antenatal care should be better than later uptake, as this will
allow more time for the beneficial effects of behaviour change to be realised.
The intervention
The intervention being evaluated is the Health in Pregnancy (HiP) grant. This was a universal, unconditional,
cash transfer of £190 for women in Great Britain and Northern Ireland reaching 25 weeks of pregnancy
if they had sought health advice from a doctor or midwife. The grant was introduced for women with a
due date on or after 6 April 2009 and subsequently withdrawn for women reaching the 25th week of
pregnancy on or after 1 January 2011.34 The payment was not taxable and was disregarded for the purpose
of means-tested benefits. Claim forms were available from the doctor or midwife; the health professional
completed their section of the form, leaving the claimant to complete her part and return the form.
The HiP grant was designed to provide additional financial support in the last months of pregnancy
towards a healthy lifestyle (e.g. in terms of diet), and it was suggested that the link to the requirement
for pregnant women to seek health advice from a health professional may have provided an incentive for
expectant mothers to seek the recommended health advice at the appropriate time.
The grant was paid by Her Majesty’s Revenue and Customs (HMRC) on receipt of a claim form partly
completed by the midwife or doctor. Payment was made directly into a bank account, with a telephone
helpline available to provide support through the claims process, including options for payment in the
event of difficulties opening a bank account. Take-up of the grant was said to be at about the same level
as for child benefit (92%; HMRC, 2011, personal communication). Advice was offered as normal by
doctors and midwives. Payment was made and administration undertaken by HMRC. The cost of the grant
was met by the Treasury.
Rationale for the study
The HiP grant represented an attempt to influence behaviour – appropriate and timely receipt of antenatal
care and advice – by means of a relatively modest, universally applied cash transfer. The evaluation of the
effect of such a payment may inform other policy aiming to change behaviour. A study evaluating payments
to influence health behaviour found that financial incentives were effective in increasing infrequent
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behaviours such as attending clinic appointments, particularly in low-income groups, and recommended
payments as being more effective than information and less restrictive than legislation.35 In general,
financial incentives have been shown to be a successful means of promoting behaviour change in general
populations.36 More recently, financial incentives have been shown to be effective in smoking cessation
among pregnant women.37 Among the general population, however, there is a suggestion of some mistrust
of financial incentives as a means of promoting healthy behaviour.38
The evaluation was restricted to Scotland based on the use of routinely collected data for the following
reasons. First, data are available at a national level for the approximately 56,000 deliveries per year. Second,
the coverage, completeness and quality of the data are considered to be very high. Third, the concentration
of deprivation within parts of Scotland is unique within the UK. For example, 6 of the 10 most deprived
electoral constituencies in the UK are in Scotland,39 and using a UK-wide Cartstairs index Scotland’s
population is over-represented in the bottom five deciles compared with England.40 If the programme was
more beneficial to disadvantaged women, then the higher proportion of such women in Scotland than in
the rest of the UK should make it easier to detect such a subgroup effect. Fourth, data on smoking at
booking (i.e. the first antenatal appointment with a health-care professional) have been routinely recorded
in Scotland for a number of years. This is not yet the case in England and Wales. Maternal discharge
forms in Scotland can be linked to National Records of Scotland (NRS) civil registration data, which provide
an estimate of completeness and also contribute further information such as social class.
In addition to the differences in terms of their deprivation profiles, England and Scotland differ markedly
in terms of the ethnic composition of the two countries. In the 2011 census, 14% of the population of
England and Wales described themselves as belonging to a non-white ethnic group41 compared with just
4% of the population of Scotland,42 and birthweight has been shown to vary markedly between the
different ethnic groups within England and Wales.43 Despite such differences, it is reasonable to believe
that the results of this study will be generalisable both to the rest of the UK and internationally. If the HiP
grant proved beneficial in Scotland, then there is every reason to believe that a similar impact on outcomes
could be achieved elsewhere, and certainly in countries with similar health systems and comparable
circumstances. Likewise, if the intervention was found to have been more effective for specific subgroups,
then it might be expected that similar subgroups would show greater benefits in other settings.
The nature of the HiP grant meant that there were potential risks and harms to the population. The HiP
grant was in the form of cash, which was given to the pregnant women with no constraint on what the
money was used for or spent on. However, economic theory would suggest that cash transfers are more
efficient than ‘vouchers’ or subsidies which try to target the expenditure in the direction of ‘appropriate
expenditure’. This is because vouchers, for example, free up disposable income if they displace
planned expenditure.
Socioeconomic position and inequalities
This study focuses on socioeconomic position not only through examination of the causes of ill health –
behavioural and biological factors, and the extent to which the socioeconomic patterning of these leads to
health inequalities – but also through the causes of the causes.44 Income is regarded as one marker of
social position that may impact on, enhance or constrain health behaviours, and this in turn may be
influenced by the wider policy context. A cash transfer such as this amounts to a change in material
circumstances, and to the poorest this may be a substantial and enabling change.
The use of Scottish routine data sources means that socioeconomic position and inequalities can be
assessed at both the individual and the area levels. The availability of both area-based deprivation and
individual social class data enable the identification of the relative importance of context and composition
and any interaction between individual- and area-level inequalities. This may, in turn, lead to the targeting
of any cash transfers to particular groups of areas or individuals. With the large numbers of data available,
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we have the power to examine the impact on different subgroups including the most deprived
socioeconomic groups. Subgroup analyses are conducted for those groups seen as having the greatest
potential to benefit from the payments, such as those living in the most deprived areas, those in the lowest
social classes, lone mothers, primiparous women and teen mothers. These groups have been identified as
having more adverse birth outcomes than the general population.30
Marital status is an important subgroup, as single mothers have consistently been shown to have poorer
birth outcomes.45 We are particularly interested in single mothers and social class. The father’s social
class is used when he is included on the birth certificate, and the mother’s social class is used if no father
is present. Social class for lone mothers is therefore an amalgamation of socioeconomic position and
lone parenthood.
Although the routinely collected data on ethnicity are incomplete and of dubious quality, ethnicity remains
important for birthweight and other neonatal outcomes.46 We shall, therefore, within the constraints of the
data, undertake all analyses on the subgroup of women from a (non-white) minority ethnic background.
These subgroup analyses may lead to conclusions regarding whether or not the reintroduction of a cash
transfer benefit universally or targeted at certain groups would help to reduce inequalities in birthweight
and other adverse perinatal events.
Research objectives
The objective of this work is to evaluate the clinical effectiveness and cost-effectiveness of the HiP grants in
Scotland. We do this by assessing the difference in birthweight between babies born to those mothers
who were eligible for the HiP grant, and babies born either before the HiP grants were introduced (women
delivering on or after 1 January 2004 and with a due date before 6 April 2009) or after it was withdrawn
(women reaching the 25th week of pregnancy on or after 1 January 2011 and delivering on or before
31 December 2013). Specific questions that we address are outlined below.
l Did the HiP grant result in a change in birthweight (our primary outcome measure) or any of a number
of secondary outcomes grouped as measures of maternal behaviour (gestation at booking, booking
before 25 weeks and maternal smoking during this pregnancy), measures of size [very low birthweight
(< 1500 g), low birthweight (< 2500 g), high birthweight (> 4000 g), crown-to-heel length and head
circumference], measures of stage [gestational age at delivery, preterm (< 37 weeks), very preterm
(< 32 weeks), weight for dates [standardised, SGA and large for gestational age (LGA)], and birth
outcomes (elective caesarean section, emergency caesarean section, stillbirths, neonatal deaths and
5-minute Apgar score)?
l Were there differential impacts of the intervention for particular subgroups defined by socioeconomic
(both area deprivation and individual occupational social class), demographic (marital status, age,
ethnicity) or obstetric (parity, maternal obesity, maternal diabetes mellitus) factors?
l Were the HiP grants cost-effective? What were their total aggregate health and cost consequences?
How did cost-effectiveness vary across important subgroups identified as having differential outcomes?
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Chapter 2 Methods
Outcomes and causal pathway
The primary outcome measure was birthweight. This is influenced by maternal nutrition, and one of the
intentions of the HiP grant was to improve this. There was also a range of secondary outcomes, which may
influence and be influenced by birthweight. Having a wide range of secondary outcomes is included in the
guidelines for evaluating natural experiments.47 The secondary outcomes for this evaluation were maternal
behaviour measures (gestation at booking, booking before 25 weeks and maternal smoking during
this pregnancy), measures of size [very low birthweight (< 1500 g), low birthweight (< 2500 g), high
birthweight (> 4000 g), crown-to-heel length and head circumference], measures of stage [gestational age
at delivery, preterm (< 37 weeks), very preterm (< 32 weeks), weight for dates (standardised, SGA and
LGA)], and birth outcomes (elective caesarean section, emergency caesarean section, stillbirths, neonatal
deaths and 5-minute Apgar score).
If maternal nutrition is seen as a key behaviour that could be influenced both through the antenatal advice
offered and through the money provided through the HiP grant, then we would expect to see changes
only in the outcomes that we were studying if there was evidence of a link between maternal nutrition
and birthweight and other outcomes. To be eligible for the HiP grant, women had to seek advice before
the 25th week of their pregnancy. Although there was nothing to stop women booking earlier in their
pregnancy, we might expect the group most impacted by the grant to be women who would normally
have booked later but were incentivised to bring forward their booking to shortly before 25 weeks.
For the intervention to work for such women, we would therefore need evidence that nutrition in the third
trimester could affect birthweight (as our primary outcome).
A recent review of dietary intake during pregnancy based on epidemiological studies and randomised
controlled trials suggested that there was evidence that maternal nutrition during the third trimester could
have an impact on birth outcomes.48 Adequate long-chain omega-3 polyunsaturated fatty acids are crucial
during the third trimester for fetal growth and the development of the nervous system,49 and a low
leucocyte zinc concentration in the third trimester is associated with low birthweight.50 Furthermore, a
meta-analysis indicated that maternal haemoglobin levels in the third trimester were associated with
birthweight, suggesting that iron is beneficial at this stage.51
An additional outcome of interest was maternal smoking. Maternal smoking is recorded at booking and
during pregnancy, and is known to be a modifiable risk factor with a large impact on birthweight.52–54
We wanted to examine the effect of the health advice given when receiving the HiP grant. This may have
had an impact on smoking during pregnancy rates, over and above that of the smoke-free legislation.
The smoking ban in public places was introduced in Scotland in March 2006.55
In the protocol we stated that models would be adjusted for maternal smoking. During the project,
following discussion of the causal pathway with the project steering group, we refined the logic model.
We decided that maternal smoking was something that could be affected by the antenatal care received
as part of the HiP intervention and, therefore, that models should not be adjusted for maternal smoking.
If the health advice given as part of the intervention reduced smoking, and models were then adjusted for
smoking, any effect of the intervention would be undetectable.
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Research design
Natural experiment using interrupted time series analysis
The HiP intervention was evaluated as a natural experiment using interrupted time series analysis.56,57
It was not possible to use a randomised or pseudo-randomised design for a number of reasons. The HiP
grant was available to all pregnant women over 25 weeks’ gestation so there was no control group.
The grant was introduced in April 2009 and withdrawn in January 2011 and was universal, so there was
no random allocation to the population. The interrupted time series approach allowed us to compare
an intervention group that received the HiP grant both with a comparison group of pregnant women
who delivered before the HiP grant was introduced and with a post-intervention group of women who
delivered after the HiP grant was withdrawn.
Outcomes before the introduction of the HiP grant in Scotland and immediately after its withdrawal were
compared with those during the period for which HiP existed. This interrupted time series approach
allowed adjustment for seasonality and temporal trends as well as for the sociodemographic and obstetric
characteristics of the mother. This adjustment for seasonality and temporal trends was important, as
birthweight (our primary outcome) is known to vary by month of birth (babies born in March, April and
May are heavier than those born in June, July and August) and, in addition, mean birthweight has been
increasing in Scotland.58
The Medical Research Council (MRC) has issued guidelines regarding the use of natural experiments to
evaluate population health interventions when exposure to the intervention has not been manipulated by
the researchers.47 The guidance advocates a number of designs including regression discontinuity designs
such as interrupted time series.
Interrupted time series can detect a discontinuity in the intercept and a discontinuity in the slope of
estimates during the intervention period compared with before the intervention period.59 The interrupted
time series design can describe the effect of the intervention on three dimensions: (1) the intercept and
slope; (2) the permanence of the effect; and (3) the immediacy of the effect. In terms of the HiP grant,
permanence was assumed during the period in which the HiP grant was in place, such that the effect of
HiP did not dilute over time, as everyone during that period was given the health advice and the £190
cash intervention. Once HiP was removed, the assumption was that any effect stopped. Sensitivity analyses
were carried out on nulliparous women to determine any carryover effect on those who had never
received advice or cash (see Strengthening the inference).
In order to conduct an analysis using interrupted time series, a well-defined interruption in the time series
is required, and it is recommended that there are at least eight data points in the time series before the
interruption and eight data points after the interruption. Other weaknesses include the inability to
determine whether or not any effects on the intercept or slope were attributable to something other than
the intervention which affected the outcome and which happened at the same time as the intervention;
if using routinely collected data, robust evaluation may be hampered by any changes to the data collection
method or coding of items, and a change in the composition of the group experiencing the intervention
compared with those who do not experience the intervention may make comparison difficult.
The HiP grant was introduced for all pregnant women over 25 weeks’ gestation from a fixed date,
meaning that there is a well-defined interruption in the time series of births in Scotland. Individual births
were used and the pre-intervention time period ran from 1 January 2004 to 30 March 2009. Our data
included month of birth, meaning that there were 63 time points (months) before the interruption; the
intervention period ran from 14 April 2009 to 7 April 2011 (25 time points) and the post-intervention
period ran from 23 April 2011 to 31 December 2013 (33 time points). Each of these is markedly greater
than the minimum recommendation of eight time points but these figures do not reflect the full power of
the study, which is achieved by using 525,400 individual observations (births; Figure 1). The routine data
used here have not been subject to any changes in the data collection method or coding, other than
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Singleton births from 1 January 2004 to 31 December 2013 (n = 544,701)
Observations excluded, n = 1025
Observations (n = 532,968)
Observations excluded, n = 5595
Singleton births (450–6500 g, 24–44 weeks) (n = 527,373)
Stillbirths excluded (n = 1973)
Observations (n = 527,373)
Statistical analysis for stillbirth and 
maternal smoking during pregnancy
525,400 observations for statistical analysis
Observations (n = 543,676)
Observations excluded, n = 124
Observations (n = 543,552)
Observations excluded, n = 2225
Observations (n = 541,327)
Observations excluded, n = 6175
Observations (n = 535,152)
Outliers excluded
according to Tukey’s
 3 IQR method, n = 2184
• Gestational age at delivery < gestational age at booking
   (gestational age at booking > 44 weeks recoded as missing)
• Gestational age at delivery = gestational age at booking
• Head circumference < 15 cm, n = 3065
• Crown-to-heel length < 20 cm, n = 425
• Maternal weight at booking < 20 kg, n = 31
• Maternal BMI < 12 and > 80 kg/m2, n = 88
• Baby’s sex missing, n = 44
• Outcome of the pregnancy missing, n = 1
• Missing data zones, n = 2050
• Missing health board of treatment, n = 2
• Gestational age at delivery missing, n = 84
• Birthweight missing, n = 385
• Birth weight, n = 190
• Head circumference, n = 708
• Crown-to-heel length, n = 555
• Maternal weight at booking, n = 679
• Maternal height, n = 298
Gestational age at delivery outside the range 24–44 weeks
2-week washout period
Births with weight outside range 450–6500 g across all
gestational ages at delivery were excluded
Implausible observations
Outliers
FIGURE 1 Flow chart showing observations received from the Information and Services Division, removal of outliers
and final sample size for analyses. BMI, body mass index; IQR, interquartile range.
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better (more complete) recording of each item. There have been changes in the composition of mothers
who gave birth during the intervention period compared with those who gave birth pre and post
intervention, but maternal social and obstetric factors were adjusted for in the analyses. However, one of
the potential weaknesses of the interrupted time series design, namely the inability to control for external
events that happen at the same time, is much harder to overcome. Sensitivity analyses were carried out
moving the HiP grant window to determine any changes in the effect of HiP on birthweight and other
secondary outcomes (see Strengthening the inference).
Study population including definitions of subgroups
The population under study was all births in Scotland between 1 January 2004 and 31 December 2013.
This was split into three distinct periods: the pre-intervention period, the intervention period during which
the HiP grant was in place and the post-intervention period. The grant was introduced for women with a
due date on or after 6 April 2009 and subsequently withdrawn for women reaching the 25th week of
pregnancy on or after 1 January 2011.34 Therefore, the HiP grant was effectively in place for all births with
a due date of delivery during the period 6 April 2009 to 15 April 2011.
In order to assign births to the correct study period, the estimated due date of delivery was calculated
from the gestational age at delivery and date of birth. Gestational age at delivery was recorded in weeks,
so there was a small loss of precision around the estimated due date of delivery. A washout period of
2 weeks around the start was chosen to ensure that births were assigned to the correct group. Births
1 week before the date on which the intervention was introduced and 1 week after the intervention
start date were excluded. A similar washout period of 1 week before the end date and 1 week after
the end date was used. The births occurring in the pre- and post-washout periods were excluded from the
analyses. Therefore, the dates for the three study periods were: pre-intervention period, 1 January 2004 to
30 March 2009; intervention period, 14 April 2009 to 7 April 2011; post-intervention period, 23 April
2011 to 31 December 2013 (Table 1).
This evaluation used pre-existing routinely collected health data. There was no recruitment, assessment or
follow-up of individuals to the study, as the information is already available in routinely collected data. The
Scottish maternity and neonatal database, a comprehensive record linkage system, was used.60 Probabilistic
linkage procedures are used to add a unique identifier to all data sets to ensure that all records relating to
an individual can be linked as required. It facilitates the linkage of a number of records from the system of
Scottish Morbidity Records (SMR), including the mother’s obstetric records (SMR02) and the baby’s birth
and neonatal information from Scottish Birth Records (SBR).61 Further links to the Stillbirth and Infant Death
Survey and the NRS birth, stillbirth and infant death records can be carried out.60 All births in Scotland are
required to be registered at NRS within 4 weeks, and 98% of these births are included in the Scottish
maternity and neonatal database. This link to NRS civil registration data provides an estimate of
completeness and contributes further information such as social class and marital status.
TABLE 1 Dates for the study periods and washout periods
Period Start date End date
Pre intervention 1 January 2004 30 March 2009
2-week washout 31 March 2009 13 April 2009
Intervention 14 April 2009 7 April 2011
2-week washout 8 April 2011 22 April 2011
Post intervention 23 April 2011 31 December 2013
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Socioeconomic position and inequalities were measured at both the individual and area level. The availability
of both area-based deprivation and individual social class allowed for the identification of the relative
importance of context and composition. Area deprivation was measured using the Scottish Index of Multiple
Deprivation (SIMD) 2009.62 The SIMD combines information across six domains: (1) income; (2) employment;
(3) health; (4) education; (5) housing; and (6) geographical access. It provides a comprehensive picture of
material deprivation in small areas within Scotland. The index ranks 6505 areas from the most deprived to
the least deprived and measures the degree of deprivation of an area relative to that of other areas. The
areas employed by the SIMD are data zones; each of the 6505 zones has a mean population of 780 people.
The reason for employing small-area geography at this scale is to permit identification of relatively small
pockets of deprivation. The health domain includes an indicator of the proportion of live singleton births of
low birthweight. Outcomes for this project are birthweight and low birthweight; therefore, it was not
appropriate to use the health domain or the composite index, which includes the health domain. The income
domain was used to assess inequalities at the area level. The income domain contains six indicators relating
to receipt of means-tested benefits and tax credits.
Individual socioeconomic position was measured using data from the birth registrations at NRS. NRS
collects occupation information for both fathers and mothers for births registered to married couples and
jointly registered by unmarried couples. For sole registered births only the mother’s occupation is recorded.
National Statistics Socioeconomic Classification (NS-SEC) was used to measure individual socioeconomic
position. The father’s social class is used when the father is included on the birth certificate and the
mother’s social class is used if no father is present.
The HiP grant was a universal benefit. We wanted to examine the impact of HiP on subgroups, as this may
lead to the targeting of any cash transfers to particular groups of areas or individuals. With the large numbers
of data available, there was power to examine the impact on different subgroups, including the most
deprived socioeconomic groups. Subgroup analyses were conducted for those groups seen as having the
greatest potential to benefit from the payments. The subgroups that we analysed were those groups
previously identified as having more adverse birth outcomes, specifically those living in the most deprived
areas (SIMD = 1), mothers who had never worked, working-class mothers (three-class collapsed version of
NS-SEC63), lone mothers, teen mothers (aged < 20 years), severely obese mothers [body mass index (BMI)
of ≥ 35 kg/m2], and mothers who had diabetes mellitus. We carried out further analyses on all SIMD quintiles
to look for evidence of a threshold effect of the HiP grant.
Marital status was an important subgroup, as single mothers have consistently been shown to have poorer
birth outcomes.45 We were particularly interested in the relationship between single mothers and social
class. Social class for lone mothers is an amalgamation of socioeconomic position and lone parenthood.
An increase in birthweight, although desirable at a population level, may not be a beneficial outcome if a
baby is already at risk of being LGA. Separate subgroup analyses were conducted for women seen to
be at high risk of delivering a LGA baby, namely women with a BMI of ≥ 35 kg/m2 and women with
diabetes mellitus.
A further key subgroup for birth outcomes was the ethnicity of the mother. In Scotland the routinely
collected data on ethnicity are incomplete and of dubious quality (56.5% missing over the period
2004–13). We carried out analyses of the primary and secondary outcomes on the subgroup of women
from a minority ethnic background. In practice, this was all non-white mothers who had their ethnicity
recorded on the birth record data. It was not possible to examine further distinctions within this non-white
ethnic group.
We hoped that these subgroup analyses would inform a discussion regarding the reintroduction of a cash
transfer benefit universally or its potential to be targeted at certain groups, thus reducing inequalities in
birthweight and other adverse perinatal events.
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Data
Ethics and information governance
The data came from the Scottish maternity and neonatal database held by the Information and Services
Division (ISD) at the NHS National Services Scotland. These data are routinely collected information from
maternal and birth records from all hospitals in Scotland. The release of the data for research purposes was
subject to agreement (6 May 2014; PAC38A/13) from the Privacy Advisory Committee at NHS National
Services Scotland and the Registrar General.64 This approval served as ethical approval to undertake the
research. The data collection, storage and release for research purposes were subject to strict ISD protocols
governing privacy, confidentiality and disclosure of data (www.isdscotland.org/Products-and-Services/Data-
Protection-and-Confidentiality) and, as such, the data cannot be shared by the researchers. The MRC/Chief
Scientist Office (CSO) Social and Public Health Science Unit, University of Glasgow was the nominated
sponsor of the research. The data provided by the ISD were anonymised, and access to the individual data
was restricted to three of the investigators (SO, RD and AL).
Structure of the data
Individual birth records were available for analysis in this study. Over the 10-year time period there were
multiple births to some mothers. Therefore, the structure of the data was multilevel; births were nested
within mothers and mothers were nested within small geographic areas known as data zones. It was
necessary to take this structure into account when calculating the power and effect sizes detectable for the
study and also during the analyses.
Power calculation
The data were clustered in small areas, that is, 6505 data zones. Each data zone has an average
population of 780. The sample size calculation takes this clustering into account. Assuming an average of
56,000 singleton live births per year, and allowing for the clustering within the 6505 data zones in
Scotland with an estimated intraclass correlation coefficient of 0.05, there was a power of 0.90 to detect
an effect of a 7-g change in birthweight at a 95% significance level. It was acknowledged that 7 g was
unlikely to be a clinically important threshold; rather, it was indicative of the power of the study. The large
data set available allowed for subgroup analysis. In the 20% most deprived areas there was a power of
0.80 to detect an effect of 13 g; among the 26% of single mothers, there was a power of 0.80 to detect
an effect of 11 g. To put these small effects into context, 50 g was the estimated mean birthweight
reduction reported in the meta-analysis of the effect of interventions in pregnancy on maternal and
obstetric outcomes.65 In terms of gains in birthweight a recent study showed a 70-g increase for every
10-mg/day increase in dietary iron intake (reducing to 34 g on adjustment for maternal factors).66
Outcome measures
The primary outcome measure, birthweight, had a completion rate of 99.9%. There was a high
completion rate (< 1.5% missing) for all outcome variables, with the exception of crown-to-heel length
(46.4% missing), head circumference (26.3% missing), gestational age at booking (15.4% missing) and
maternal smoking (8.9%).
Covariates
Birthweight can be affected by many obstetric and maternal characteristics, such as the sociodemographic
determinants of the baby and mother and medical risks of the current and previous pregnancies, as well as
the environmental and behavioural characteristics of the mother. (For the covariates used in this study,
see Table 4. Item non-response rates for each of the covariates by year are shown in Table 14.) The
missingness ranged from no missing values for the baby’s sex (although note that 44 cases with missing
sex were excluded; see Figure 1) to 83.3% for ethnicity in the year 2004. As marital status was poorly
recorded in the ISD maternity data, marital status from the linked NRS birth registration was used.
METHODS
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The linkage to the NRS birth records allowed for the measurement of individual social class. Occupational
social class as measured by NS-SEC was used as a measure of individual socioeconomic position. SIMD
2009 was used as a measure of area-based deprivation.
Removing outliers
A strength of using routinely collected data is the size of the sample available to analyse. However, a
drawback is that researchers are unable to return to the original data collector to check and edit implausible
values. There were issues with extreme values for some of the continuous variables such as maternal height
and weight. In order to ensure the quality of the data, two methods were used to identify implausible
values and outliers. Previously published values were used to identify completely implausible values for head
circumference, crown-to-heel length, maternal weight and maternal BMI,67,68 and Tukey’s method for
removing outliers was used.69 Tukey’s method identifies values above and below a certain fraction of the
interquartile range (IQR). The formulae used to identify the outliers in the data set were:
Values < (Quartile 1)− (3 × IQR). (1)
Values > (Quartile 3) + (3 × IQR). (2)
These cases were identified as outliers and removed from the data set (see Figure 1).
Imputation methods
Item non-response values were imputed using multiple imputation by chained equations (MICE). MICE uses
a series of univariate analyses to predict missing values. For each variable to be imputed, imputed values
are drawn from a conditional distribution based on univariate regression models. This process is repeated
multiple times using previously estimated values and converges to a stable multivariate solution. The multiple
imputation commands within Stata (StataCorp LP, College Station, TX, USA) version 13 were used.70
The variables used in the imputation model to predict the missing values were: health board of residence;
health board of treatment; birthweight; head circumference; gestational age at booking; gestational age at
delivery; maternal age; maternal weight at booking; maternal height; parity; SIMD; primary household SES;
ethnicity; marital status; maternal smoking during pregnancy; maternal smoking at booking; diabetes
mellitus; 5-minute Apgar score; mode of delivery; outcome of the pregnancy; sex; birth year; birth month;
and study period (pre intervention, intervention, post intervention).
Before being used in the imputation model, continuous variables were transformed using the lnskew0
command in Stata. The transformations were ln( – x – k) if x was negatively skewed and ln(x – k) if x was
positively skewed.71
Owing to the large proportion of missing values, ethnicity was not used in the imputation model and
missing values for ethnicity were not imputed. Given that a high proportion of values were missing for
crown-to-heel length (46.4%), we also chose not to impute these data. The clustering of births within
mothers, data zones and health board was ignored when creating the imputed data sets. Instead of using
the hierarchical structure of the data – births nested within mothers nested within data zones nested
within health board – health board of hospital of birth and health board of residence of mother were used
in the imputation model as fixed effect parameters. The variable included in the imputation that had the
most missing values over the study period (2004–13) was head circumference, with 26.3% missing.
Therefore, 30 imputed data sets were created, in line with recommendations.72 Although there are no
strict rules regarding the circumstances under which multiple imputation should be conducted, we felt that
it was reasonable to impute just over one-quarter of the data for this one variable given the large number
of covariates available on which to base our imputation. These data sets were analysed identically and the
results were combined to get estimates and standard errors for the multiple imputed data. These results
were compared with the complete-case analysis results.
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Numbers of observations used in analyses
The data set from ISD contained all singleton births in Scotland with a date of birth between 1 January 2004
and 31 December 2013. For this analysis, only births between 24 and 44 weeks’ gestation were included.
Figure 1 details how observations were removed. The initial population size was 543,676 births (24–44 weeks’
gestation). There were exclusions attributable to impossible-to-resolve gestational age at booking and
gestational age at delivery, implausible values and outliers. Births with an expected date of delivery before
1 January 2004 and after 31 December 2013, and births during the washout period around the intervention
introduction and withdrawal dates were also removed. Overall, 18,276 (3.4%) cases were removed from the
data set sent by ISD. The final sample available for analyses was 525,400.
For the subgroup analyses the size of the data sets are shown in Tables 2 and 3. The sample sizes are
shown for the complete cases and also the sizes for the imputed data sets. There were a range of values
for five subgroups and one strengthening the inference group. These were mothers with diabetes mellitus,
severely obese mothers, lone mothers, mothers in working-class households, mothers in never-worked
households and nulliparous mothers. This was due to missing values for these variables and, therefore,
they were imputed, sometimes as being in the category concerned and sometimes not. The sample sizes
range from just over 8000 in the diabetes mellitus subgroup to > 180,000 mothers in working-class
households. There were over 240,000 births in the nulliparous group.
Statistical analysis
It is possible that harm may have occurred as a result of the cash transfer. The £190 was given as money
to the pregnant women with no restriction on how it should be spent, and we do not know what the
money was spent on. The aim was to examine how the intervention group differed from the comparison
groups; birthweight could have reduced or increased. We carried out two-sided hypothesis tests to ensure
that potentially harmful effects could be detected.
TABLE 2 Sample sizes for subgroup analyses
Imputed
Numbersa
TotalPre intervention Intervention Post intervention
Main population 271,826 109,366 144,208 525,400
SIMD1 69,975 28,669 38,004 136,648
SIMD2 55,685 23,127 30,788 109,600
SIMD3 50,328 20,738 27,624 98,690
SIMD4 48,680 19,421 25,207 93,308
SIMD5 47,158 17,411 22,585 87,154
Mothers with diabetes mellitus 3170–3331 1713–1748 3448–3481 8361–8529
Severely obese mothers 19,216–19,612 9027–9175 12,879–13,039 41,249–41,739
Lone mothers 15,978–16,040 5881–5929 7255–7284 29,147–29,214
Working class 94,468–94,644 37,598–37,661 49,480–49,593 181,635–181,827
Never worked class 41,612–41,701 17,423–17,457 23,309–23,366 82,398–82,501
Teen mothers 20,764 7364 7821 35,949
Nulliparous 126,843–126,963 51,705–51,747 65,336–65,379 243,921–244,048
After smoking ban (main population) 122,012 109,775 144,663 375,093
METHODS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
12
TABLE 2 Sample sizes for subgroup analyses (continued )
Imputed
Numbersa
TotalPre intervention Intervention Post intervention
Complete cases
SIMD1 69,975 28,669 38,004 136,648
SIMD2 55,685 23,127 30,788 109,600
SIMD3 50,328 20,738 27,624 98,690
SIMD4 48,680 19,421 25,207 93,308
SIMD5 47,158 17,411 22,585 87,154
Mothers with diabetes mellitus 2422 1664 3390 7476
Severely obese mothers 11,539 7208 10,852 29,599
Lone mothers 15,546 5824 7200 28,570
Working class 92,067 37,181 48,694 177,942
Never worked class 40,471 17,216 22,932 80,619
Teen mothers 20,764 7364 7821 35,949
Nulliparous 126,005 51,392 65,198 242,595
Non-white mothers 4810 4631 7694 17,135
a The numbers relate to the following outcomes: birthweight; low birthweight; high birthweight; gestational age at
booking; booking before 25 weeks; gestational age at delivery; preterm; very preterm; weight-for-dates z-score;
SGA; LGA; head circumference; crown-to-heel length; elective caesarean; emergency caesarean; 5-minute Apgar score;
neonatal death.
Note
Stillbirths were not included when analysing the above outcomes.
TABLE 3 Sample sizes for subgroup analyses
Imputed
Numbersa
TotalPre intervention Intervention Post intervention
Main population 272,935 109,775 144,663 527373
SIMD1 70,344 28,793 38,139 137,276
SIMD2 55,929 23,220 30,882 110,031
SIMD3 50,525 20,829 27,710 99,064
SIMD4 48,845 19,478 25,280 93,603
SIMD5 47,292 17,455 22,652 87,399
Mothers with diabetes mellitus 3199–3366 1725–1760 3471–3504 8428–8597
Severely obese mothers 19,341–19,739 9091–9239 12,954–13,115 41,522–42,014
Lone mothers 15,978–17,144 5881–6,332 7255–7732 29,153–31,178
Working class 94,683–95,610 37,629–37,982 49,591–49,944 181,903–183,536
Never work class 41,638–42,623 17,454–17,792 23,331–23,704 82,445–84,119
Teen mothers 20,864 7393 7849 36,106
Nulliparous 126,556 51,604 65,447 243,607
After smoking ban (main population) 122,012 109,775 144,663 376,450
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The main statistical design used was interrupted time series.59 Interrupted time series can detect whether
or not the intervention has an effect over and above the underlying temporal trend; it detects whether or
not the effect size (slope) changes after the intervention has been introduced. The use of interrupted time
series overcomes other biases such as autocorrelation of repeated measurements (measurements taken
close together are related), seasonal effects (birthweight varies according to month of birth), the duration
of the intervention (pre-intervention, intervention and post-intervention comparisons) and random variation
of the measurement (birthweight).
Outcomes were measured on individual births, which were nested within mothers, with mothers
themselves clustered within data zones. Multilevel models were used to determine whether or not the
outcomes changed during the intervention period in which the HiP grants were in effect. Multilevel linear
regression was used for continuous outcomes (birthweight, gestation at booking, gestational age at
delivery, weight-for-dates). Multilevel logistic regression was used when the outcome was dichotomous
[booking before 25 weeks, maternal smoking during pregnancy, stillbirths, neonatal deaths, very low
birthweight (< 1500 g), low birthweight (< 2500 g) and high birthweight (> 4000 g), preterm (< 36 weeks),
very preterm (< 32 weeks), SGA and LGA, elective caesarean section, emergency caesarean section and
5-minute Apgar score of < 7]. Two-level models with births nested within data zones were fitted for the
following outcomes: very low birthweight, very preterm, stillbirth and neonatal deaths (Table 4), as the
three-level model, which included a level for mothers nested within data zones, did not converge owing to
the sparseness of the data (few, and often just one, births per woman).
All analyses were adjusted for temporal trends and seasonal variations in outcomes as well as for maternal
age, sex of baby, gestational age at delivery, parity, mode of delivery, marital status, maternal height,
maternal BMI, maternal diabetes mellitus, social class and area deprivation. Table 4 details the exact
covariates included in the model for birthweight and all secondary outcomes. (Note that not all covariates
were included in each model.) In the protocol, it was stated that adjustments would also be made for
TABLE 3 Sample sizes for subgroup analyses (continued )
Imputed
Numbersa
TotalPre intervention Intervention Post intervention
Complete cases
SIMD1 70,344 28,793 38,139 137,276
SIMD2 55,929 23,220 30,882 110,031
SIMD3 50,525 20,829 27,710 99,064
SIMD4 48,845 19,478 25,280 93,603
SIMD5 47,292 17,455 22,652 87,399
Mothers with diabetes mellitus 2446 1675 3410 7531
Severely obese mothers 11,617 7260 10,914 29,791
Lone mothers 15,546 5824 7200 28,570
Working class 92,070 37,181 48,695 177,946
Never worked class 40,471 17,217 22,932 80,620
Teen mothers 20,864 7393 7849 36,106
Nulliparous 127,399–127,516 51,917–51,959 65,585–65,629 243,607
Non-white mothers 4838 4655 7726 17,219
a The numbers relate to the following outcomes: stillbirth, maternal smoking.
Note
Stillbirths were included when analysing the above outcomes.
METHODS
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TABLE 4 Main models specification (unadjusted for gestational age at booking and maternal smoking)
Covariates
Birthweighta Booking status Measures of stage
Measures
of size Other birth outcomes
Maternal
smoking
during
pregnancyBW LBW
Very
LBW HBW GB Bb425W GD Preterm
Very
preterm z-score SGA LGA HC CHL
MD
SB 5 ApS NDElC EmC
Periods ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗
Period 1: pre
intervention
Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref
Period 2:
intervention (HiP grant)
Period 3: post
intervention
Year ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗
Interaction year period ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗
Period 1
Period 2
Period 3
Months ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗
January Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref
February
March
April
May
June
July
August
September
October
November
December
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TABLE 4 Main models specification (unadjusted for gestational age at booking and maternal smoking) (continued )
Covariates
Birthweighta Booking status Measures of stage
Measures
of size Other birth outcomes
Maternal
smoking
during
pregnancyBW LBW
Very
LBW HBW GB Bb425W GD Preterm
Very
preterm z-score SGA LGA HC CHL
MD
SB 5 ApS NDElC EmC
Sex ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗
Male Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref
Female
Gestational age at
delivery (weeks) ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗
Quadratic term
gestational age at
delivery (weeks) ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗
Birthweight (g) ✗ ✗ ✗ ✗
Quadratic term
birthweight (g) ✗ ✗ ✗
Modes of delivery ✗ ✗
Vaginal Ref Ref
Elective caesarean
Emergency caesarean
Age (years) group ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗
< 20 Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref
20–24
25–29
30–34
35–39
≥ 40
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Covariates
Birthweighta Booking status Measures of stage
Measures
of size Other birth outcomes
Maternal
smoking
during
pregnancyBW LBW
Very
LBW HBW GB Bb425W GD Preterm
Very
preterm z-score SGA LGA HC CHL
MD
SB 5 ApS NDElC EmC
BMI at booking
(kg/m2) ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗
Quadratic term BMI
at booking (kg/m2) ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗
Height (cm) ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗
Quadratic term
height (cm) ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗
Ethnic groupsa ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗
Non-white Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref
White
Parity ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗
0 Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref
1
2
3+
Marital status ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗
Married to each other Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref
Joint registration: same
address
Joint registration:
different address
Sole registration
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TABLE 4 Main models specification (unadjusted for gestational age at booking and maternal smoking) (continued )
Covariates
Birthweighta Booking status Measures of stage
Measures
of size Other birth outcomes
Maternal
smoking
during
pregnancyBW LBW
Very
LBW HBW GB Bb425W GD Preterm
Very
preterm z-score SGA LGA HC CHL
MD
SB 5 ApS NDElC EmC
Primary household
social classes ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗
Managerial and
professional
Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref
Intermediate
Working
Never worked/
long-term unemployed
Diabetes mellitus ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗
No Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref
Yes
Income domains of
the SIMD ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗
1: most deprived Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref
2
3
4
5: least deprived
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Covariates
Birthweighta Booking status Measures of stage
Measures
of size Other birth outcomes
Maternal
smoking
during
pregnancyBW LBW
Very
LBW HBW GB Bb425W GD Preterm
Very
preterm z-score SGA LGA HC CHL
MD
SB 5 ApS NDElC EmC
Previous caesarean
section
No ✗ ✗
Yes Ref Ref
Statistical models
Three-level linear
regression (area,
maternal and
baby level)
+ + + + + +
Three-level binomial logistic
regression (area, maternal and
baby level)
+ + + + + + + + + +
Two-level binomial logistic
regression (area and baby level)
+ + + +
✗, variables considered for adjustment in the statistical analysis; +, statistical models; 5 ApS, 5-minutes Apgar score; Bb425W, booking before 25 weeks; BW, birthweight; CHL, crown-to-heel
length; ElC, elective caesarean; EmC emergency caesarean; GB, gestational age at booking; GD, gestational age at delivery; HBW, high birthweight; HC, head circumference; LBW, low
birthweight; MD, mode of delivery; ND, neonatal death; Ref, reference; SB, stillbirth.
a Complete cases adjusted for ethnicity.
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maternal smoking. However, this was not done owing to the intention of the intervention to have a
potential effect on maternal behaviour such as maternal smoking (see Outcomes and causal pathway). In
order to comply with the protocol, results are presented for both adjusting and not adjusting for maternal
smoking. Temporal trends were assessed by the inclusion of time (year and month) terms in the model,
and seasonal variations were assessed by the inclusion of month as a fixed effect. Departures from a linear
trend were assessed using quadratic terms in addition to linear terms for maternal height, maternal BMI,
gestational age and birthweight when used as a covariate and categories for maternal age. Quadratic
terms were assessed in the models for each outcome and tested for significance using the complete cases.
The best fit for each outcome was chosen and that model was used for all other models for that outcome.
Table 4 details which models had quadratic terms included for maternal height, maternal BMI, gestational
age at delivery and birthweight.
The simplest model for the intervention effect included a dummy variable ‘intervention period’ with three
categories (pre intervention, intervention and post intervention), with adjustment for relevant factors
(see Table 4). To assess whether or not the temporal trend was constant across the three different periods,
an interaction between the intervention period and year was fitted for each outcome.
The modelling strategy was to fit a series of increasingly complex models for each outcome. The first
model was a null model containing the outcome and a constant. Models with two or three levels were
fitted according to whether or not the models converged (Table 4). Then, a model including the relevant
covariates was fitted and, finally, a model including all relevant covariates and the interaction between
period and year was fitted. If the interaction was significant, then that model was chosen; if the interaction
was not significant, then the model without the interaction was chosen. This strategy was followed using
the complete cases and once the final model (including interaction or not) was selected, that model was
used to fit all subsequent models for that outcome, including the subgroups and moving window analyses.
In order to make the results for period interpretable when the interaction was significant, two separate
models were fitted.
Fitting interaction models
To estimate the effect for the intervention period, the variable year was centred around 2010 (i.e. coded
from –6 in 2004 to +3 in 2013). Using the variables period_1 (pre intervention: 1, yes; 0, no), period_2
(intervention: 1, yes; 0, no) and period_3 (post intervention: 1, yes; 0, no), the interactions were created as
follows (model M1):
int_1 = period_1 × year
int_2 = period_2 × year
int_3 = period_3 × year.
To estimate the effect for the post-intervention period (period_3), year was centred around 2012 and the
interactions were created as follows (model M2):
int_1 = period_1 × (year − 2)
int_2 = period_2 × (year − 2)
int_3 = period_3 × (year − 2).
In each case the model contained an intercept, period_2, period_3, int_1, int_2 and int_3 in addition to
the other variables. Identical estimates of int_1, int_2 and int_3 (and all other variables) were obtained
under both models; only the estimates of the intercept, period_2 and period_3 differed.
The interpretation of period_2 is then the effect of the intervention in the middle of the intervention
period compared with the outcome that would have been expected had the pre-intervention trend
continued. Similarly, the interpretation of period_3 is the post-intervention effect, measured in the middle
of the post-intervention period, compared with the effect that would have been expected had the
pre-intervention trend continued.
METHODS
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Subgroup analyses
Subgroup analyses were conducted for those groups seen to have the greatest potential to benefit from
the payments, namely those living in the most deprived areas, those in the ‘never worked’ social class
group, those in the ‘manual worker’ social class group, lone mothers, teen mothers, and those mothers for
whom an increase in mean birthweight was not desirable, namely severely obese mothers and mothers
with diabetes mellitus. For each group the main analysis was replicated, and the results from the combined
analysis of the 30 imputed data sets are reported.
Given that some subgroups contained small numbers, and bearing in mind the potential importance of the
intervention, the results of all subgroup analyses are reported rather than just those that reached statistical
significance. The above process involved conducting many tests which are not independent of each other.
Rather than adjusting confidence intervals (CIs) or p-values to account for this, the results of all analyses are
presented, and caution should be exercised when interpreting results that are close to conventional
statistical significance. Readers should use the width of the CI, which shows the range of possible effect
sizes, to aid their interpretation.
Ethnicity
Ethnicity was poorly recorded in the routine data set, with 56.5% of data missing over the 10-year period.
Missingness varied across the years; 83.3% of data were missing in 2004 and 23.6% in 2013. Ethnicity
was not imputed and was not included in the main analyses. In order to gauge the effect of ethnicity on
the HiP grant intervention, analyses were carried out on the subgroup of non-white mothers identified in
the data set. In addition, the models for the complete cases were fitted to include ethnicity along with
other covariates.
Economic analysis
The objective of the economic analysis was to assess the total aggregate health and cost consequences
attributable to the HiP grant during its years of implementation (April 2009 to April 2011) from the
perspective of the NHS. The pre-intervention years (January 2004 to March 2009) served as the comparison.
Health and cost consequences were mediated through either a birthweight or a gestational age at birth
perspective, in addition to smoking during pregnancy. Birthweight was categorised as very low (< 1500 g),
low (1500–2499 g) or normal (> 2500 g). Gestational age at birth was categorised as very preterm
(< 33 weeks), preterm (33–36 weeks) or normal (> 36 weeks).
All costs are presented in 2015 Great British pounds using the Hospital and Community Health Services
index73 to adjust, where necessary. No discounting was used.
Model overview
Figure 2 presents the conceptual analysis approach. We presented the health and cost change during
the intervention period compared with during the pre-intervention period. The model is based on the
incremental numbers of cases (of preterm, low birthweight or poor maternal outcomes) attributable
to the HiP grant. This can be explained in five steps:
1. estimate the baseline cases per annum during the pre-intervention period, apply to an intervention duration
2. apply the adjusted effect of the intervention
3. estimate the intervention period cases
4. estimate the total incremental cases during the entire intervention period
5. estimate the cost impact.
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Parameter sources
A summary of parameters used in the model is presented in Table 5.
Health outcomes
The incremental number of cases attributable to the HiP grant was derived from adjusted effect estimates
from the HiP grant analysis. The outputs of the HiP grant analysis included a number of dependent
variables, including each of the birthweight, gestational age and maternal smoking covariates that were
adjusted for a number of covariates (see Statistical analysis). In the main analysis using imputed data, the
HiP grant had no significant effect on very preterm (OR 1.11, 95% CI 0.98 to 1.25) and preterm (OR 1.02,
95% CI 0.97 to 1.08) births. The HiP grant also trended towards a reduction of very low birthweight
(OR 0.87, 95% CI 0.68 to 1.10) but had a negligible effect on low birthweight (OR 1.02, 95% CI 0.96 to
1.09). The HiP also had no effect on maternal smoking (OR 1.02, 95% CI 0.99 to 1.06). The effect of
maternal smoking on health was, in turn, mediated through a composite of ectopic pregnancy, placenta
previa, abruptio placentae, preterm premature rupture of membranes (PPROM) and pre-eclampsia.
TABLE 5 Parameters used in the model
Adjusted intervention effect Mean, OR SE, ln OR Source
Preterm 1.02 0.06 HiP
Very preterm 1.11 0.06 HiP
Smoking during pregnancy 1.02 0.02 HiP
Low birthweight 1.02 0.03 HiP
Very low birthweight 0.87 0.12 HiP
Baseline maternal smoking 23% HiP
Cost of HiP grant (£1 × 6) 20.422 HiP
Costs by gestational age Mean (£) SE (£) Source
Very preterm (< 33 weeks) 7591 363 74–76
Preterm (33–36 weeks) 2078 25 74–76
Normal (> 36 weeks) 893 3 74–76
Costs by birthweight Mean (£) SE (£) Source
Very low (< 1500 g) 6428 380 74–76
Low (1500–2499 g) 2138 36 74–76
Normal (> 2500 g) 905 3 74–76
Costs by maternal outcome Mean (£) SE (£) Source
Ectopic pregnancy 2083 417 74–76
Placenta previa 12,099 2420 74–76
Abruptio placentae 9139 1828 74–76
PPROM 4772 954 74–76
Pre-eclampsia 10,466 2093 74–76
ln OR, natural logarithm of the OR; PPROM, preterm premature rupture of membranes; SE, standard error; £, 2015 Great
British pounds.
Number of 
cases/year
Baseline Relative effect Absolute effect
Number of 
cases/year
Incremental
cases
Cost
OR Total cost
FIGURE 2 Conceptual analysis approach.
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Cost parameters
Unit costs by gestational age, birthweight and maternal outcomes were derived from a re-analysis of
the Oxford Record Linkage Study75 and NHS Reference Costs,76 which were summarised in a report by
Godfrey et al.74 on smoking during pregnancy.
Because the cost of a preterm birth is a composite cost of different costs related to different gestational
ages, a weighted cost must be derived. In Godfrey et al.’s74 report, gestational age was categorised as
20–23 weeks; 24–27 weeks; 28–31 weeks; 32–36 weeks; or 37+ weeks (Table 6). Each cost by gestational
age was then weighted by the estimates of prevalence in the HiP pre-intervention period to derive weighted
estimates of very preterm (< 33 weeks), preterm (33–36 weeks) and normal (> 36 weeks). Note that very
preterm consisted of the categories including 28–31 weeks and preterm consisted of 32–36 weeks.
The total weighted index hospitalisation cost of a preterm birth was £2801 (Table 6), whereas the cost of a
birth at normal gestational age was estimated to be £893.
Similar methods were used to generate unit costs for birthweight (Table 7). The weighted costs of very low
birthweight (< 1500 g), low birthweight (1500–2499 g) and normal birthweight (> 2500 g) were £6428,
£2138 and £905, respectively.
Smoking during pregnancy costs were estimated by taking account of their attributable effects on negative
pregnancy outcomes. Smoking during pregnancy increases the risks of poor maternal outcomes, such as
ectopic pregnancy, placenta previa, abruptio placentae, PPROM and pre-eclampsia.74 The unit costs of each
are summarised in Table 5.
The cost of the HiP grant used in the model was £20.422 million. It should be noted that this is a slight
underestimation of the true cost (£20.780 million); this reflects the fact that the annual number of births
TABLE 6 Cost of index hospitalisation by gestational age
Gestational age Mean (£) SE (£) n Weight Weighted cost (£)
20–23 weeks 1367 3024 0 0.00 0
24–27 weeks 7980 535 385 0.02 196
28–31 weeks 7501 130 1675 0.11 799
32–36 weeks 2078 15 13,655 0.87 1806
Total – – 15,715 1.00 2801
37+ weeks 893 2 256,111 1.00 893
SE, standard error; £, 2015 Great British pounds.
TABLE 7 Cost of index hospitalisation by birthweight
Birthweight Mean (£) SE (£) n Weight Weighted cost (£)
< 1000 g 6970 516 411 0.23 1618
1000–1499 g 6264 156 1360 0.77 4810
1500–1999 g 3506 63 2907 0.23 790
2000–2499 g 1741 14 9994 0.77 1349
Total weighted ‘very low birthweight’ – – 1771 1 6428
Total weighted ‘low birthweight’ – – 12,901 1 2138
> 2500 g 905 2 257,154 905
SE, standard error; £, 2015 Great British pounds.
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was increasing over the period but we use the number of births in the pre-intervention period, as we need
to be able to make a comparison to this time.
Analysis
Baseline cases were estimated assuming a constant rate throughout the pre-intervention period applied to a
duration of the HiP intervention years. Baseline risks were converted to odds in order to apply the HiP effect
estimate. The resultant effects were converted back to risks to estimate the absolute number of cases.
For maternal outcomes, the attributable risk and number of cases attributable to smoking were estimated
before applying an effect estimate of HiP on maternal smoking. The population attributable risk as a result
of smoking is estimated using the following equation:
E ⋅ (RR−1)
E ⋅ (RR−1) + 1
, (3)
where E = prevalence of smoking during pregnancy [23% (HiP study)] and RR = relative risk of the
outcome for smoking during pregnancy versus no smoking during pregnancy. The relative risks of ectopic
pregnancy, placenta previa, abruptio placentae, PPROM and pre-eclampsia were 1.89, 2.84, 2.62, 2.30
and 0.59, respectively, derived from Godfrey et al.’s report.74 The baseline prevalence for each pregnancy
was not measured in the HiP study. Therefore, Godfrey et al.’s74 estimates for England were scaled by the
Scottish population.
Uncertainty was incorporated using probabilistic sensitivity analysis and bootstrapping. The model was built
in Microsoft Excel® 2007 (Microsoft Corporation, Redmond, WA, USA).
Strengthening the inference
As the allocation of the intervention was not randomised and the intervention and control periods
occurred at different time points, pregnant women in the intervention and control groups could have been
subjected to different exposures. In particular, the timing of the introduction and withdrawal of the HiP
grant overlapped with other policies and interventions that may have had an impact on birthweight. Here,
we consider a number of factors that could have affected birth outcomes during the intervention period
that may not be attributable to the HiP grant.
Healthy Start is a means-tested voucher scheme for pregnant women and women with children under 4 years
of age.77 If the women are in receipt of certain benefits then they are eligible for free vitamins and vouchers
to be spent on liquid and formula milk and fruit and vegetables. This scheme replaced the means-tested parts
of the Welfare Food Scheme in the UK (including Scotland) in 2006 and is still currently in place.
We conducted sensitivity analyses to try to ascertain whether or not any observed effects could be attributed
to the HiP grant as opposed to Healthy Start or other such interventions. The basis for these sensitivity
analyses was the timing of the HiP intervention. This timing – of both introduction and withdrawal – was
well defined and fixed, and using the interrupted time series approach enabled us to estimate any effects
associated with this intervention window and ascribe those to HiP grants. The HiP intervention window was
defined by two parameters, namely the start date and the duration. We repeatedly varied these parameters –
effectively changing the start and end dates of the HiP intervention window – to examine the extent to
which the effects that we found were dependent on the dates. If the strongest ‘intervention’ effect coincided
with the dates during which the HiP grant was in place, then we could be more confident that the effect
was associated with the HiP grants rather than another intervention with a slightly different timeline. For
the strengthening the inference sensitivity analysis, we therefore varied both the start date and duration; five
different start dates and three different durations were chosen, giving 15 different potential ‘intervention’
windows (note that one of these windows was the actual HiP window). We expected to find a dilution of
any effects of the HiP grant when the intervention window was moved.
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Table 8 shows the start and end dates for each of the moving window or potential ‘intervention’ periods
considered. In order to mimic the main analyses, there was a 2-week washout period applied to all dates
so the actual date used to calculate the end of the pre-intervention period was 1 week before the start
dates shown in Table 8; the start of the intervention period was 1 week after the start dates, the end of
the intervention period is 1 week before the end dates, and the start of the post-intervention period was
1 week after the end dates.
A further piece of legislation that may have affected birthweight was the introduction of the smoking
ban in public places in Scotland in March 2006. This may have had an effect on the level of smoking in
pregnant women and, therefore, may have affected the rate of change of birthweight of babies born after
this time. We carried out a further analysis using 1 January 2007 to 1 April 2009 as the pre-intervention
HiP grant period. This time period was chosen to ensure that pregnancies in the pre-intervention period
were all after the smoking ban had come into effect.
The effect of the HiP grant on birthweight and other secondary outcomes might have had a carryover
effect after the withdrawal of the programme. In other words, post intervention, the trend in birthweight
might not return to the same rate as pre intervention. This contamination could be attributable to women
who gave birth during the intervention subsequently having a birth post intervention but still heeding the
health advice given during their first pregnancy. An additional analysis using only the subgroup of
primiparous women was carried out to avoid such contamination.
In 2009 there was an outbreak of swine flu (influenza virus A/H1N1pdm09) in Scotland (and the UK).
Pregnant women were adversely affected by this virus, resulting in poorer perinatal outcomes.78 There
were two outbreak periods, July 2009 and October–November 2009. To try to take this into account,
a further analyses removing births from 1 July 2009 to 30 November 2009 in the intervention period was
carried out.
TABLE 8 Start and end dates for moving window periods
Time period
Duration
18 months 24 monthsa 30 months
Actual HiP
Start date 6 April 2009 6 April 2009 6 April 2009
End date 6 October 2010 15 April 2011 6 October 2011
12 months before
Start date 6 April 2008 6 April 2008 6 April 2008
End date 6 October 2009 15 April 2010 6 October 2010
6 months before
Start date 6 October 2008 6 October 2008 6 October 2008
End date 6 April 2010 15 October 2010 6 April 2011
6 months after
Start date 6 October 2009 6 October 2009 6 October 2009
End date 6 April 2011 15 October 2011 6 April 2012
12 months after
Start date 6 April 2010 6 April 2010 6 April 2010
End date 6 October 2011 15 April 2012 6 October 2012
a This is a 2-year + 1-week period in all cases. The actual HiP grant was in place for 2 years and 1 week, so the same
length of time was chosen for all the moving window periods to mirror the main results.
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Models fitted and interpretation
Models fitted
For birthweight, gestational age at booking, booking before 25 weeks, preterm delivery, very preterm
delivery, and neonatal death there was a main analysis, 12 subgroup analyses and 17 analyses designed
to strengthen inference. For other outcomes, there was a main analysis, 12 subgroup analyses and two
analyses strengthening the inference. Within that framework multiple imputation was used to account
for missing data. Models were fitted using the complete cases and using the combined results from the
30 imputation models. The results of complete-case analysis and multiple imputations were compared.
There was also the change from the protocol of not adjusting for maternal smoking. Models were fitted
both adjusting and not adjusting for maternal smoking and these results were compared. We detail below
the models that are presented for each of the main analyses and subgroup analyses.
For the main analyses four different models are reported: (1) complete cases not adjusting for maternal
smoking; (2) imputed not adjusting for maternal smoking; (3) complete cases adjusting for maternal
smoking; and (4) imputed adjusting for maternal smoking.
For the subgroup analyses, only the models using imputed data and not adjusting for maternal smoking
are reported.
For the strengthening the inference analyses, only the models using imputed data and not adjusting for
maternal smoking are reported.
For the ethnicity analyses, only the models using complete cases and not adjusting for maternal smoking
are reported.
Interpretation
The results are displayed in two different ways depending on whether or not the interaction between year
and period (pre intervention, intervention and post intervention) was significant.
The models with no interaction showed the main effects of the intervention and post-intervention periods
compared with the pre-intervention period, over and above the overall trend over time. The trend was
fitted using the year of birth as a continuous variable.
The models with a significant interaction showed the main effects of the intervention and post-intervention
periods compared with the pre-intervention period. This time the trend was not consistent over time, but
different for each period. There were three trends shown, one for each period.
Changes from the protocol
Not adjusting for maternal smoking or gestational age at booking
In the protocol we stated that models would be adjusted for maternal smoking and gestational age at
booking. During the project, following discussion of the causal pathway with the project steering group,
we refined the logic model. We decided that both maternal smoking and gestational age at booking were
behaviours that could be affected by the HiP intervention. Therefore, models should not be adjusted for
maternal smoking or gestational age at booking. If the health advice given as part of the intervention
reduced smoking and then models were adjusted for smoking, any effect of the intervention would be
undetectable. The same is true for gestational age at booking.
Not using health board and data zone clustering in the imputation model
In the protocol, it was stated that a joint modelling approach to account for the clustering within data
zones and health boards would be undertaken. It was not possible to use this approach, as the size
(525,400 observations) and the structure (four levels of nesting) of the data set meant the models would
take too long to run and thus threaten the completion of the project within the timescale. In practice,
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the clustering of births within mothers, data zones and health board was ignored when creating the
imputed data sets. Instead of using the hierarchical structure of the data, that is, births nested within
mothers nested within data zones nested within health board, health board of hospital of birth and health
board of residence of mother were used in the imputation model as fixed-effect parameters. It is unlikely
that this approach would have had a major influence on the size and direction of the effect of the HiP
grant on birthweight or other secondary outcomes.
Spontaneous delivery
In the protocol, it was stated that mode of delivery would be used to identify spontaneous preterm births
and induced preterm births. Mode of delivery was of interest, because a potential reason for induced
preterm births was evidence of poor fetal growth; a proportion of these babies would become more
severely growth retarded (more extreme SGA) or stillborn. The protocol specified that an analysis of
preterm births stratified by mode of delivery and according to whether the birth was induced or
spontaneous would be carried out. This was not done, as the data available from ISD were not able to
distinguish the categories of induced or spontaneous birth.
Ethnicity breakdown into further ethnic groups
In the protocol, we said that the possibility of further distinction between ethnic groups would be
examined. This was not done, as the variable from ISD was categorised only as ‘white’ and ‘non-white’.
The ethnicity variable was incomplete, as only 43.5% of the observations included information on ethnicity.
Fitting interactions between subgroup and intervention
In the protocol, it was stated that before carrying out specific subgroup analysis, interaction terms would
be used to identify differential effects (e.g. an assessment of whether or not there was a differential effect
of the intervention for single women would involve a test of the significance of the interaction between
marital status and the intervention effect). In practice, the models took a long time to run (each outcome
required 31 models to be fitted and took 3–4 days). It was decided that all the subgroup analyses would
be run as specified in the protocol, whether or not any differential effects existed. This means that all
results are presented.
Combinations of subgroups
In the protocol, it was stated that subgroup analyses would be conducted for selected combinations of
those groups seen as having the greatest potential to benefit from the HiP grant. As there was little
difference in effect size and significance from the main results, and little difference between the subgroups,
no combinations were selected to be analysed.
Not adjusting for gestational age at delivery in models with caesarean section
as outcomes
In the protocol’s statistical analysis plan it was stated that gestational age at delivery would be included in
the models for outcomes emergency caesarean section and elective caesarean section. In practice, it was
not possible to adjust for gestational age, as there was a strong association between births at early
gestational age and emergency caesarean section (Table 9) and between births at late gestational age and
elective caesarean section.
TABLE 9 Proportion of preterm (< 37 weeks’ gestation) births by mode of delivery
Mode of delivery, n (%)
Preterm (< 37 weeks)
No Yes
Vaginal 373,184 (95.6) 17,235 (4.4)
Elective caesarean 52,784 (95.3) 2575 (4.7)
Emergency caesarean 69,596 (87.6) 9886 (12.4)
Missing 133 7
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Chapter 3 Results
Description of outcomes and covariates
Summary statistics for all outcomes by year are presented in Tables 10–13. In the main analysis, the mean
birthweight for live singleton births was 3418 g. Of live singleton births, 0.63% were low birthweight, 5.65%
were preterm and 4.89% were SGA babies (Table 10). Stillbirths and neonatal deaths represented 0.37%
and 0.07%, respectively, of the study population (Table 12). Maternal- and family-level as well as area-level
variables are described by year and over the study period in Table 14 before and after multiple imputation.
Results for the main analysis
For the main analysis, we reported the results for the primary and secondary outcomes using the imputed
data, both with and without adjusting the models for gestational age at booking and maternal smoking
during pregnancy. The results for the complete cases are presented in Appendices 2 and 3. We have more
confidence in the results obtained from the imputed data, as it is easy to find examples for which the
complete cases are not a random sample of all births. For example, in 2004 3.64% of women had a BMI
at booking recorded as being ≥ 35 kg/m2. With BMI missing for 54.51% of births, this meant that the
observed prevalence of severe obesity was 8.00%, somewhat larger than the average imputed prevalence
across the 30 imputed data sets of 7.01%. We have included the results for the complete-case analyses for
completeness. Similarly, we believe that we were mistaken to suggest in our protocol that we would adjust
for gestational age at booking and maternal smoking during pregnancy for the reasons given in Chapter 2,
Changes from the protocol. We favour the unadjusted results, but, again, present the adjusted results for
completeness as a per-protocol analysis.
Results for the primary outcome
The analyses using the imputed data show no statistically significant effect of the intervention on birthweight.
The results are similar whether adjusting the model for gestational age at booking and maternal smoking
during pregnancy or not, with the estimated changes in birthweight and 95% CI being –2.6 g (95% CI –6.9
to 1.7 g) and –2.3 g (95% CI –6.6 to 1.9 g), respectively (Table 15). Over the 10-year period under study there
was a general trend of increasing birthweight. Based on the analysis of the imputed data, without adjustment
for gestational age at booking or maternal smoking during pregnancy, we estimate this increase to have
been 3.3 g per year (95% CI 2.4 to 4.2 g). This trend did not differ significantly between the pre-intervention,
intervention and post-intervention periods.
The analysis of complete cases suggested that, compared with the pre-intervention period, birthweight
decreased by 9.0 g (95% CI 3.7 to 14.3 g) during the intervention period when not adjusting the model
for gestational age at booking and maternal smoking during pregnancy. The result was similar when
adjusting the model for gestational age at booking and maternal smoking during pregnancy (Table 15).
Results for the secondary outcomes
The analysis performed on imputed data not adjusting for gestational age at booking and maternal
smoking during pregnancy showed no statistically significant effect of the programme on most of the
measures of stage and size (Tables 16–19). However, compared with the pre-intervention period, maternal
booking behaviour changed during the intervention period. The mean gestational age at booking
decreased by 0.35 weeks (95% CI 0.29 to 0.41 weeks) during the period in which the HiP grant was in place
and the odds of booking before 25 weeks increased by 10% (OR 1.10, 95% CI 1.02 to 1.18; Table 16).
However, the odds of neonatal death increased by 84% (OR 1.84, 95% CI 1.22 to 2.78; Table 19) and the
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TABLE 10 Description of the outcomes over time: measures of size
Outcomes 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2004–13
Birthweight (g)
CC, mean (SD) 3396.70
(574.10)
3399.60
(575.70)
3408.00
(569.90)
3411.30
(569.00)
3416.10
(570.60)
3424.50
(565.80)
3426.60
(561.20)
3427.50
(569.60)
3431.90
(560.70)
3438.10
(545.90)
3418.30
(566.40)
Very LBW (< 1500 g)
CC, yes (%) 0.71 0.66 0.68 0.69 0.64 0.63 0.59 0.64 0.61 0.43 0.63
LBW (< 2500 g)
CC, yes (%) 5.66 5.76 5.41 5.43 5.28 5.02 4.86 5.18 4.85 4.33 5.17
HBW (≥ 4000 g)
CC, yes (%) 13.29 13.27 13.51 13.75 13.95 14.10 13.98 14.28 14.12 14.08 13.84
Head circumference (cm)
CC
Mean (SD) 34.67 (1.45) 34.69 (1.45) 34.72 (1.45) 34.75 (1.45) 34.71 (1.47) 34.74 (1.48) 34.71 (1.50) 34.70 (1.48) 34.67 (1.51) 34.59 (1.50) 34.70 (1.48)
Missing (%) 23.65 24.81 22.28 25.64 24.98 19.98 21.10 31.08 33.13 36.76 26.32
Imputed
Mean
(min., max.)
34.57
(34.57, 34.57)
34.59
(20.5, 42.00)
34.62
(34.58, 34.59)
34.65
(34.64, 34.65)
34.64
(34.63, 34.64)
34.66
(34.65, 34.66)
34.64
(34.63, 34.64)
34.62
(34.61, 34.63)
34.61
(34.60, 34.61)
34.58
(34.57, 34.58)
34.60
Crown-to-heel length (cm)
CC
Mean (SD) 51.05 (2.93) 51.13 (3.05) 51.11 (3.08) 51.17 (3.06) 50.96 (3.08) 51.20 (3.09) 51.25 (3.11) 51.38 (3.06) 51.51 (3.05) 51.50 (3.06) 51.2 (3.10)
Missing (%) 47.67 48.42 44.60 49.24 50.22 42.22 44.85 45.85 46.20 44.88 46.42
CC, complete case; (min., max.), minimum and maximum (of mean or % yes) across the 30 imputations; SD, standard deviation.
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TABLE 11 Description of the outcomes over time: measures of stage
Outcomes 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2004–13
Gestational age at delivery (weeks)
CC, mean (SD) 39.28 (1.86) 39.33 (1.84) 39.30 (1.84) 39.33 (1.82) 39.34 (1.83) 39.36 (1.81) 39.37 (1.79) 39.34 (1.80) 39.32 (1.78) 39.35 (1.68) 39.34 (1.80)
Preterm
CC, yes (%) 6.08 6.04 5.84 5.65 5.90 5.67 5.39 5.53 5.53 4.92 5.65
Very preterm
CC, yes (%) 1.19 1.05 1.10 1.06 1.08 1.02 1.02 1.09 1.00 0.74 1.04
Weight-for-dates (z-score)
CC, mean (SD) –0.023 (1.01) –0.034 (1.01) –0.016 (1.00) –0.011 (1.00) –0.0029 (1.00) 0.009 (1.00) 0.007 (0.99) 0.020 (1.00) 0.035 (0.99) 0.033 (0.98) 0.0019 (1.00)
SGA
CC, yes (%) 5.46 5.59 5.17 5.06 5.01 4.83 4.62 4.65 4.38 4.23 4.89
LGA
CC, yes (%) 9.81 9.50 9.45 9.76 9.73 9.99 9.61 10.02 10.15 9.97 9.80
CC, complete case; SD, standard deviation.
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TABLE 12 Description of the outcomes over time: birth outcomes
Outcomes 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2004–13
Elective caesarean
CC
Yes (%) 8.76 9.02 9.70 10.02 9.97 10.30 11.19 11.57 11.96 12.73 10.54
Missing (%) 0.03 0.03 0.03 0.04 0.03 0.02 0.02 0.02 0.02 0.03 0.03
Imputed
Yes, %
(min., max.)
8.76
(8.76, 8.77)
9.02
(9.02, 9.03)
9.70
(9.70, 9.71)
10.02
(10.02, 10.03)
9.97
(9.97, 9.97)
10.30
(10.30, 10.31)
11.19
(11.19, 11.20)
11.58
(11.57, 11.58)
11.96
(11.96, 11.96)
12.73
(12.73, 12.74)
10.54
Emergency caesarean
CC
Yes (%) 14.87 15.23 14.92 14.85 14.77 14.71 15.15 15.67 15.32 15.83 15.13
Missing (%) 0.03 0.03 0.03 0.04 0.03 0.02 0.02 0.02 0.02 0.03 0.03
Imputed
Yes, %
(min., max.)
14.88
(14.87, 14.88)
15.23
(15.23, 15.24)
14.93
(14.92, 14.93)
14.86
(14.85, 14.87)
14.77
(14.77, 14.77)
14.71
(14.71, 14.71)
15.16
(15.16, 15.15)
15.67
(15.67, 15.67)
15.32
(15.32, 15.33)
15.83
(15.83, 15.84)
15.13
Stillbirth
CC, yes (%) 0.44 0.42 0.40 0.41 0.41 0.37 0.36 0.37 0.33 0.24 0.37
5-minute Apgar score of < 7
CC
Yes (%) 1.43 1.41 1.40 1.48 1.38 1.33 1.35 1.29 1.30 1.26 1.36
Missing (%) 2.14 2.24 2.79 1.31 0.87 0.78 0.65 0.69 0.80 0.89 1.29
Imputed
Yes, %
(min., max.)
1.43
(1.43, 1.44)
1.42
(1.42, 1.43)
1.42
(1.42, 1.42)
1.49
(1.49, 1.50)
1.39
(1.38, 1.39)
1.34
(1.34, 1.35)
1.36
(1.35, 1.36)
1.30
(1.30, 1.30)
1.31
(1.31, 1.31)
1.26
(1.26, 1.27)
1.37
Neonatal death
CC
Yes (%) 0.09 0.08 0.06 0.06 0.08 0.09 0.08 0.09 0.06 0.03 0.07
CC, complete case; (min., max.), minimum and maximum (of mean or % yes) across the 30 imputations.
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TABLE 13 Description of the outcomes over time: maternal behaviour
Outcomes 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2004–13
Gestation at booking, weeks
CC
Mean (SD) 13.42 (5.43) 13.32 (5.32) 13.12 (5.29) 12.97 (5.16) 12.69 (4.97) 12.97 (4.73) 12.32 (4.58) 11.56 (4.62) 11.03 (4.69) 10.98 (4.85) 12.37 (5.05)
Missing (%) 9.99 13.60 18.57 23.11 21.38 29.23 18.84 12.38 4.40 0.93 15.35
Imputed
Mean
(min., max.)
13.38
(13.37, 13.39)
13.23
(13.22, 13.24)
13.10
(13.08, 13.11)
13.02
(13.00, 13.04)
12.76
(12.75, 12.77)
12.72
(12.70, 12.75)
12.20
(12.19, 12.22)
11.47
(11.46, 11.47)
11.06
(11.05, 11.07)
10.97
(10.97, 10.97)
12.38
Booking before 25 weeks
CC
Yes (%) 85.22 82.11 77.54 73.53 75.57 68.10 78.62 85.17 93.02 95.93 81.39
Missing (%) 9.99 13.60 18.57 23.11 21.38 29.23 18.84 12.38 4.40 0.93 15.35
Imputed
Yes, %
(min., max.)
95.00
(94.96, 95.04)
95.48
(95.43, 95.54)
95.68
(95.63, 95.75)
96.06
(96.01, 96.14)
96.44
(96.39, 96.51)
96.93
(96.88, 96.98)
97.27
(97.24, 97.30)
97.47
(97.46, 97.49)
97.38
(97.36, 97.40)
96.86
(96.85, 96.86)
96.48
Maternal smoking during pregnancy
CC
Yes (%) 23.60 21.85 20.10 18.17 18.26 18.90 17.91 18.09 17.95 18.06 19.24
Missing (%) 9.06 9.36 13.17 15.55 13.66 6.85 6.11 6.36 5.36 4.13 8.93
Imputed
Yes, %
(min., max.)
25.84
(25.75, 25.92)
24.71
(24.64, 24.81)
23.21
(23.05, 23.34)
22.31
(22.17, 22.48)
21.37
(21.27, 21.50)
20.42
(20.30, 20.52)
19.16
(19.10, 19.22)
19.32
(19.25, 19.40)
19.02
(18.97, 19.07)
18.78
(18.73, 18.83)
21.36
CC, complete cases; (min., max.), minimum and maximum (of mean or % yes) across the 30 imputations; SD, standard deviation.
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TABLE 14 Description of the covariates over time
Outcomes 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2004–13
Baby’s sex
CC
Male 51.23 51.70 51.12 51.30 51.06 51.29 50.81 51.45 51.43 51.49 51.28
Female 48.77 48.30 48.88 48.70 48.94 48.71 49.19 48.55 48.57 48.51 48.72
Maternal age (years)
CC
< 20 7.90 7.89 7.59 7.64 7.32 6.95 6.66 5.99 5.51 5.06 6.84
20–24 18.66 18.93 18.89 19.29 19.24 19.34 18.58 18.40 18.09 17.66 18.71
25–29 24.51 24.56 25.26 25.93 27.20 27.52 27.64 27.32 27.74 27.39 26.54
30–34 29.62 29.12 28.30 26.90 26.40 26.73 27.65 28.64 29.46 30.37 28.29
35–39 16.22 16.34 16.80 16.99 16.38 16.00 15.96 15.9 15.5 15.64 16.17
≥ 40 3.09 3.16 3.16 3.26 3.46 3.46 3.50 3.74 3.70 3.88 3.44
Maternal height (cm)
CC
Mean (SD) 163.48 (6.48) 163.59 (6.48) 163.67 (6.48) 163.84 (6.47) 163.84 (6.50) 163.99 (6.43) 164.06 (6.45) 164.13 (6.43) 164.27 (6.42) 164.29 (6.41) 163.9 (6.50)
Missing (%) 19.82 18.99 18.12 18.69 17.10 15.28 8.84 8.04 9.56 3.94 13.79
Imputed
Mean
(min., max.)
163.51
(163.49, 163.53)
163.61
(163.58, 163.63)
163.65
(163.63, 163.67)
163.79
(163.76, 163.81)
163.81
(163.78, 163.83)
163.99
(163.97, 164.02)
164.06
(164.04, 164.07)
164.12
(164.11, 164.13)
164.26
(164.24, 164.27)
164.27
(164.26, 164.28)
163.90
Maternal BMI (kg/m2)
CC
Mean (SD) 25.93 (5.44) 25.87 (5.41) 25.92 (5.39) 25.95 (5.46) 26.05 (5.53) 26.00 (5.46) 26.09 (5.57) 26.13 (5.61) 26.18 (5.63) 26.09 (5.60) 26.05 (5.53)
Missing (%) 54.50 50.43 46.70 47.90 29.20 25.10 13.64 12.03 13.13 5.23 29.44
Imputed
Mean
(min., max.)
25.88
(25.83, 25.92)
25.87
(25.84, 25.89)
25.98
(25.86, 25.93)
25.94
(25.91, 25.97)
26.08
(26.06, 26.11)
26.06
(26.04, 26.08)
26.25
(26.24, 26.27)
26.31
(26.29, 26.33)
26.43
(26.42, 26.44)
26.15
(26.13, 26.16)
26.09
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Outcomes 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2004–13
Gestational age at booking
CC
0–12 weeks 46.78 44.34 44.08 42.00 45.06 37.99 49.19 61.44 71.74 77.22 51.97
13–24 weeks 38.44 37.77 33.47 31.52 30.51 30.11 29.42 23.74 21.28 18.71 29.42
≥ 25 weeks 4.79 4.29 3.88 3.36 3.05 2.67 2.55 2.45 2.58 3.14 3.25
Missing (%) 9.99 13.60 18.57 23.11 21.38 29.23 18.84 12.38 4.40 0.93 15.35
Imputed, mean (min., max.)
0–12 weeks 52.47
(52.35, 52.57)
52.48
(52.32, 52.62)
54.63
(54.47, 54.96)
54.79
(54.67, 55.01)
57.20
(57.05, 57.35)
56.84
(56.54, 57.07)
62.12
(61.87, 62.22)
70.75
(70.64, 70.89)
74.72
(74.63, 74.82)
77.97
(77.94, 78.00)
61.46
13–24 weeks 42.47
(42.36, 42.59)
42.93
(42.80, 43.08)
40.93
(40.60, 41.14)
41.10
(40.97, 41.27)
39.10
(38.94, 39.26)
39.96
(39.73, 42.55)
35.09
(34.93, 35.34)
21.70
(26.57, 26.85)
22.64
(22.26, 22.74)
18.89
(18.86, 18.91)
34.94
≥ 25 weeks 5.06
(5.03, 5.11)
4.60
(4.51, 4.65)
4.44
(4.39, 4.50)
4.11
(4.03, 4.18)
3.70
(3.63, 3.75)
3.20
(3.14, 3.77)
2.80
(2.76, 2.84)
2.55
(2.53, 2.58)
2.64
(2.62, 2.66)
3.14
(3.14, 3.17)
3.60
Parity
CC
0 43.91 45.47 46.96 47.34 47.11 49.57 45.56 45.64 44.88 45.13 46.17
1 33.76 32.27 32.8 33.26 33.82 31.93 34.33 33.16 34.74 34.46 33.47
2 13.67 13.76 12.8 12.83 12.73 12.28 13.22 13.05 13.42 13.26 13.09
3+ 7.01 6.98 6.39 6.16 6.22 6.03 6.50 6.72 6.79 6.84 6.56
Missing (%) 1.65 1.52 1.04 0.41 0.12 0.18 0.38 1.44 0.18 0.31 0.71
Imputed, mean (min., max.)
0 44.53
(44.47, 44.61)
46.04
(45.99, 46.17)
47.36
(47.33, 47.41)
47.49
(47.46, 47.53)
47.15
(47.14, 47.17)
49.63
(49.62, 49.64)
45.70
(45.68, 45.74)
46.22
(46.18, 46.28)
44.94
(44.92, 44.95)
45.24
(45.22, 45.26)
46.44
1 34.43
(34.33, 34.49)
32.90
(32.77, 32.95)
33.23
(33.20, 33.29)
33.42
(33.39, 33.46)
33.87
(33.85, 33.89)
32.01
(31.99, 32.02)
34.49
(34.46, 34.51)
33.75
(33.70, 33.79)
34.81
(34.79, 34.84)
34.57
(34.56, 34.60)
33.76
2 13.97
(13.89, 14.01)
14.04
(14.00, 14.09)
12.98
(12.95, 13.03)
12.91
(12.88, 12.94)
12.76
(12.74, 12.77)
12.32
(12.30, 12.33)
13.30
(13.28, 13.31)
13.29
(13.26, 13.33)
13.46
(13.44, 13.47)
13.33
(13.31, 13.34)
13.22
3+ 7.06
(7.04, 7.13)
7.03
(7.01, 7.05)
6.42
(6.41, 6.44)
6.18
(6.17, 6.19)
6.23
(6.22, 6.23)
6.04
(6.03, 6.05)
6.52
(6.51, 6.52)
6.75
(6.74, 6.77)
6.80
(6.79, 6.81)
6.85
(6.84, 6.86)
6.58
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TABLE 14 Description of the covariates over time (continued )
Outcomes 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2004–13
Previous caesarean section
CC
Yes (%) 11.27 10.75 10.75 10.85 10.61 10.38 11.25 10.7 10.72 10.94 10.82
Missing (%) 0.00 0.00 0.03 0.13 0.00 0.00 0.17 1.28 0.05 0.22 0.19
Imputed
Yes, %
(min., max.)
11.27
(11.27, 11.27)
10.75
(10.75, 10.75)
10.75
(10.75, 10.75)
10.87
(10.86, 10.88)
10.61
(10.61, 10.61)
10.38
(10.38, 10.38)
11.26
(11.25, 11.27)
10.81
(10.79, 10.82)
10.73
(10.72, 10.73)
10.97
(10.96, 10.98)
10.84
Diabetes mellitus
CC
Yes (%) 0.74 0.83 0.78 0.87 1.15 1.44 1.52 1.74 2.39 2.71 1.42
Missing (%) 34.63 30.66 29.25 30.36 16.28 8.42 2.31 2.14 2.49 2.41 15.61
Imputed
Yes, %
(min., max.)
1.06
(1.00, 1.12)
1.15
(1.11, 1.19)
1.12
(1.06, 1.20)
1.25
(1.19, 1.32)
1.35
(1.31, 1.38)
1.55
(1.53, 1.58)
1.57
(1.55, 1.59)
1.79
(1.77, 1.80)
2.44
(2.43, 2.46)
2.77
(2.74, 2.79)
1.61
Obese (BMI ≥ 35 kg/m2)
CC
Yes (%) 3.64 3.55 3.90 3.97 5.74 5.77 7.05 7.28 7.43 7.70 5.63
Missing (%) 54.51 50.43 46.69 47.86 29.22 25.09 13.64 12.03 13.13 5.23 29.44
Imputed
Yes, %
(min., max.)
7.01
(6.82, 7.17)
6.76
(6.59, 6.88)
6.80
(6.57, 6.94)
7.06
(6.87, 7.15)
7.97
(7.76, 8.06)
7.69
(7.56, 7.79)
8.73
(8.64, 8.81)
8.93
(8.83, 9.01)
9.54
(9.43, 9.65)
8.27
(8.22, 8.33)
7.90
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Outcomes 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2004–13
Marital status
CC
Married to
each other
52.05 51.21 50.56 48.45 47.59 48.56 48.26 47.48 48.00 48.14 48.99
Joint same
address
29.98 30.00 30.76 31.51 32.74 33.50 33.49 33.8 34.10 34.43 32.47
Joint
different
address
9.85 10.43 10.40 10.72 10.83 11.33 11.56 11.92 12.26 11.96 11.14
Sole 6.07 5.69 5.78 5.71 5.43 5.35 5.30 5.25 5.03 4.86 5.44
Missing (%) 2.05 2.66 2.50 3.62 3.41 1.61 1.39 1.91 0.60 0.63 1.97
Imputed, mean
(min., max.)
Married to
each other
53.05
(52.99, 53.09)
52.48
(52.44, 52.54)
51.79
(51.73, 51.84)
50.41
(50.33, 50.48)
49.46
(49.37, 49.54)
49.12
(49.09, 49.16)
49.02
(48.98, 49.06)
48.31
(48.26, 48.34)
48.27
(48.25, 48.29)
48.42
(48.40, 48.45)
49.99
Joint same
address
30.63
(30.57, 30.69)
30.86
(30.80, 30.90)
31.57
(31.51, 31.63)
32.60
(32.53, 32.69)
33.77
(33.70, 33.84)
33.92
(33.87, 33.98)
33.91
(33.87, 33.95)
34.28
(34.22, 34.32)
34.32
(34.28, 34.34)
34.62
(34.63, 34.70)
33.09
Joint
different
address
10.10
(10.09, 10.16)
10.77
(10.73, 10.81)
10.70
(10.66, 10.74)
11.08
(11.01, 11.12)
11.17
(11.10, 11.21)
11.51
(11.49, 11.57)
11.71
(11.68, 11.73)
12.09
(12.06, 12.13)
12.35
(12.34, 12.36)
12.05
(12.03, 12.08)
11.37
Sole 6.22
(6.18, 6.25)
5.88
(5.86, 5.91)
5.95
(5.92, 5.99)
5.91
(5.86, 5.96)
5.60
(5.57, 5.63)
5.44
(5.41, 5.47)
5.36
(5.34, 5.38)
5.32
(5.30, 5.35)
5.07
(5.05, 5.08)
4.87
(4.85, 4.88)
5.56
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TABLE 14 Description of the covariates over time (continued )
Outcomes 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2004–13
Social class
CC
Managerial
and
professional
28.10 28.08 29.04 28.68 28.50 29.68 29.14 29.66 29.84 29.29 29.01
Intermediate 20.69 20.35 19.81 19.35 19.45 19.78 19.42 18.77 19.34 18.82 19.57
Working 34.13 34.18 33.52 33.71 33.79 34.03 34.02 3404 33.97 33.29 33.87
Never
worked/
long-term
unemployed
15.04 14.73 15.13 14.64 14.85 15.26 16.04 15.98 16.25 15.45 15.34
Missing (%) 2.05 2.66 2.50 3.62 3.41 1.25 1.39 1.55 0.60 3.15 2.21
Imputed, mean
(min., max.)
Managerial
and
professional
28.62
(28.58, 28.66)
28.79
(28.76, 28.83)
29.76
(29.70, 29.83)
29.90
(29.83, 29.96)
29.68
(29.62, 29.77)
30.01
(29.98, 30.04)
29.64
(29.60, 29.66)
30.20
(30.15, 30.24)
30.01
(29.98, 30.05)
30.26
(30.21, 30.34)
29.70
Intermediate 21.11
(21.06, 21.19)
20.89
(20.81, 20.94)
20.32
(20.26, 20.38)
20.11
(20.00, 20.17)
20.17
(20.10, 20.23)
20.03
(20.00, 20.07)
19.70
(19.66, 19.73)
19.08
(19.05, 19.13)
19.46
(19.43, 19.48)
19.42
(19.34, 19.50)
20.02
Working 34.85
(34.78, 34.89)
35.10
(35.05, 35.16)
34.37
(34.28, 34.43)
34.85
(34.77, 34.95)
34.87
(34.78, 34.93)
34.44
(34.41, 34.49)
34.45
(34.40, 34.48)
34.53
(34.47, 34.58)
34.17
(34.14, 34.23)
34.35
(34.24, 34.41)
34.60
Never
worked/
long-term
unemployed
15.41
(15.38, 15.47)
15.22
(15.18, 15.26)
15.55
(15.51, 15.62)
15.14
(15.10, 15.19)
15.28
(15.24, 15.33)
15.51
(15.49, 15.55)
16.22
(16.19, 16.25)
16.19
(16.17, 16.24)
16.35
(16.33, 16.38)
15.97
(15.95, 16.00)
15.69
Ethnic group
CC
White 13.02 15.38 20.20 24.00 30.19 41.66 54.82 63.60 65.63 70.55 40.21
Non-white 1.20 1.28 1.54 1.86 2.49 3.71 4.40 5.02 4.99 5.88 3.26
Missing (%) 85.77 83.34 78.26 74.14 67.22 54.63 40.77 31.38 29.38 23.57 56.53
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Outcomes 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2004–13
Smoking at booking
CC
Never
smoked
60.78 61.98 57.97 57.90 59.88 58.67 63.60 62.80 63.65 65.88 61.31
Current
smoker
9.17 8.67 9.23 8.75 8.86 9.34 12.35 12.48 13.17 12.77 10.50
Former
smoker
23.04 21.84 21.07 19.51 18.51 18.43 19.30 19.76 18.55 17.71 19.73
Missing (%) 7.02 7.51 11.72 13.83 12.75 13.56 4.76 4.95 4.63 3.64 8.45
Imputed, mean
(min., max.)
Never
smoked
65.47
(65.38, 65.60)
66.98
(66.89, 67.06)
66.02
(65.84, 66.15)
67.55
(67.41, 67.69)
68.95
(68.86, 69.09)
68.13
(68.00, 68.22)
66.99
(66.93, 67.06)
66.33
(66.21, 66.42)
66.90
(66.81, 66.99)
68.46
(68.41, 68.51)
67.20
Current
smoker
9.90
(9.84, 9.99)
9.53
(9.47, 9.60)
10.50
(10.41, 10.59)
10.15
(10.07, 10.23)
10.12
(10.05, 10.23)
10.90
(10.79, 11.00)
12.91
(12.84, 12.97)
13.06
(12.97, 13.12)
13.74
(13.67, 13.82)
13.23
(13.18, 13.27)
11.42
Former
smoker
24.62
(24.53, 24.74)
23.49
(23.41, 23.57)
23.48
(23.39, 23.63)
22.30
(22.15, 22.44)
20.93
(20.82, 21.08)
20.97
(20.88, 21.09)
20.10
(20.04, 20.15)
20.60
(20.53, 20.65)
19.37
(19.28, 19.42)
18.30
(18.25, 18.36)
21.38
SIMD 2009 income quintiles
CC
1: most
deprived
25.16 25.66 25.60 26.14 26.08 25.93 26.31 26.47 26.34 26.29 26.01
2 20.28 20.08 20.43 20.79 20.79 21.00 21.05 21.56 21.33 21.23 20.86
3 18.36 18.38 18.51 18.22 18.84 19.20 18.93 18.87 19.36 19.07 18.78
4 18.07 18.18 17.83 17.89 17.69 17.70 17.84 17.59 17.34 17.51 17.76
5: least
deprived
18.13 17.70 17.63 16.96 16.60 16.14 15.88 15.52 15.64 15.90 16.59
Missing (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
CC, complete cases; (min., max.), minimum and maximum (of mean or % yes) across the 30 imputations; SD, standard deviation.
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TABLE 15 Results of analysis for the primary outcome using the complete cases and the imputed data both
unadjusted and adjusted for gestational age at booking and maternal smoking
Parameter
Birthweight (g), coefficient (95% CI)
Analysis unadjusted on gestational age at
booking and maternal smoking
Analysis adjusted on gestational age at
booking and maternal smoking as suggested
in the protocol paper
Complete cases Imputed data Complete cases Imputed data
Period
Period 1a 0.00 0.00 0.00 0.00
Period 2b –9.00 (–14.30 to 3.70) –2.60 (–6.90 to 1.70) –9.20 (–15.00 to –3.40) –2.30 (–6.60 to 1.90)
Period 3c –13.40 (–21.00 to 5.80) –5.00 (–11.10 to 1.00) –17.60 (–25.90 to 9.40) –5.20 (–11.20 to 0.80)
Global test 1d 0.002 0.30 0.0001 0.20
Trend
All yearse 4.80 (3.60 to 6.00) 3.30 (2.40 to 4.20) 1.80 (0.50 to 3.10) 0.80 (–0.10 to 1.70)
Interactions
Interaction 1f
Interaction 2
g
Interaction 3h
Global test 2i 0.06 0.20 0.03 0.06
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
TABLE 16 Results of analysis for the secondary outcomes using the imputed data unadjusted for gestational age at
booking and maternal smoking: maternal behaviour
Parameter
Maternal behaviour
Gestational age at booking
(weeks), coefficient (95% CI)
Booking before 25 weeks,
OR (95% CI)
Maternal smoking during
this pregnancy, OR (95% CI)
Periods
Period 1a 0.00 1.00 1.00
Period 2b –0.35 (–0.41 to 0.29) 1.10 (1.02 to 1.18) 1.02 (0.99 to 1.06)
Period 3c –1.10 (–1.20 to 1.02) 0.91 (0.83 to 1.00) 1.17 (1.11 to 1.22)
Global test 1d
Trend
All yearse
Interactions
Interaction 1f –0.14 (–0.15 to 0.13) 1.09 (1.08 to 1.11) 0.92 (0.91 to 0.93)
Interaction 2g –0.57 (–0.62 to 0.53) 1.11 (1.04 to 1.18) 0.92 (0.90 to 0.95)
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TABLE 16 Results of analysis for the secondary outcomes using the imputed data unadjusted for gestational age at
booking and maternal smoking: maternal behaviour (continued )
Parameter
Maternal behaviour
Gestational age at booking
(weeks), coefficient (95% CI)
Booking before 25 weeks,
OR (95% CI)
Maternal smoking during
this pregnancy, OR (95% CI)
Interaction 3h –0.21 (–0.24 to 0.17) 0.88 (0.84 to 0.91) 0.99 (0.97 to 1.01)
Global test 2i < 0.0001 < 0.0001 < 0.0001
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
TABLE 17 Results of analysis for the secondary outcomes using the imputed data unadjusted for gestational age at
booking and maternal smoking: measures of size
Parameter
Measures of size
Very LBW,
OR (95% CI)
LBW, OR
(95% CI)
HBW, OR
(95% CI)
Head circumference (cm),
coefficient (95% CI)
Crown-to-heel length
(cm), coefficient (95% CI)
Periods
Period 1a 1.00 1.00 1.00 0.00 0.00
Period 2b 0.87
(0.68 to 1.10)
1.02
(0.96 to 1.09)
0.98
(0.94 to 1.01)
–0.04
(–0.05 to 0.03)
0.07
(0.04 to 0.10)
Period 3c 0.92
(0.66 to 1.28)
1.06
(0.97 to 1.17)
0.96
(0.92 to 1.01)
–0.11
(–0.13 to 0.09)
0.23
(0.18 to 0.27)
Global test 1d 0.40 0.40 0.30
Trend
All yearse 1.00
(0.95 to 1.05)
0.98
(0.96 to 0.99)
1.01
(1.00 to 1.02)
Interactions
Interaction 1f 0.007
(0.004 to 0.01)
0.023
(0.016 to 0.031)
Interaction 2g –0.02
(–0.03 to –0.01)
0.08
(0.05 to 0.10)
Interaction 3h –0.033
(–0.04 to 0.025)
0.04
(0.02 to 0.06)
Global test 2i 0.90 0.05 0.20 < 0.0001 0.0004
HBW, high birthweight; LBW, low birthweight.
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
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TABLE 18 Results of analysis for the secondary outcomes using the imputed data unadjusted for gestational age at
booking and maternal smoking: measures of stage
Parameter
Measures of stage
Gestational
age at delivery
(weeks),
coefficient
(95% CI)
Preterm, OR
(95% CI)
Very
preterm, OR
(95% CI)
z-score,
coefficient
(95% CI)
SGA, OR
(95% CI)
LGA, OR
(95% CI)
Periods
Period 1a 0.00 1.00 1.00 0.00 1.00 1.00
Period 2b –0.04
(–0.06 to 0.02)
1.02
(0.97 to 1.08)
1.11
(0.98 to 1.25)
–0.007
(–0.02 to 0.002)
1.01
(0.96 to 1.06)
0.99
(0.95 to 1.03)
Period 3c –0.17
(–0.19 to 0.14)
1.22
(1.14 to 1.31)
1.46
(1.25 to 1.71)
–0.01
(–0.03 to 0.0008)
1.02
(0.95 to 1.10)
0.98
(0.93 to 1.04)
Global test 1d 0.10 0.80 0.80
Trend
All yearse 0.007
(0.005 to 0.009)
0.97
(0.96 to 0.98)
0.997
(0.989 to 1.01)
Interactions
Interaction 1f 0.025
(0.020 to 0.029)
0.96
(0.95 to 0.97)
0.93
(0.91 to 0.95)
Interaction 2g 0.15
(0.13 to 0.17)
0.73
(0.70 to 0.76)
0.61
(0.56 to 0.68)
Interaction 3h 0.06
(0.04 to 0.07)
0.86
(0.83 to 0.88)
0.71
(0.66 to 0.76)
Global test 2i < 0.0001 < 0.0001 < 0.0001 0.06 0.40 0.20
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
TABLE 19 Results of analysis for the secondary outcomes using the imputed data unadjusted for gestational age at
booking and maternal smoking: birth outcomes
Parameter
Other birth outcomes
Mode of delivery
Stillbirth,
OR (95% CI)
5-minute
Apgar score,
OR (95% CI)
Neonatal
death, OR
(95% CI)
Elective caesarean,
OR (95% CI)
Emergency
caesarean,
OR (95% CI)
Periods
Period 1a 1.00 1.00 1.00 1.00 1.00
Period 2b 1.01
(0.97 to 1.05)
1.07
(1.03 to 1.10)
1.01
(0.85 to 1.21)
0.92
(0.84 to 1.01)
1.84
(1.22 to 2.78)
Period 3c 1.07
(1.00 to 1.13)
1.17
(1.12 to 1.23)
0.91
(0.71 to 1.17)
0.88
(0.78 to 1.01)
1.52
(0.84 to 2.74)
Global test 1d 0.01 0.40 0.20 0.004
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odds of having an emergency caesarean section also increased by 7% during the intervention period
(OR 1.07, 95% CI 1.03 to 1.10; Table 19).
The results were similar when using the imputed data and adjusting the models for gestational age at
booking and maternal smoking during pregnancy (Tables 20–23).
Results of the subgroup analysis
For the subgroup analysis, we report the results for the primary and secondary outcomes using the
imputed data, unadjusted for gestational age at booking and maternal smoking during pregnancy.
The primary outcome
Using the imputed data, the results showed that birthweight decreased by 12.2 g (95% CI 3.6 to 20.8 g)
in the most deprived areas during the intervention period (Table 24), and that there was no statistically
significant effect of the intervention on birthweight in any of the subgroups of mothers who we might
have expected to benefit the most from the grant (Table 25).
The secondary outcomes
During the intervention period, gestational age at booking decreased in all the SIMD subgroups: –0.5 weeks
(95% CI –0.6 to –0.4 weeks) in SIMD1 (the most deprived areas; see Appendix 15); –0.32 weeks (95% CI
–0.45 to –0.19 weeks) in SIMD2 (see Appendix 19); –0.34 weeks (95% CI –0.48 to –0.20 weeks) in SIMD3
TABLE 19 Results of analysis for the secondary outcomes using the imputed data unadjusted for gestational age at
booking and maternal smoking: birth outcomes (continued )
Parameter
Other birth outcomes
Mode of delivery
Stillbirth,
OR (95% CI)
5-minute
Apgar score,
OR (95% CI)
Neonatal
death, OR
(95% CI)
Elective caesarean,
OR (95% CI)
Emergency
caesarean,
OR (95% CI)
Trend
All yearse 1.05
(1.04 to 1.06)
0.98
(0.94 to 1.01)
1.01
(0.99 to 1.03)
0.91
(0.83 to 0.995)
Interactions
Interaction 1f 0.983
(0.976 to 0.990)
Interaction 2
g
1.02
(0.99 to 1.05)
Interaction 3h 1.00
(0.98 to 1.02)
Global test 2i 0.08 0.02 0.10 0.90 0.10
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
DOI: 10.3310/phr05060 PUBLIC HEALTH RESEARCH 2017 VOL. 5 NO. 6
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Leyland et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
43
TABLE 20 Results of analysis for the secondary outcomes using the imputed data and adjusting for gestational age
at booking and maternal smoking: maternal behaviour
Imputed
Maternal behaviour
Gestational age at booking
(weeks), coefficient (95% CI)
Booking before 25 weeks,
OR (95% CI)
Maternal smoking during
this pregnancy, OR (95% CI)
Periods
Period 1a 0.00 1.00 1.00
Period 2b –0.35 (–0.41 to 0.28) 1.09 (1.02 to 1.17) 1.02 (0.98 to 1.06)
Period 3c –1.10 (–1.19 to 1.02) 0.91 (0.83 to 0.99) 1.03 (0.95 to 1.11)
Global test 1d
Trend
All yearse
Interactions
Interaction 1f –0.14 (–0.15 to 0.13) 1.09 (1.08 to 1.11) 0.918 (0.912 to 0.925)
Interaction 2g –0.57 (–0.62 to 0.52) 1.11 (1.04 to 1.17) 0.92 (0.90 to 0.95)
Interaction 3h –0.21 (–0.24 to 0.18) 0.88 (0.84 to 0.92) 0.99 (0.90 to 0.95)
Global test 2i < 0.0001 < 0.0001 < 0.0001
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
TABLE 21 Results of analysis for the secondary outcomes using the imputed data and adjusting for gestational age
at booking and maternal smoking: measures of size
Imputed
Measures of size
Very LBW,
OR (95% CI)
LBW, OR
(95% CI)
HBW, OR
(95% CI)
Head
circumference
(cm), coefficient
(95% CI)
Crown-to-heel
length (cm),
coefficient (95% CI)
Periods
Period 1a 1.00 1.00 1.00 0.00 0.00
Period 2b 0.86
(0.68 to 1.10)
1.01
(0.95 to 1.09)
0.98
(0.94 to 1.01)
–0.04
(–0.05 to 0.03)
0.07
(0.03 to 0.10)
Period 3c 0.93
(0.66 to 1.30)
1.05
(0.96 to 1.15)
0.96
(0.92 to 1.01)
–0.10
(–0.12 to 0.09)
0.22
(0.17 to 0.27)
Global test 1d 0.40 0.50 0.30
Trend
All yearse 1.01
(0.96 to 1.06)
0.99
(0.98 to 1.01)
1.00
(0.99 to 1.01)
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TABLE 21 Results of analysis for the secondary outcomes using the imputed data and adjusting for gestational age
at booking and maternal smoking: measures of size (continued )
Imputed
Measures of size
Very LBW,
OR (95% CI)
LBW, OR
(95% CI)
HBW, OR
(95% CI)
Head
circumference
(cm), coefficient
(95% CI)
Crown-to-heel
length (cm),
coefficient (95% CI)
Interactions
Interaction 1f 0.007
(0.004 to 0.01)
0.02
(0.01 to 0.03)
Interaction 2g –0.02
(–0.03 to 0.01)
0.07
(0.05 to 0.10)
Interaction 3h –0.033
(–0.040 to 0.025)
0.04
(0.02 to 0.06)
Global test 2i 0.90 0.05 0.10 < 0.0001 0.0009
HBW, high birthweight; LBW, low birthweight.
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
TABLE 22 Results of analysis for the secondary outcomes using the imputed data and adjusting for gestational age
at booking and maternal smoking: measures of stage
Imputed
Measures of stage
Gestational
age at delivery
(weeks),
coefficient
(95% CI)
Preterm, OR
(95% CI)
Very
preterm, OR
(95% CI)
z-score,
coefficient
(95% CI)
SGA, OR
(95% CI)
LGA, OR
(95% CI)
Periods
Period 1a 0.00 1.00 1.00 0.00 1.00 1.00
Period 2b –0.03
(–0.05 to 0.01)
1.01
(0.96 to 1.07)
1.09
(0.97 to 1.24)
–0.007
(–0.02 to 0.003)
1.01
(0.95 to 1.06)
0.99
(0.95 to 1.03)
Period 3c –0.15
(–0.17 to 0.12)
1.19
(1.11 to 1.28)
1.41
(1.20 to 1.65)
–0.01
(–0.03 to 0.001)
1.01
(0.94 to 1.09)
0.98
(0.93 to 1.04)
Global test 1d 0.10 0.90 0.80
Trend
All yearse 0.002
(–0.0002 to 0.004)
0.99
(0.98 to 0.998)
0.99
(0.98 to 0.99)
continued
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TABLE 22 Results of analysis for the secondary outcomes using the imputed data and adjusting for gestational age
at booking and maternal smoking: measures of stage (continued )
Imputed
Measures of stage
Gestational
age at delivery
(weeks),
coefficient
(95% CI)
Preterm, OR
(95% CI)
Very
preterm, OR
(95% CI)
z-score,
coefficient
(95% CI)
SGA, OR
(95% CI)
LGA, OR
(95% CI)
Interactions
Interaction 1f 0.023
(0.020 to 0.028)
0.96
(0.95 to 0.97)
0.93
(0.91 to 0.96)
Interaction 2
g
0.16
(0.14 to 0.17)
0.73
(0.70 to 0.76)
0.61
(0.55 to 0.67)
Interaction 3h 0.06
(0.05 to 0.07)
0.85
(0.83 to 0.88)
0.70
(0.66 to 0.75)
Global test 2i < 0.0001 < 0.0001 < 0.0001 0.02 0.30 0.10
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
TABLE 23 Results of analysis for the secondary outcomes using the imputed data and adjusting for gestational age
at booking and maternal smoking: birth outcomes
Imputed
Birth outcomes
Mode of delivery
Stillbirth,
OR (95% CI)
5-minute
Apgar score,
OR (95% CI)
Neonatal
death, OR
(95% CI)
Elective
caesarean,
OR (95% CI)
Emergency
caesarean,
OR (95% CI)
Periods
Period 1a 1.00 1.00 1.00 1.00 1.00
Period 2b 1.01
(0.97 to 1.05)
1.06
(1.03 to 1.10)
1.01
(0.84 to 1.21)
0.92
(0.84 to 1.01)
1.84
(1.22 to 2.78)
Period 3c 1.08
(1.01 to 1.14)
1.17
(1.11 to 1.22)
0.90
(0.70 to 1.16)
0.88
(0.77 to 1.00)
1.54
(0.85 to 2.78)
Global test 1d 0.004 0.40 0.10 0.004
Trend
All yearse 1.05
(1.04 to 1.06)
0.98
(0.94 to 1.02)
1.01
(0.99 to 1.03)
0.91
(0.84 to 0.997)
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TABLE 23 Results of analysis for the secondary outcomes using the imputed data and adjusting for gestational age
at booking and maternal smoking: birth outcomes (continued )
Imputed
Birth outcomes
Mode of delivery
Stillbirth,
OR (95% CI)
5-minute
Apgar score,
OR (95% CI)
Neonatal
death, OR
(95% CI)
Elective
caesarean,
OR (95% CI)
Emergency
caesarean,
OR (95% CI)
Interactions
Interaction 1f 0.983
(0.975 to 0.99)
Interaction 2
g
1.02
(0.99 to 1.04)
Interaction 3h 1.00
(0.98 to 1.02)
Global test 2i 0.10 0.02 0.10 0.90 0.10
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
TABLE 24 Results of subgroup analysis for the primary outcome using the imputed data unadjusted for gestational
age at booking and maternal smoking: subgroups related to the socioeconomic position of the area of residence
(SIMD2009 version 2)
Parameter
Birthweight (g), coefficient (95% CI)
SIMD1: most
deprived areas SIMD2 SIMD3 SIMD4
SIMD5: least
deprived areas
Periods
Period 1a 0.00 0.00 0.00 0.00 0.00
Period 2b –12.20
(–20.80 to 3.60)
–1.30
(–10.80 to 8.20)
–1.80
(–11.50 to 8.00)
3.80
(–6.00 to 13.70)
1.10
(–9.00 to 11.20)
Period 3c –22.10
(–34.20 to 10.00)
–8.00
(–21.40 to 5.30)
1.30
(–12.50 to 15.00)
6.80
(–7.10 to 20.80)
1.00
(–13.30 to 15.30)
Global test 1d 0.002 0.30 0.70 0.60 0.90
Trend
All yearse 7.00
(5.20 to 8.90)
4.30
(2.20 to 6.40)
2.30
(0.20 to 4.40)
0.70
(–1.50 to 2.80)
0.10
(–2.10 to 2.30)
continued
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(see Appendix 23); –0.24 weeks (95% CI –0.39 to –0.10 weeks) in SIMD4 (see Appendix 27); and –0.2 weeks
(95% CI –0.4 to –0.1 weeks) in SIMD5 (the least deprived areas; see Appendix 31).
In the most deprived areas (SIMD1), the odds of having an emergency caesarean section increased by 10%
(OR 1.10, 95% CI 1.03 to 1.18; see Appendix 18).
In the 20% of areas in the middle of the deprivation range (SIMD3), the odds of the mothers booking
before 25 weeks increased by 24% during the intervention period (OR 1.24, 95% CI 1.06 to 1.45) but the
odds of the mothers smoking during pregnancy increased by 10% (OR 1.10, 95% CI 1.01 to 1.20;
see Appendix 23).
During the intervention, babies’ standardised weight-for-dates (z-score) decreased by 0.4 for mothers with
diabetes mellitus (95% CI 0.1 to 0.6; see Appendix 37).
For severely obese mothers, the odds of booking before 25 weeks increased by 35% during the
intervention period (OR 1.35, 95% CI 1.05 to 1.72; see Appendix 39).
Sole registered mothers were more likely to book earlier during the intervention period; the mean
gestational age at booking decreased by 0.4 weeks (95% CI 0.1 to 0.7 weeks; Appendix 43).
In the working-class group, mothers were likely to book 0.5 weeks earlier (95% CI 0.4 to 0.6 weeks), and
the odds of booking before 25 weeks in this group increased by 19% (OR 1.19, 95% CI 1.04% to 1.35%;
see Appendix 47).
TABLE 24 Results of subgroup analysis for the primary outcome using the imputed data unadjusted for gestational
age at booking and maternal smoking: subgroups related to the socioeconomic position of the area of residence
(SIMD2009 version 2) (continued )
Parameter
Birthweight (g), coefficient (95% CI)
SIMD1: most
deprived areas SIMD2 SIMD3 SIMD4
SIMD5: least
deprived areas
Interactions
Interaction 1f
Interaction 2
g
Interaction 3h
Global test 2i 0.02 0.40 0.90 0.30 0.40
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
Note
When using the complete cases and adjusting the analysis for ethnicity, the mean gestational age at booking decreased
by 1.1 weeks (95% CI 1.0 weeks to 1.2 weeks) and the odds of booking before 25 weeks increased by 36% (OR 1.36,
95% CI 1.17 to 1.58; see Appendix 63). However, birthweight decreased by 12.8 g (95% CI 4.6 to 20.9 g; see Appendix 64)
and the odds of neonatal death increased by > 180% (OR 2.84; 95% CI 1.26% to 6.38%; see Appendix 66) during
the intervention.
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TABLE 25 Results of subgroup analysis for the primary outcome using the imputed data unadjusted for gestational age at booking and maternal smoking: other subgroups
Parameter
Birthweight (g), coefficient (95% CI)
Severely obese
mothers
Mothers with
diabetes mellitus Lone mothers
Mothers from
working-class
group
Mothers from
never worked
group Teen mothers Non-white mothers
Periods
Period 1a 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Period 2b –13.20
(–33.00 to 6.70)
–14.08
(–62.90 to 34.80)
–4.00
(–23.50 to 15.50)
–5.90
(–13.40 to 1.60)
–1.60
(–13.00 to 9.80)
–1.50
(–17.90 to 15.00)
–6.00
(–30.50 to 18.40)
Period 3c –41.00
(–69.30 to 12.70)
–68.60
(–138.30 to 1.10)
–22.30
(–49.30 to 4.70)
–13.50
(–24.00 to 2.90)
–10.60
(–26.50 to 5.40)
–11.60
(–34.70 to 11.50)
–20.70
(–56.70 to 15.30)
Global test 1d 0.003 0.03 0.10 0.04 0.20 0.40 0.40
Trend
All yearse 1.20
(–3.20 to 5.70)
–8.90
(–19.90 to 2.00)
5.50
(1.40 to 9.60)
5.30
(3.70 to 6.90)
3.40
(1.00 to 5.90)
5.10
(1.60 to 8.50)
7.50
(1.50 to 13.60)
Interactions
Interaction 1f
Interaction 2g
Interaction 3h
Global test 2i 0.007 0.0002 0.60 0.60 0.40 0.30 0.40
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
Note
When using the complete cases and adjusting the analysis for ethnicity, the mean gestational age at booking decreased by 1.1 weeks (95% CI 1.0 weeks to 1.2 weeks) and the odds of
booking before 25 weeks increased by 36% (OR 1.36, 95% CI 1.17 to 1.58; see Appendix 63). However, birthweight decreased by 12.8 g (95% CI 4.6 to 20.9 g; see Appendix 64) and the
odds of neonatal death increased by > 180% (OR 2.84; 95% CI 1.26 to 6.38; see Appendix 66) during the intervention.
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For mothers who lived in households in which the head of the household had never worked, there was
no statistically significant effect of the intervention on the primary outcome or most of the secondary
outcomes (see Appendices 51–54), but there was a reduction of 0.3 weeks in the mean gestation at
booking (95% CI 0.1 weeks to 0.5 weeks; see Appendix 51).
Gestational age at booking decreased by 0.5 weeks among teen mothers during the intervention period
(95% CI 0.2 to 0.8 weeks; see Appendix 55).
Gestational age at booking decreased by 0.7 weeks among non-white mothers during the intervention
period (95% CI 0.2 to 1.1 weeks; see Appendix 59). However, the odds of being SGA increased by 30%
for this group (OR 1.30, 95% CI 1.01 to 1.67; see Appendix 61).
Results of sensitivity analysis
Subgroup of nulliparous mothers
In the subgroup of nulliparous mothers (see Appendix 70), the odds of having a 5-minute Apgar score of
< 7 decreased by 13% during the intervention period (OR 0.87, 95% CI 0.77 to 0.99), but the odds of
having an elective caesarean section increased by 16% during the same period (OR 1.16, 95% CI 1.08 to
1.26; see Appendix 70).
Impact of restricting the pre-intervention period to the period following the
introduction of the smoking ban in public places
When restricting the pre-intervention period to the post-smoking-ban period, the odds of preterm birth
increased by 81% and the odds of very preterm birth increased by 280% during the intervention period
(see Appendix 73). The odds of neonatal deaths increased by 108% during the intervention period
(see Appendix 74).
Impact of moving the Health in Pregnancy grant period
When restricting the pre-intervention period to 18 months, the odds of booking before 25 weeks
increased by 12% (OR 1.12, 95% CI 1.03 to 1.22) and the odds of preterm birth decreased by 10%
(OR 0.90, 95% CI 0.84 to 0.96) during the intervention period. However, the odds of neonatal deaths
also increased by 98% (OR 1.98, 95% CI 1.31 to 2.98; see Appendix 75).
When the pre-intervention period was extended to 30 months, the odds of booking before 25 weeks
increased by 10% (OR 1.10, 95% CI 1.03 to 1.17) during the supposed intervention period. However, the
odds of preterm birth increased by 10% (OR 1.10, 95% CI 1.04 to 1.16), the odds of very preterm birth
increased by 28% (OR 1.28, 95% CI 1.14 to 1.44) and the odds of neonatal death increased by 76%
(OR 1.76, 95% CI 1.16 to 2.66; see Appendix 76).
When births that occurred during the peak months of the 2009 swine flu outbreak were excluded,
the odds of booking before 25 weeks increased by 9% (OR 1.09, 95% CI 1.02 to 1.17) during the
intervention period. However, the odds of preterm birth increased by 7% (OR 1.07, 95% CI 1.01 to 1.13),
the odds of very preterm birth by 19% (OR 1.19, 95% CI 1.04 to 1.34) and the odds of neonatal death
by 97% (OR 1.97, 95% CI 1.27 to 3.06; see Appendix 77).
Impact of moving the intervention period to 1 year before the real Health in
Pregnancy grant period
When moving the HiP grant period to 1 year before the real intervention period but maintaining its length
at 24 months, the odds of neonatal death increased by 85% during the supposed intervention period
(OR 1.85, 95% CI 1.22 to 2.81). The odds of preterm birth decreased by 12% (OR 0.88, 95% CI 0.80 to
0.97) and the odds of booking before 25 weeks increased by 23% (OR 1.23, 95% CI 1.09 to 1.38;
RESULTS
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see Appendix 78). The results were similar regardless of whether the intervention lasted 24, 18, and
30 months, except in the cases of preterm and very preterm births (see Appendices 78–80).
Impact of moving the intervention period to 6 months before the real Health in
Pregnancy grant period
When evaluating the HiP grant as though it began 6 months before it really began, and maintaining the
intervention length at 24 months, the odds of neonatal death increased by 64% during the supposed
intervention period (OR 1.64, 95% CI 1.08 to 2.49). However, the odds of preterm birth decreased by 12%
(OR 0.88, 95% CI 0.82 to 0.94) and the odds of booking before 25 weeks increased by 16% (OR 1.16,
95% CI 1.06 to 1.27; see Appendix 81). The results were similar when the supposed intervention period
was shortened to 18 months, although the odds of very preterm birth also decreased by > 50% (OR 0.47,
95% CI 0.38 to 0.58; see Appendix 82). Only the odds of booking before 25 weeks were statistically
significant when the intervention lasted 30 months (OR 1.15, 95% CI 1.06 to 1.24; see Appendix 83).
Impact of moving the intervention period to 6 months after the real Health in
Pregnancy grant period
Moving the start of the HiP grant period to 6 months after the real intervention period but maintaining its
length at 24 months resulted in a decrease in mean birthweight of 4.7 g (95% CI 0.5 to 8.8 g), and the odds
of preterm and very preterm birth increased by 14% (OR 1.14, 95% CI 1.09 to 1.20) and 34% (OR 1.34,
95% CI 1.20 to 1.48), respectively. The odds of booking before 25 weeks increased by 9% during the
supposed intervention period (OR 1.09, 95% CI 1.02 to 1.17; see Appendix 84). The results were similar
when the intervention lasted for 30 months (see Appendix 88). However, when the intervention lasted for
18 months, the odds of neonatal death increased by 51% (OR 1.51, 95% CI 1.02 to 2.23; see Appendix 85).
Impact of moving the intervention period to 1 year after the real Health in
Pregnancy grant period
Moving the start of the HiP grant period to 1 year after the real intervention period and keeping its length
at 24 months showed a decrease in mean birthweight of 4.2 g (95% CI 0.1 to 8.2 g), and the odds of
preterm and very preterm birth increased by 30% (OR 1.30, 95% CI 1.23 to 1.36) and 69% (OR 1.69,
95% CI 1.51 to 1.88), respectively (see Appendix 87). The results were similar when the intervention lasted
18 and 30 months (see Appendices 88 and 89).
Summary of results for the main analysis and moving windows
For the primary outcome (birthweight) and five secondary outcomes (gestational age at booking; booking
before 25 weeks; preterm delivery; very preterm delivery; and neonatal deaths), the main analysis and
moving windows results are summarised in Figures 3–8.
Economic analysis results
The HiP intervention period was not associated with any meaningful differences in birthweight outcomes
(very low birthweight: –83, 95% CI –223 to 80; low birthweight: 199, 95% CI –189 to 592; normal
birthweight: –116, 95% CI –471 to 238), although it trended towards a reduction in births of very low
birthweight. The HiP intervention period also led to negligible differences in gestational age outcomes
(very preterm: 90, 95% CI –20 to 204; preterm: 28, 95% CI –303 to 355; term: –118, 95% CI –427 to 191).
Finally, it also led to negligible differences in maternal outcomes. These results consequently meant that
there were negligible differences in index hospitalisation costs from a birthweight approach (–£0.2M,
95% CI –£1.0M to £0.6M); a preterm approach (£0.6M, 95% CI –£0.1M to £1.4M); and a maternal
outcomes approach (£0.2M, 95% CI –£0.1M to £0.5M). These figures were in contrast to a HiP grant cost
of £20.4M (Table 26).
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FIGURE 4 Coefficient and 95% CI for gestational age at booking during the HiP grant period and moving windows.
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FIGURE 5 Odds ratio and 95% CI for booking before 25 weeks during the HiP grant period and moving windows.
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FIGURE 6 Odds ratio and 95% CI for preterm delivery during the HiP grant period and moving windows.
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FIGURE 7 Odds ratio and 95% CI for very preterm delivery during the HiP grant period and moving windows.
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FIGURE 8 Odds ratio and 95% CI for neonatal death during the HiP grant period and moving windows.
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TABLE 26 Incremental outcomes and costs attributable to HiP grant intervention
Outcomes (95% CI)
Preterm Birthweight Pregnancy (maternal)
Very preterm (< 33 weeks) 90
(–20 to 204)
Very low (< 1500 g) –83
(–223 to 80)
Ectopic pregnancy 6 (–4 to 15)
Preterm (33–36 weeks) 28
(–303 to 355)
Low (1500–2499 g) 199
(–189 to 592)
Placenta previa 4 (–3 to 11)
Normal (> 36 weeks) –118
(–427 to 191)
Normal (> 2500 g) –116
(–471 to 238)
Abruptio placentae 1 (–1 to 3)
PPROM 37 (–25 to 98)
Pre-eclampsia –6 (–17 to 4)
Cost, £ million (95% CI)
Preterm 0.6
(–0.1 to 1.4)
Birthweight cost –0.2
(–1.0 to 0.6)
Pregnancy cost 0.2
(–0.1 to 0.5)
HiP 20.4 HiP cost 20.4 HiP cost 20.4
Δcost 21.1
(20.3 to 21.8)
Δcost 20.2
(19.5 to 21.0)
Δcost 20.6
(20.3 to 21.0)
Δcost, change in cost.
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Chapter 4 Discussion
Principal findings
There is no evidence that the HiP grant affected birthweight. The analysis in which we have the most
confidence, namely that relating to the analysis of 30 imputed data sets, indicates that singleton births during
the eligible period (births to mothers with a due date of delivery between 14 April 2009 and 7 April 2011)
had a mean birthweight that was 2.6 g lower than that of babies born during the pre-intervention period,
from 1 January 2004 to 30 March 2009 (95% CI –6.9 to 1.7 g). This change in mean birthweight was trivial
as well as not significant and reflected a like-for-like comparison through the inclusion of important maternal,
obstetric and sociodemographic confounders, as well as the seasonality in birthweight and the secular trend
of increasing birthweight.
The results of the complete-case analysis suggest that the HiP grant was associated with a significant
decrease in birthweight of 9.0 g (95% CI 3.7 to 14.3 g). The difference between these two results reflects
the fact that the complete cases represent a biased sample of the 532,968 singleton births that were
available for analysis.
In retrospect, the fact that we found no effect of the HiP grant on birthweight is perhaps not surprising,
given that the known modifiable determinants of low birthweight are largely limited to maternal smoking
and some specific aspects of nutrition.14,23–25,48 To this extent, the choice of birthweight as the primary
outcome measure of this study was somewhat optimistic.
Our findings for mean birthweight were supported by other measures of size and weight-for-dates.
There was no significant effect on the odds of low birthweight, very low birthweight or high birthweight,
suggesting that no part of the birthweight distribution was affected. Similarly, there was no significant
effect on the continuous measure of weight-for-dates (z-score) or on the odds of being either SGA or LGA.
There was evidence of a significant effect on head circumference (the mean head circumference of babies
associated with the intervention was 0.04 cm smaller than for babies pre intervention; 95% CI 0.03 to
0.05 cm) and crown-to-heel length (the mean length of babies in the intervention was 0.07 cm longer than
babies pre intervention, 95% CI 0.04 to 0.10 cm). However, these changes of < 1 mm are too small to be
of any clinical relevance and reflect the power available to the study through the use of a large routine
data set.
We do see a significant and positive impact on the date of booking. Mean gestational age at booking
during the intervention period was 0.35 weeks lower than pre intervention (95% CI 0.29 to 0.41 weeks).
This is a small effect, equivalent to a population shift of about 2.5 days, which in itself might be
considered unimportant. More important, however, is the increase in the odds of booking before
25 weeks; the HiP grant was associated with a 10% increase in the odds of booking before 25 weeks
(OR 1.10, 95% CI 1.02 to 1.18), suggesting that very late bookers were likely to seek help earlier.
This effect can be seen in Table 13; the crude proportion failing to book before 25 weeks [3.5% over the
10-year study period based on the imputed data (96.5% booked before 25 weeks)] decreased from 3.9%
in 2006–8 to 2.8% in 2009–11. A 1.1% absolute increase in the proportion of women seeking antenatal
care earlier in their pregnancy represents about 600 women each year. Women who book late in their
pregnancy tend to be more disadvantaged than those who book earlier; across the 10-year study period,
those booking at 25 weeks or later were more likely to be from a household in which the head of the
household had never worked (24% compared with 15% booking before 25 weeks), to be a lone parent
(12% vs. 5%) and to have been under the age of 20 years at the time of birth (12% vs. 6%).
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The only measure of maternal health behaviour – smoking during pregnancy – was unchanged by
the intervention. It is worth noting, however, that the odds of smoking during pregnancy showed
strong declines during the study period, with a reduction of 8% per year between 2004 and 2011.
Crude (imputed) rates of maternal smoking fell from 25.8% in 2004 to 18.8% in 2013.
The intervention was not associated with a significant effect on elective caesarean sections but it was
associated with an increase in emergency caesarean section (OR 1.07, 95% CI 1.03 to 1.10). On its own,
it is unclear if an increase in the emergency caesarean section rate is a good or a bad thing. Even if there
is no adverse health effect for mother or infant, surgical intervention represents an opportunity cost.
However, emergency as opposed to elective caesarean section should indicate a perceived need to
intervene for the safety of the mother or infant, and so an increase in this rate may be indicative of
something going wrong.
There were adverse outcomes associated with the intervention. Gestational age at delivery showed a small
reduction of 0.04 weeks (about 7 hours; 95% CI 0.02 to 0.06 weeks). This small decrease in mean
gestational age is accompanied by no significant effect on preterm births and a small (but again not
significant) increase in the odds of very preterm births (OR 1.11, 95% CI 0.98 to 1.25). This increase in
very preterm deliveries is likely to be associated with the increase in the emergency caesarean section rate
noted above (see Table 5).
The principal adverse finding is a large increase in the odds of neonatal death associated with the
intervention period (OR 1.84, 95% CI 1.22 to 2.78). The crude neonatal mortality rate, averaging 0.07%
between 2004 and 2013, was higher between 2009 and 2011 (0.08–0.09%) than in the 2 years before
(0.06–0.08%) or after (0.03–0.06%). This increase during the intervention period should be considered
against a background of falling neonatal mortality, with the odds of neonatal death falling by 9% per
year (95% CI 0% to 17%). There was no significant impact on either the stillbirth rate or the 5-minute
Apgar score.
With such limited impact on outcomes, the economic analysis showed that the HiP grant had very little
economic effect (positive or negative).
Impact on inequalities
Extensive subgroup analyses were undertaken to enable us to determine whether effects were stronger,
or indeed whether they just differed, for the most disadvantaged groups. These could potentially be
indications of effects on those with most to gain from the intervention, which are not observed when
the whole population is analysed (and with adjustment for measures of disadvantage).
There were no significant effects of the HiP grant on the subgroup of women with diabetes mellitus.
For all other subgroups, gestational age at booking was significantly reduced during the intervention
period; notably, the effect was more pronounced (i.e. the decrease in gestational age at booking
associated with the intervention period was larger) for those women with a BMI at booking of ≥ 35 kg/m2,
women living in the most deprived 20% of areas, lone mothers, women living in low social class
households and teen mothers. Conversely, the effect was less pronounced for women living in the more
advantaged areas. Of these subgroups, women with a BMI at booking of ≥ 35 kg/m2 and women
living in low social class households had increased odds of booking before 25 weeks. These odds were
significantly increased relative to the pre-intervention period, but were also larger than those found for
all women.
Women living in the most deprived 40% of areas and women living in households in which the head of
household had never worked showed significant increases in the odds of emergency caesarean section.
However, in each case these odds were lower than those seen for the general population.
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For women living in the most deprived 20% of areas, the intervention period was associated with a
decrease in mean offspring birthweight of 12 g (95% CI 4 to 21 g). Although this difference itself is
probably too small to be important, there was a significant decrease in the odds of high birthweight babies
(OR 0.93, 95% CI 0.86 to 1.00) and no significant change in the odds of low birthweight or very low
birthweight babies.
Among the subgroup of mothers for whom ethnicity was recorded as a group other than white, the
intervention period was associated with a decrease in mean gestational age. This group also saw a
significant increase in the odds of having a baby that was small for its gestational age (OR 1.30, 95% CI
1.01 to 1.67).
Robustness and generalisability
We undertook a number of further analyses in an attempt to find evidence for whether or not the
relationship between the intervention and the key outcomes was likely to be causal, and to try to
understand better how the intervention may have worked. The first of these analyses related to the
post-intervention period; following withdrawal of the intervention (for women who reached the 25th week
of pregnancy on or after 1 January 2011), the return of an outcome to a pre-intervention level may be
seen to strengthen the case that the change in outcome was attributable to the intervention. However, if
an outcome was maintained, or if its effect was increased post intervention, then it may be that behaviour
change was maintained following withdrawal of the intervention. Alternatively, it could be indicative of
macro-level effects unrelated to the intervention. It is also possible that the effect of macro-level activities
could be modified by the intervention; the unpredictable nature of such modifications would be difficult to
detect with a non-randomised design.
The decrease in mean gestational age at booking seen during the intervention period was extended post
intervention; relative to the pre-intervention period, mean gestational age at booking was 0.35 weeks
(95% CI 0.29 to 0.41 weeks) lower during the intervention period and 1.10 weeks (95% CI 1.02 to
1.20 weeks) lower post intervention. These decreases were seen over and above the decreasing trends in
gestational age at booking and may reflect the introduction and pursuit of Health improvement, Efficiency
and governance improvements, Access to services, Treatment appropriate to individuals (HEAT) targets.
A Health Improvement Target for 2012/13 was outlined as follows: ‘At least 80% of pregnant women in
each SIMD quintile will have booked for antenatal care by the 12th week of gestation by March 2015 so
as to ensure improvements in breast feeding rates and other important health behaviours’.79 Although this
was not formally introduced as a target during the intervention period, it is possible that health boards
were preparing for its introduction and trying to increase the numbers of women booking by 12 weeks in
all deprivation groups. Similarly, eligibility for the Healthy Start vouchers begins at 10 weeks of pregnancy
and requires the signature of a health professional, so this would have been an added incentive for the
more disadvantaged groups (i.e. those eligible for Healthy Start) to book earlier for antenatal care.
However, uptake of Healthy Start vouchers in pregnancy is generally low, and given that the scheme
started in 2006 it would have no influence on the analysis that was restricted to the post-smoking ban
period (from 2007 onwards). However, it is certainly plausible that the change in mean gestational age at
booking was attributable to the HEAT targets rather than to the HiP grant. The same is not true, however,
for the increase in the odds of booking before 25 weeks. The target of 25 weeks was related to eligibility
for the HiP grants and not the HEAT targets. Following the withdrawal of the HiP grants, there was a small
decrease in the odds of booking before 25 weeks (OR 0.91, 95% CI 0.83 to 1.00).
The odds of emergency caesarean section increased following the withdrawal of the HiP grant (OR 1.17,
95% CI 1.12 to 1.23). This meant that the odds of a woman receiving an emergency caesarean section
were higher in the post-intervention period than during the intervention, after full adjustment for all
covariates. The extent to which this could be attributable to the HiP grant is unclear.
The neonatal mortality rate remained high in the post-intervention period relative to the pre-intervention
period, although this difference was not significant (OR 1.52, 95% CI 0.84 to 2.74). It is also the case
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that the odds of neonatal mortality in the post-intervention period, although lower than during the
intervention, were not significantly lower. The extent to which the increase in the odds of neonatal
mortality might be attributable to the HiP grants is, therefore, unclear. It is clear, however, that the odds of
both preterm and very preterm births increased significantly in the post-intervention period but not during
the intervention, and the higher mortality rate post intervention could be associated with this increase.
Nulliparous women formed a group that would largely be coming into contact with antenatal services for
the first time and, as such, their behaviour would not be influenced by previous experience. The results
for both mean gestational age at booking and the odds of booking before 25 weeks for this group were
very similar to the results for all women. This group, however, had increased odds of elective caesarean
section in both the intervention period (OR 1.16, 95% CI 1.08 to 1.26) and post intervention (OR 1.26,
95% CI 1.13 to 1.40). The odds of emergency caesarean section were elevated in the post-intervention
period (OR 1.08, 95% CI 1.02 to 1.15) but not during the intervention (OR 1.00, 95% CI 0.96 to 1.05).
The ban on smoking in public places was introduced in Scotland on 26 March 2006. An evaluation of the
impact of the ban on pregnancy outcomes found an anticipatory effect, with rates of SGA births, preterm
births and spontaneous preterm births all decreasing as of 1 January 2006.80 Because of the potentially
contaminating effect of the introduction of the smoking ban on the outcomes that we were considering,
and, in particular, the effect on the pre-intervention trends, we repeated the main analysis for all outcomes
shortening the pre-intervention period by excluding all births before 1 January 2007.
When births from 2004–6 were excluded, we found a reduced, but still significant, reduction in mean
gestational age at booking of 0.17 weeks (95% CI 0.06 to 0.28 weeks), and the increase in the odds of
booking before 25 weeks was no longer significant (OR 1.05, 95% CI 0.92 to 1.20). Mean gestational age
at delivery was significantly lower and the odds of preterm and very preterm births were significantly
higher during the intervention period, whereas the odds of emergency caesarean section during the
intervention period were elevated, as noted above (OR 1.07, 95% CI 1.01 to 1.15).
To understand the findings when excluding the period before the smoking ban, it is important to
understand the nature of the estimates presented. As detailed above (see Chapter 2, Models fitted and
interpretation), the estimates represent the mean change from the underlying (pre-intervention) trend
associated with the intervention period. Using preterm births as an example, the OR of 1.02 (95% CI 0.97
to 1.08) associated with the intervention period given in Table 18 represents a slight (non-significant)
increase over the rate that would have been observed in 2010 had the pre-intervention trend remained
in place [the pre-intervention trend, estimated from January 2004 to March 2009, being a small annual
increase in the odds of preterm delivery (OR 0.96, 95% CI 0.95 to 0.97)]. The much larger estimate seen
in Table 99 (OR 1.81, 95% CI 1.64 to 2.01) is a departure from a much steeper annual decline pre
intervention seen from January 2007 to March 2009 (OR 0.74, 95% CI 0.71 to 0.77). Therefore, a plausible
explanation for the increased odds of preterm births when the pre-smoking ban period is excluded is that
the introduction of the smoking ban was associated with a rapid but short-lived decrease in preterm births;
preterm births during the intervention period were in line with the longer-term trend in such deliveries.
We investigated the effect of allowing the start and end dates (or more accurately the start and duration) of
the intervention period to vary for selected outcomes. The purpose of this sensitivity analysis was to ascertain
whether or not the actual intervention period represented the strongest ‘dose’, with a correspondingly
greater impact on outcomes than other periods that may have overlapped, but did not completely coincide,
with the intervention period. With a non-randomised study design such as ours, it is important to note that
there may be several external factors at play. This moving window analysis was designed to overcome the
difficulty in adjusting for all the different policies, interventions or events happening at different times in the
wider context that may have influenced our outcomes.
The results of this analysis were not conclusive, with a great deal of overlap between estimates and CIs
associated with differing hypothetical intervention periods. The extent of the overlap was not surprising
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given the overlap between the intervention periods, which can be seen in Table 8. We can see from
Figure 4, however, that smaller decreases in mean gestational age at booking were associated with earlier
intervention windows, thereby suggesting that the downwards trend in booking times had started
before the intervention period but that further declines were relatively modest following withdrawal of
the intervention.
Interpretation
To understand the findings presented here, it is necessary to consider the wider context of the period
under study. In particular, we looked for the influence of factors or events that may have impacted on
births in Scotland at some stage, whether these be Scotland-wide, UK-wide or more global in nature.
Above (see Robustness and generalisability), we discussed the introduction of a HEAT target, which was
designed to increase the proportion of women from the most disadvantaged areas who booked before the
12th week of pregnancy and concluded that, although this may have contributed to the decrease in the
mean gestational age at booking, it was unlikely to have caused the increase in the proportion of women
booking before the 25th week during the intervention period. This was both because of the relationship of
the 25-week target to the HiP grant, and because the proportion of women booking before 25 weeks fell
significantly following withdrawal of the grant.
We undertook a sensitivity analysis relating to the introduction of the smoking ban in public places in
Scotland that happened during the pre-intervention period, which was known to be associated with
positive outcomes and behaviour change. However, the results of this sensitivity analysis were unclear,
given that the exclusion of the period prior to the introduction of the smoking ban may have resulted in an
atypical pre-intervention period during which there were rapid changes in some outcomes. This led to our
finding of a significant increase in preterm births compared with the short-term (post-smoking-ban) trend,
but no significant increase compared with the longer-term trend.
Two other global events are worth some consideration. The first of these is the influenza A virus
A/H1N1pdm09 of swine origin (swine flu), which was declared to be a pandemic in June 2009. This virus
was known to affect pregnant women and perinatal outcomes adversely, increasing the odds of preterm
delivery and perinatal mortality in the UK.78,81 The outbreak peaked during the intervention period in
July 2009, and again from October to November 2009. It is difficult to know in exactly which stage of
pregnancy exposure to the virus had the greatest impact on outcomes. We excluded 5 months of births
from July to November 2009, inclusive, as a form of sensitivity analysis to ascertain whether or not
excluding the peak months of the pandemic changed any results. Excluding these months left most results
unchanged, but did lead to a significant increase in the odds of both preterm (OR 1.07, 95% CI 1.01 to
1.13) and very preterm birth (OR 1.19, 95% CI 1.04 to 1.34). The increased odds of neonatal death
remained significant (OR 1.97, 95% CI 1.27 to 3.06). The fact that these effects were larger than those
recorded in the main analysis indicates that the months excluded were lower risk than the months
included. It may be, therefore, that the months excluded for this sensitivity analysis were not just
conservative (in the sense that the peak months of the pandemic only were excluded) but also that the
month of delivery was not necessarily the most important factor affecting these outcomes.
Finally, the global financial crisis may have impacted on these results in ways that are difficult to predict.
Often considered to have begun with the collapse of the Lehman Brothers bank in September 2008, the
crisis resulted in recessions in many countries, including the UK, and the subsequent imposition of austerity
measures. There are many plausible mechanisms by which this crisis might have influenced perinatal
outcomes. One such route might be through increasing maternal malnutrition caused by economic hardship;
certainly, use of food banks has increased in the UK.82 Alternatively, it may be that increasing job insecurity,
associated with high levels of unemployment or precarious employment, has led to high levels of anxiety and
psychosocial stress, and thus that these have influenced outcomes. It is not clear how or when any such
effects would manifest themselves; although the poorest groups could be hardest hit, it is also plausible that
DOI: 10.3310/phr05060 PUBLIC HEALTH RESEARCH 2017 VOL. 5 NO. 6
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Leyland et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
63
there would be some protection for the worse off (such as the long-term unemployed) through the welfare
state, whereas those with jobs experience falling salaries and the stress of job insecurity. Therefore, our
sensitivity analyses focused not only on the most disadvantaged groups but also on groups from across the
spectrum of social advantage and disadvantage, and considered the population as broken down into
quintiles of deprivation. The results of these analyses were not, however, able to determine any effect that
may be attributable to the global financial crisis.
Strengths and weaknesses
A strength of the study was the very high quality, completeness and coverage of the linked routine
maternity hospital discharges and SBR.83 Linked data were available for about 98% of births in Scotland,84
with knowledge of all registered births. Such high-quality data are not currently available at a national level
for other countries in the UK, which means that it was not possible to extend this evaluation of HiP grants
beyond Scotland. To a large extent, the data were complete, with few missing data in most of the key
variables considered. This completeness was not universal and data on some variables, such as ethnicity
and maternal smoking, were poorly collected for some or all of the study period.
The methods used were appropriate for the analysis of these data. Individual data were used yielding high
power for the analyses and enabling data hierarchies of births nested within mothers and of mothers
nested within small areas to be taken into account. Multiple imputation was used to account for the fact
that the data were not complete. The results of the analysis of the multiply imputed data at times differed
from the complete-case analysis, thus suggesting that the data were not missing completely at random but
that missing values were patterned in ways that were associated with other (observed) variables. A large
number (30) of imputed data sets meant that the variability within the data was preserved through the
imputation process.
The study was based on routinely collected data, which meant that there was no information regarding
how the money was spent. The HiP grant was an unconditional cash transfer – there was no restriction
placed on how the money could be spent – and there is no way of knowing if it was spent in ways that
might improve, damage, or have no impact on the health of the mother and fetus.
The study design remains a major limitation. This was essentially an uncontrolled before-and-after study
(although unusually there was a period after the withdrawal of the intervention as well as before its
introduction to give comparison groups). The interference of changes in the context that occurred during
the study period – including, but not necessarily limited to, the introduction of the ban on smoking in public
places, the introduction of a HEAT target to increase the proportion of women from the most deprived
areas who sought early antenatal advice, the swine flu pandemic and the global financial crisis – may have
influenced a number of the outcomes for all women or selected subgroups in ways that are difficult to
predict with any certainty. This means that results from this study should be seen as indicative rather than
definitive; in the study protocol we acknowledged that this study design meant that it might be difficult to
attribute any effects with certainty to the HiP grant and suggested that, in such a case, a randomised
controlled trial might be necessary.85 It would have been possible to have conceived a randomised design for
the original grant when it was introduced. Failing this, another design facilitating evaluation such as a
stepped wedge design, as recommended by the House of Commons Health Committee in 2009,86 would
have satisfied any political requirement to introduce an (untested) intervention across the country. It remains
the case that policy interventions are still rarely introduced in such a way as to facilitate rigorous evaluation
and we would urge policy-makers to consider the importance of the evaluation of policy and to work with
researchers to utilise designs that would facilitate such evaluation, when considering introducing or
changing such public health programmes in the future.
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Patient and public involvement
This project had no direct patient involvement, as the analysis used anonymised patient records. There
would be benefits to the participation of pregnant women in a qualitative component of a future study as
a means of understanding whether and how the cash incentive led to behaviour changes including earlier
contact with health services. Such research could also explore how the money was spent and whether or
not it contributed to a healthier lifestyle. In a retrospective study such as this, evaluating an intervention
that has already been withdrawn, the difficulty in and potential bias of recalling such details made this
element impractical.
There was little room for the involvement of the public in designing this research project. The intervention
had already been designed, delivered and withdrawn. The methodology for the evaluation was determined
by the intervention design and best practice in statistics, economics and the evaluation of natural
experiments. The project would have benefited from public involvement on the project steering group,
particularly from groups focusing on pregnancy and on poverty. Such involvement would have ensured
that we were able to allay any fears over the use of confidential data in our analyses and that we reported
our results with sufficient sensitivity.
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Chapter 5 Conclusions
Implications for health care
We found no effect of the HiP grant on birthweight. Given the difficulty that has been found in changing
birthweight, this is probably not surprising, especially given the relatively small sum of money that the
grant amounted to.
We found an increase in the odds of booking before 25 weeks to be associated with the HiP grant.
We believe that it is likely that this is a direct effect of the £190 cash transfer acting as an incentive; seeking
antenatal care before the 25th week was a condition of receiving the money and, following withdrawal of
the grant, the odds of booking before 25 weeks fell significantly. This is in line with other examples of
health behaviour being influenced by cash incentives,36 and suggests that it is possible to ‘nudge’ behaviour,
including health-care-seeking behaviour. The care provided was normal care, and so the only implication for
health service provision was an increased uptake of services. The group of women targeted by such an
intervention – those who do not normally present to antenatal services until the 25th week of pregnancy
or later – tend to be more disadvantaged than those who present earlier in the pregnancy, with higher
proportions of worklessness, lone parents and teen mothers.
However, we did find significant increases in the likelihood of one adverse outcome, namely neonatal
mortality. It does not appear likely that this was associated with the intervention for two reasons. First, there
is no clear mechanism by which the intervention could have brought about this adverse result. If it were the
case that the £190 cash transfer had been spent in ways that led to higher neonatal mortality, then we
would expect the effect to be more pronounced in certain subgroups, namely for poorer women for whom
£190 might have represented a larger increase in available cash. This does not appear to have been the case
for women living in the most deprived areas or for women living in households in which the head of
household was a semiskilled or unskilled manual worker, for example. Second, if the payment of £190
associated with the introduction of the HiP grant caused an increase in neonatal mortality then its removal
should have brought about an equivalent decrease. The small decrease we found on removal of the grant
was far from significant and left the neonatal mortality rate higher than that seen prior to the introduction
of HiP. We feel that the impact of extraneous factors, such as the swine flu pandemic and the global
financial crises, are more likely to have been the causes of the increase in neonatal mortality. Unfortunately,
however, it is not possible to isolate and thereby distinguish the effects of these global phenomena.
It is unclear whether the increase in emergency caesarean sections that we found was an adverse effect
(i.e. an unnecessary and expensive surgical intervention) or whether such emergency interventions brought
about improvements in maternal and infant health. Given that we found a significant increase in the rate of
emergency caesarean sections in the post-intervention period, not only in relation to the pre-intervention
period but also in relation to the period during which the HiP grants were in place, it seems unlikely that the
HiP grant could have caused such an increase. It is plausible that this outcome and other related outcomes
(such as the odds of preterm or very preterm delivery, which were elevated but not significantly so) were
also related to the global context including the swine flu pandemic and the global financial crisis.
The outcomes that were used for the analyses contained in this report were restricted to those that are
routinely collected and do not include, for example, any measures of maternal wellbeing or mental health.
It is possible that such outcomes could have been affected by the cash transfer, and it is important to note
that the absence of evidence of an effect is not the same as evidence of the absence of an effect. It is possible
that booking shortly before the deadline – say in the 23rd or 24th week of pregnancy – does not leave much
time for the effect of any behavioural changes to be realised. It may be that earlier booking would lead to an
increased dose of antenatal care, and that either reinforcement of health messages over a longer antenatal
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period would lead to behaviour change, or earlier intervention would lead to behaviour change earlier in the
pregnancy. Either consequence of earlier booking might improve infant outcomes.
Recommendations for research
It seems likely that the HiP grant was responsible for an increase in the proportion of women booking
before 25 weeks, which represents a step in the right direction, but the big question is why this did not
translate into an improvement in any of the other outcomes evaluated. We have suggested above
(see Implications for health care) that this may in part reflect the threshold of 25 weeks being too late in
the pregnancy to modify behaviour in any way that would lead to notable differences in birthweight or
other outcomes indicating improved infant health. Our first recommendation for further research is,
therefore, to test whether a threshold earlier than 25 weeks would lead to increased exposure to antenatal
care and advice (increased frequency of antenatal visits), and whether any accompanying change in health
behaviour (such as smoking or diet) occurring earlier in the pregnancy would lead to improvements in
maternal and infant health outcomes. We recommend evaluation of the economic benefit that can be
achieved through such a modified threshold and any consequent improvement in results.
It should be noted that the disadvantaged nature of the approximately 4% of women who do not book
before 25 weeks offers an opportunity and a challenge. If the health-seeking behaviour of this group can
be modified then this offers an opportunity to provide services to a group with great potential to benefit
and, as a result, potentially to reduce inequalities in pregnancy outcomes. However, linking financial
incentives to booking targets may result in an effective penalty for those women who are in greatest need
of the money but fail to seek professional advice before the deadline, and if the incentive did not lead to
behaviour change in this group then this could lead to an increase in inequalities.
Our other recommendations concern the nature of the intervention, and, although these questions are
pertinent to such an intervention to improve pregnancy outcomes, they are relevant to many interventions
in different fields.
Our second recommendation is to evaluate whether or not this intervention has greater impact, and higher
cost-effectiveness, when delivered as a targeted or as a universal intervention. The HiP grant was universal;
all women could claim the same cash transfer regardless of personal circumstances. This approach has
many benefits, including an easier application process (no need for the complicated form filling that would
be required for a means-tested grant) and a lack of stigma or perceived stigma attached to the grant, both
of which should lead to higher uptake. There is clearly an opportunity cost; by targeting the payment to
those in the greatest need, the payment could be increased or the money saved could be used for other
purposes. An increased payment may not lead directly to an improvement in outcomes, but may provide
an added incentive to seek advice before the deadline. Targeting the payments also comes with an
attached cost, as there is a need to assess the eligibility of claimants.
Our third recommendation for future research is to test whether or not outcomes differ depending on
whether the payment is conditional or unconditional. The cash transfer in the HiP grant was unconditional
and could be spent as the recipient wished. This means that women were, in theory, able to spend the
money received on cigarettes, alcohol or other products that could damage the fetus. An alternative
approach would be to issue vouchers rather than cash with restrictions on what can be bought with those
vouchers (as happens, e.g., with the Healthy Start voucher scheme77). In fact, the two approaches are not as
distinct as they might at first appear, because spending a conditional payment on goods that would have
been bought anyway will free up cash to be spent as the recipient chooses. Their success depends in part
on the retailer enforcing any conditions that are attached, and restricting the retailers that can be used or
the goods that can be purchased may prove a disincentive, or may create inequalities between communities
with differential access to participating retailers. However, the success of conditional payments will also
depend on the acceptability of the restriction of goods to those women included in the scheme.
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Our fourth and final recommendation is to investigate the relationship between the size of the payment
and subsequent outcomes. The cash payment served two purposes: first, as an incentive to earlier
health-care booking in pregnancy, and second, as additional financial support. Varying the size of the
payment may not only indicate the optimal payment in terms of cost-effectiveness but may also,
in combination with changes to the threshold in the first recommendation above, lead to a better
understanding of the separate roles of antenatal care and financial support. For a given booking date a
dose–response relationship between the size of the payment and outcomes would emphasise the value of
the financial support, whereas improved outcomes associated with earlier antenatal booking at the same
level of financial support would highlight the importance of the antenatal care itself.
Research answering these questions would determine whether or not a modification of the HiP grant
should be considered as an option for policy-makers looking to improve pregnancy outcomes and to
address inequalities in health from the beginning of the life course.
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Appendix 1 Models specification (adjusted on
gestational age at booking and maternal smoking)
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TABLE 27 Models specification (adjusted on gestational age at booking and maternal smoking)
Covariates
Birthweight Booking status Measures of stage
Measures
of size Other birth outcomes
Maternal
smokingBW LBW
Very
LBW HBW GB Bb425W GD Preterm
Very
preterm z-score SGA LGA HC CHL
MD
SB
5
ApS NDElC EmC
Periods
Period 1:
pre intervention
Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref
Period 2:
intervention
(HiP grant)
Period 3: post
intervention
Year ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗
Interaction year and period
Period 1
Period 2
Period 3
A
PPEN
D
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w
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Covariates
Birthweight Booking status Measures of stage
Measures
of size Other birth outcomes
Maternal
smokingBW LBW
Very
LBW HBW GB Bb425W GD Preterm
Very
preterm z-score SGA LGA HC CHL
MD
SB
5
ApS NDElC EmC
Months
January Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref
February
March
April
May
June
July
August
September
October
November
December
Sex
Male Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref
Female
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TABLE 27 Models specification (adjusted on gestational age at booking and maternal smoking) (continued )
Covariates
Birthweight Booking status Measures of stage
Measures
of size Other birth outcomes
Maternal
smokingBW LBW
Very
LBW HBW GB Bb425W GD Preterm
Very
preterm z-score SGA LGA HC CHL
MD
SB
5
ApS NDElC EmC
Gestational
age at delivery
(weeks) ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗
Quadratic term
gestational
age at delivery
(weeks) ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗
Birthweight (g) ✗ ✗ ✗ ✗
Quadratic term
birthweight (g) ✗ ✗ ✗
Modes of delivery
Vaginal Ref Ref
Elective
caesarean
Emergency
caesarean
A
PPEN
D
IX
1
N
IH
R
Journals
Library
w
w
w
.journalslibrary.nihr.ac.uk
82
Covariates
Birthweight Booking status Measures of stage
Measures
of size Other birth outcomes
Maternal
smokingBW LBW
Very
LBW HBW GB Bb425W GD Preterm
Very
preterm z-score SGA LGA HC CHL
MD
SB
5
ApS NDElC EmC
Age (years) group
< 20 Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref
20–24
25–29
30–34
35–39
≥ 40
BMI at
booking
(kg/m2) ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗
Quadratic term
BMI at
booking
(kg/m2) ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗
Height (cm) ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗
Quadratic term
height (cm) ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗
Parity
0 Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref
1
2
3+
continued
D
O
I:10.3310/phr05060
PU
BLIC
H
EA
LTH
RESEA
RCH
2017
VO
L.5
N
O
.6
©
Q
ueen
’s
Printer
and
C
ontroller
of
H
M
SO
2017.
This
w
ork
w
as
produced
by
Leyland
et
al.
under
the
term
s
of
a
com
m
issioning
contract
issued
by
the
Secretary
of
State
for
H
ealth.
This
issue
m
ay
be
freely
reproduced
for
the
purposes
of
private
research
and
study
and
extracts
(or
indeed,
the
fullreport)
m
ay
be
included
in
professionaljournals
provided
that
suitable
acknow
ledgem
ent
is
m
ade
and
the
reproduction
is
not
associated
w
ith
any
form
of
advertising.
A
pplications
for
com
m
ercialreproduction
should
be
addressed
to:
N
IH
R
Journals
Library,
N
ationalInstitute
for
H
ealth
Research,
Evaluation,
Trials
and
Studies
C
oordinating
C
entre,
A
lpha
H
ouse,
U
niversity
of
Southam
pton
Science
Park,
Southam
pton
SO
16
7N
S,
U
K
.
83
TABLE 27 Models specification (adjusted on gestational age at booking and maternal smoking) (continued )
Covariates
Birthweight Booking status Measures of stage
Measures
of size Other birth outcomes
Maternal
smokingBW LBW
Very
LBW HBW GB Bb425W GD Preterm
Very
preterm z-score SGA LGA HC CHL
MD
SB
5
ApS NDElC EmC
Marital status
Married to each
other
Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref
Joint
registration:
same address
Joint
registration:
different address
Sole registration
Primary household social classes
Managerial and
professional
Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref
Intermediate
Working
Never worked/
long-term
unemployed
Diabetes mellitus
No Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref
Yes
Income domains of the SIMD
1: most deprived Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref
2
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Covariates
Birthweight Booking status Measures of stage
Measures
of size Other birth outcomes
Maternal
smokingBW LBW
Very
LBW HBW GB Bb425W GD Preterm
Very
preterm z-score SGA LGA HC CHL
MD
SB
5
ApS NDElC EmC
3
4
5: least deprived
Gestational age at booking (weeks)
0–12 Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref
13–24
25+
Smoking status at booking
Never smoked Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref
Current smoker
Former smoker
Smoking status during pregnancy
No Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref
Yes
Previous caesarean section
No Ref Ref
Yes
Statistical models
3-level linear
regression
(area, maternal
and baby level)
+ + + + + +
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TABLE 27 Models specification (adjusted on gestational age at booking and maternal smoking) (continued )
Covariates
Birthweight Booking status Measures of stage
Measures
of size Other birth outcomes
Maternal
smokingBW LBW
Very
LBW HBW GB Bb425W GD Preterm
Very
preterm z-score SGA LGA HC CHL
MD
SB
5
ApS NDElC EmC
3-level binomial
logistic regression
(area, maternal and
baby level)
+ + + + + + + + + +
2-level multinomial
logistic regression
(area and baby level)
+ + + +
✗, variables considered for adjustment in the statistical analysis; +, statistical models; 5 ApS, 5-minute Apgar score; Bb425W, booking before 25 weeks; BW, birthweight; CHL, crown-to-heel
length; ElC, elective caesarean; EmC, emergency caesarean; GB, gestational age at booking; GD, gestational age at delivery; HBW, high birthweight; HC, head circumference; MD, mode of
delivery; LBW, low birthweight; MS, maternal smoking during pregnancy; ND, neonatal death; Ref, reference; SB, stillbirth.
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Appendix 2 Results of the analysis for the
secondary outcomes using the complete cases
unadjusted for gestational age at booking and
maternal smoking: maternal behaviour
TABLE 28 Complete cases unadjusted for gestational age at booking and maternal smoking: maternal behaviour
Parameter
Maternal behaviour
Gestational age at booking
(weeks), coefficient (95% CI)
Booking before 25 weeks,
OR (95% CI)
Maternal smoking during this
pregnancy, OR (95% CI)
Periods
Period 1a 0.00 1.00 1.00
Period 2b –0.60 (–0.70 to 0.50) 1.05 (0.96 to 1.15) 0.98 (0.94 to 1.02)
Period 3c –1.50 (–1.60 to 1.40) 0.93 (0.82 to 1.05) 1.06 (1.00 to 1.12)
Global test 1d – – –
Trend
All yearse
Interactions
Interaction 1f –0.13 (–0.15 to 0.12) 1.10 (1.08 to 1.12) 0.94 (0.93 to 0.95)
Interaction 2g –0.82 (–0.87 to 0.76) 1.25 (1.16 to 1.35) 0.93 (0.90 to 0.96)
Interaction 3h –0.27 (–0.30 to 0.23) 0.94 (0.89 to 0.98) 0.99 (0.97 to 1.02)
Global test 2i < 0.0001 < 0.0001 < 0.0001
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
Note
Dashes indicate that no data were available.
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Appendix 3 The results of analysis for the
secondary outcomes using the complete cases
unadjusted for gestational age at booking and
maternal smoking: measures of size
TABLE 29 Complete cases unadjusted for gestational age at booking and maternal smoking: measures of size
Parameter
Measures of size
Very LBW,
OR (95% CI)
LBW, OR
(95% CI)
HBW, OR
(95% CI)
Head circumference
(cm), coefficient
(95% CI)
Crown-to-heel
length (cm)
coefficient (95% CI)
Periods
Period 1a 1.00 1.00 1.00 0.00 0.00
Period 2b 1.06
(0.78 to 1.45)
1.08
(0.99 to 1.17)
0.93
(0.90 to 0.98)
–0.03
(–0.05 to 0.02)
0.10
(0.09 to 0.20)
Period 3c 1.18
(0.75 to 1.84)
1.14
(1.01 to 1.29)
0.90
(0.85 to 0.95)
–0.10
(–0.14 to 0.07)
0.33
(0.27 to 0.39)
Global test 1d 0.70 0.09 0.002
Trend
All yearse 0.96
(0.89 to 1.03)
0.97
(0.95 to 0.99)
1.02
(1.01 to 1.03)
Interactions
Interaction 1f 0.008
(0.004 to 0.01)
0.005
(–0.005 to 0.02)
Interaction 2g –0.03
(–0.04 to 0.01)
0.11
(0.08 to 0.14)
Interaction 3h –0.05
(–0.06 to 0.04)
0.03
(0.01 to 0.05)
Global test 2i 0.80 0.07 0.05 < 0.0001 < 0.0001
HBW, high birthweight; LBW, low birthweight.
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
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Appendix 4 The results of analysis for the
secondary outcomes using the complete cases
unadjusted for gestational age at booking and
maternal smoking: measures of stage
TABLE 30 Complete cases unadjusted for gestational age at booking and maternal smoking: measures of stage
Parameter
Measures of stage
Gestational age at
delivery (weeks),
coefficient (95% CI)
Preterm, OR
(95% CI)
Very preterm,
OR (95% CI)
z-score,
coefficient
(95% CI)
SGA, OR
(95% CI)
LGA, OR
(95% CI)
Periods
Period 1a 0.00 1.00 1.00 0.00 1.00 1.00
Period 2b –0.03
(–0.06 to 0.005)
1.05
(0.98 to 1.12)
1.10
(0.93 to 1.30)
–0.02
(–0.03 to 0.008)
1.01
(0.95 to 1.08)
0.96
(0.91 to 1.00)
Period 3c –0.14
(–0.18 to 0.11)
1.26
(1.14 to 1.39)
1.45
(1.16 to 1.81)
–0.03
(–0.05 to 0.01)
1.04
(0.95 to 1.14)
0.95
(0.88 to 1.01)
Global test 1d 0.001 0.60 0.20
Trend
All yearse 0.010
(0.008 to 0.013)
0.97
(0.95 to 0.98)
1.00
(0.99 to 1.02)
Interactions
Interaction 1f 0.018
(0.012 to 0.024)
0.96
(0.95 to 0.98)
0.94
(0.91 to 0.98)
Interaction 2g 0.14
(0.13 to 0.16)
0.71
(0.68 to 0.75)
0.59
(0.55 to 0.66)
Interaction 3h 0.04
(0.02 to 0.05)
0.87
(0.84 to 0.90)
0.72
(0.67 to 0.78)
Global test 2i < 0.0001 < 0.0001 < 0.0001 0.20 0.50 0.40
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
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Appendix 5 The results of analysis for the
secondary outcomes using the complete cases
unadjusted for gestational age at booking and
maternal smoking: birth outcomes
TABLE 31 Complete cases unadjusted for gestational age at booking and maternal smoking: birth outcomes
Parameter
Birth outcomes
Mode of delivery
Stillbirth,
OR (95% CI)
5-minute
Apgar score,
OR (95% CI)
Neonatal death,
OR (95% CI)
Elective
caesarean,
OR (95% CI)
Emergency
caesarean,
OR (95% CI)
Periods
Period 1a 1.00 1.00 1.00 1.00 1.00
Period 2b 1.04
(0.99 to 1.10)
1.03
(0.99 to 1.08)
0.95
(0.78 to 1.16)
0.87
(0.77 to 0.98)
2.17
(1.28 to 3.69)
Period 3c 1.17
(1.08 to 1.26)
1.02
(0.93 to 1.12)
0.88
(0.66 to 1.17)
0.82
(0.70 to 0.97)
1.76
(0.81 to 3.80)
Global test 1d < 0.0001 0.60 0.05 0.003
Trend
All yearse 1.04
(1.03 to 1.05)
0.97
(0.93 to 1.02)
1.01
(0.99 to 1.04)
0.86
(0.77 to 0.97)
Interactions
Interaction 1f 0.99
(0.98 to 1.00)
Interaction 2
g
0.99
(0.96 to 1.02)
Interaction 3h 1.00
(0.98 to 1.02)
Global test 2i 0.40 0.90 0.20 0.90 0.02
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
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Appendix 6 The results of analysis for the
secondary outcomes using the complete cases and
adjusting the model for gestational age at booking
and maternal smoking: maternal behaviour
TABLE 32 Complete cases and adjusting the model for gestational age at booking and maternal smoking:
maternal behaviour
Parameter
Maternal behaviour
Gestational age at booking
(weeks), coefficient (95% CI)
Booking before 25 weeks,
OR (95% CI)
Maternal smoking during this
pregnancy, OR (95% CI)
Periods
Period 1a 0.00 1.00 1.00
Period 2b –0.60 (–0.70 to 0.50) 1.06 (0.96 to 1.16) 0.99 (0.95 to 1.04)
Period 3c –1.50 (–1.60 to 1.40) 0.94 (0.83 to 1.06) 0.96 (0.90 to 1.02)
Global test 1d
Trend
All yearse
Interactions
Interaction 1f –0.14 (–0.15 to 0.12) 1.10 (1.08 to 1.12) 0.93 (0.92 to 0.94)
Interaction 2
g
–0.82 (–0.87 to 0.77) 1.26 (1.17 to 1.35) 0.94 (0.91 to 0.98)
Interaction 3h –0.29 (–0.32 to 0.26) 0.97 (0.92 to 1.02) 1.00 (0.98 to 1.02)
Global test 2i < 0.0001 < 0.0001 < 0.0001
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
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Appendix 7 The results of analysis for the
secondary outcomes using the complete cases and
adjusting the model for gestational age at booking
and maternal smoking: measures of size
TABLE 33 Complete cases and adjusting the model for gestational age at booking and maternal smoking:
measures of size
Parameter
Measures of size
Very LBW,
OR (95% CI)
LBW, OR
(95% CI)
HBW, OR
(95% CI)
Head circumference
(cm), coefficient
(95% CI)
Crown-to-heel
length (cm),
coefficient (95% CI)
Periods
Period 1a 1.00 1.00 1.00 0.00 0.00
Period 2b 1.08
(0.76 to 1.53)
1.08
(0.98 to 1.19)
0.95
(0.90 to 0.99)
–0.05
(–0.07 to 0.03)
0.20
(0.15 to 0.25)
Period 3c 1.17
(0.71 to 1.91)
1.20
(1.05 to 1.38)
0.91
(0.85 to 0.97)
–0.13
(–0.16 to 0.11)
0.53
(0.46 to 0.60)
Global test 1d 0.80 0.02 0.007
Trend
All yearse 0.97
(0.90 to 1.05)
0.99
(0.96 to 1.01)
1.01
(1.00 to 1.02)
Interactions
Interaction 1f 0.0097
(0.005 to 0.014)
–0.04
(–0.05 to 0.03)
Interaction 2
g
–0.04
(–0.05 to 0.02)
0.08
(0.05 to 0.1)
Interaction 3h –0.055
(–0.064 to 0.045)
0.04
(0.02 to 0.07)
Global test 2i 0.80 0.047 0.06 < 0.0001 < 0.0001
HBW, high birthweight; LBW, low birthweight.
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
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Appendix 8 The results of analysis for the
secondary outcomes using the complete cases and
adjusting the model for gestational age at booking
and maternal smoking: measures of stage
TABLE 34 Complete cases and adjusting the model for gestational age at booking and maternal smoking:
measures of stage
Parameter
Measures of stage
Gestational
age at delivery
(weeks),
coefficient
(95% CI)
Preterm, OR
(95% CI)
Very
preterm,
OR (95% CI)
z-score,
coefficient
(95% CI)
SGA, OR
(95% CI)
LGA, OR
(95% CI)
Periods
Period 1a 0.00 1.00 1.00 0.00 1.00 1.00
Period 2b –0.03
(–0.06 to 0.003)
1.06
(0.98 to 1.14)
1.10
(0.91 to 1.32)
–0.02
(–0.03 to 0.008)
1.03
(0.96 to 1.11)
0.97
(0.92 to 1.02)
Period 3c –0.10
(–0.14 to 0.06)
1.21
(1.09 to 1.35)
1.32
(1.03 to 1.70)
–0.04
(–0.06 to 0.02)
1.10
(1.00 to 1.22)
0.95
(0.88 to 1.02)
Global test 1d 0.0001 0.07 0.40
Trend
All yearse 0.004
(0.0008 to 0.007)
0.98
(0.96 to 0.99)
0.99
(0.98 to 1.00)
Interactions
Interaction 1f 0.01
(0.008 to 0.02)
0.97
(0.95 to 0.98)
0.96
(0.93 to 1.00)
Interaction 2g 0.14
(0.12 to 0.16)
0.72
(0.68 to 0.76)
0.61
(0.54 to 0.69)
Interaction 3h 0.04
(0.03 to 0.05)
0.87
(0.84 to 0.90)
0.74
(0.69 to 0.80)
Global test 2i < 0.0001 < 0.0001 < 0.0001 0.01 0.90 0.30
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
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Appendix 9 The results of analysis for the
secondary outcomes using the complete cases and
adjusting the model for gestational age at booking
and maternal smoking: birth outcomes
TABLE 35 Complete cases and adjusting the model for gestational age at booking and maternal smoking:
birth outcomes
Parameter
Birth outcomes, OR (95% CI)
Mode of delivery
Stillbirth
5-minute
Apgar score
Neonatal
death
Elective
caesarean
Emergency
caesarean
Periods
Period 1a 1.00 1.00 1.00 1.00 1.00
Period 2b 1.06
(1.00 to 1.12)
1.02
(0.97 to 1.08)
0.99
(0.78 to 1.26)
0.88
(0.77 to 1.01)
2.58
(1.38 to 4.82)
Period 3c 1.17
(1.08 to 1.28)
1.08
(1.01 to 1.16)
0.99
(0.72 to 1.38)
0.81
(0.67 to 0.98)
1.97
(0.79 to 4.90)
Global test 1d 0.0001
Trend
All yearse 1.03
(1.02 to 1.05)
0.97
(0.92 to 1.02)
1.02
(0.99 to 1.05)
0.87
(0.75 to 0.99)
Interactions
Interaction 1f 0.99
(0.98 to 1.01)
Interaction 2
g
0.98
(0.95 to 1.01)
Interaction 3h 0.99
(0.97 to 1.02)
Global test 2i 0.30 0.70 0.30 0.90 0.20
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
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Appendix 10 Other parameter estimates for the
primary and secondary outcomes using the imputed
data and unadjusted for gestational age at booking
and maternal smoking: maternal behaviour
TABLE 36 Other parameter estimates for the primary and secondary outcomes using the imputed data and
unadjusted for gestational age at booking and maternal smoking: maternal behaviour
Other parameter
estimates
Maternal behaviour
Gestational age at booking
(weeks), coefficient (95% CI)
Booking before 25 weeks,
OR (95% CI)
Maternal smoking during this
pregnancy, OR (95% CI)
Months
January 0.00 1.00 1.00
February –0.02 (–0.09 to 0.05) 0.98 (0.91 to 1.06) 1.00 (0.96 to 1.04)
March –0.09 (–0.20 to 0.02) 1.03 (0.95 to 1.12) 0.96 (0.92 to 0.99)
April –0.10 (–0.20 to 0.03) 0.98 (0.90 to 1.06) 0.95 (0.91 to 0.99)
May –0.06 (–0.10 to 0.01) 0.94 (0.87 to 1.02) 0.93 (0.89 to 0.97)
June –0.05 (–0.10 to 0.02) 0.97 (0.90 to 1.05) 0.94 (0.90 to 0.98)
July 0.10 (0.04 to 0.20) 0.96 (0.89 to 1.04) 0.92 (0.88 to 0.96)
August 0.10 (0.05 to 0.20) 0.97 (0.90 to 1.04) 0.90 (0.87 to 0.94)
September –0.05 (–0.10 to 0.02) 0.95 (0.88 to 1.02) 0.91 (0.88 to 0.95)
October –0.10 (–0.20 to 0.04) 0.98 (0.91 to 1.06) 0.90 (0.86 to 0.94)
November –0.09 (–0.20 to 0.02) 0.96 (0.89 to 1.04) 0.92 (0.88 to 0.96)
December –0.20 (–0.3 to 0.10) 1.01 (0.93 to 1.09) 0.92 (0.88 to 0.95)
Global test < 0.0001 0.60 < 0.0001
Age (years) group
< 20 0.00 1.00 1.00
20–24 –0.53 (–0.60 to 0.46) 1.19 (1.12 to 1.27) 0.90 (0.87.88 to 0.93)
25–29 –0.76 (–0.83 to 0.69) 1.46 (1.37 to 1.56) 0.76 (0.74 to 0.79)
30–34 –0.80 (–0.90 to 0.70) 1.67 (1.55 to 1.79) 0.70 (0.67 to 0.72)
35–39 –0.70 (–0.80 to 0.60) 1.74 (1.61 to 1.88) 0.68 (0.65 to 0.70)
40+ –0.40 (–0.50 to 0.30) 1.63 (1.47 to 1.82) 0.61 (0.58 to 0.65)
Global test < 0.0001 < 0.0001 < 0.0001
BMI (kg/m2)
BMI at booking 0.11 (0.08 to 0.13) 0.89 (0.87 to 0.91)
Quadratic term BMI
at booking
–0.0016 (–0.0020 to 0.0013) 1.00 (1.00 to 1.00)
continued
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TABLE 36 Other parameter estimates for the primary and secondary outcomes using the imputed data and
unadjusted for gestational age at booking and maternal smoking: maternal behaviour (continued )
Other parameter
estimates
Maternal behaviour
Gestational age at booking
(weeks), coefficient (95% CI)
Booking before 25 weeks,
OR (95% CI)
Maternal smoking during this
pregnancy, OR (95% CI)
Height (cm)
Height
Quadratic term
height
Parity
0 0.00 1.00 1.00
1 –0.05 (–0.08 to 0.02) 1.28 (1.24 to 1.33) 1.27 (1.24 to 1.29)
2 0.25 (0.20 to 0.29) 1.15 (1.09 to 1.21) 1.80 (1.76 to 1.85)
3+ 0.83 (0.77 to 0.90) 0.79 (0.75 to 0.85) 2.59 (2.51 to 2.68)
Global test < 0.0001 < 0.0001 < 0.0001
Marital status
Married to each
other
0.00 1.00 1.00
Joint registration:
same address
0.02 (–0.01 to 0.06) 1.12 (1.07 to 1.17) 3.30 (3.22 to 3.37)
Joint registration:
different address
0.22 (0.16 to 0.27) 1.06 (0.99 to 1.12) 4.30 (4.18 to 4.43)
Sole registration 1.47 (1.40 to 1.54) 0.52 (0.49 to 0.55) 5.33 (5.11 to 5.57)
Global test < 0.0001 < 0.0001 < 0.0001
Primary household social classes
Managerial and
professional
0.00 1.00 1.00
Intermediate –0.13 (–0.17 to 0.09) 1.14 (1.09 to 1.20) 1.44 (1.40 to 1.48)
Working –0.16 (–0.19 to 0.12) 1.22 (1.17 to 1.28) 2.46 (2.40 to 2.53)
Never worked/
long-term
unemployed
0.52 (0.46 to 0.57) 0.74 (0.70 to 0.78) 2.87 (2.78 to 2.96)
Global test < 0.0001 < 0.0001 < 0.0001
Diabetes mellitus
No 0.00 1.00 1.00
Yes –0.5 (–0.6 to 0.4) 1.10 (0.95 to 1.27) 0.89 (0.83 to 0.96)
Income domains of the SIMD
1: most deprived 0.00 1.00 1.00
2 –0.40 (–0.50 to 0.30) 1.05 (0.99 to 1.11) 0.87 (0.84 to 0.89)
3 –0.30 (–0.40 to 0.20) 0.87 (0.81 to 0.92) 0.70 (0.68 to 0.72)
4 –0.30 (–0.40 to 0.20) 0.85 (0.80 to 0.91) 0.54 (0.52 to 0.56)
5: least deprived –0.40 (–0.50 to 0.30) 0.86 (0.81 to 0.92) 0.41 (0.39 to 0.43)
Global test < 0.0001 < 0.0001 < 0.0001
Blank cells indicate that terms were not included in the models.
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Appendix 11 Other parameter estimates for the
primary and secondary outcomes using the imputed
data and unadjusted for gestational age at booking
and maternal smoking: measures of size
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TABLE 37 Other parameter estimates for the primary and secondary outcomes using the imputed data and unadjusted for gestational age at booking and maternal smoking:
measures of size
Other parameter
estimates
Measures of size
Birthweight (g),
coefficient (95% CI)
Very LBW, OR
(95% CI) LBW, OR (95% CI) HBW, OR (95% CI)
Head circumference (cm),
coefficient (95% CI)
Crown-to-heel length (cm),
coefficient (95% CI)
Months 0.00
January 4.90 (–0.60 to 10.40) 1.00 1.00 1.00 0.00 0.00
February 4.60 (–0.80 to 10.00) 0.95 (0.70 to 1.28) 1.01 (0.93 to 1.10) 1.04 (0.99 to 1.09) –0.01 (–0.03 to 0.002) –0.02 (–0.06 to 0.02)
March 11.90 (6.40 to 17.50) 0.90 (0.67 to 1.21) 1.06 (0.98 to 1.15) 1.02 (0.98 to 1.06) –0.01 (–0.03 to 0.004) –0.004 (–0.04 to 0.03)
April 10.30 (4.80 to 15.70) 0.89 (0.66 to 1.18) 0.96 (0.89 to 1.05) 1.08 (1.03 to 1.12) –0.02 (–0.04 to –0.009) –0.02 (–0.06 to 0.02)
May 10.60 (5.20 to 16.10) 0.99 (0.74 to 1.33) 1.01 (0.93 to 1.10) 1.06 (1.02 to 1.11) –0.04 (–0.05 to 0.02) –0.04 (–0.07 to 0.003)
June 14.90 (9.50 to 20.20) 1.03 (0.77 to 1.38) 0.96 (0.88 to 1.04) 1.07 (1.03 to 1.12) –0.04 (–0.06 to 0.02) –0.02 (–0.06 to 0.02)
July 18.70 (13.30 to 24.00) 1.11 (0.83 to 1.49) 0.95 (0.88 to 1.03) 1.08 (1.03 to 1.13) –0.04 (–0.06 to 0.02) –0.03 (–0.07 to 0.005)
August 18.60 (13.20 to 24.00) 0.93 (0.69 to 1.25) 0.94 (0.87 to 1.03) 1.09 (1.05 to 1.14) –0.04 (–0.05 to 0.02) 0.04 (0.002 to 0.08)
September 18.80 (13.40 to 24.20) 0.95 (0.71 to 1.28) 0.99 (0.91 to 1.08) 1.11 (1.07 to 1.16) –0.02 (–0.04 to 0.004) 0.01 (–0.03 to 0.05)
October 16.60 (11.10 to 22.10) 1.03 (0.77 to 1.38) 0.92 (0.85 to 1.00) 1.13 (1.08 to 1.17) –0.02 (–0.03 to 0.0002) 0.01 (–0.03 to 0.05)
November 5.50 (0.01 to 11.00) 0.74 (0.54 to 1.00) 0.98 (0.90 to 1.07) 1.11 (1.07 to 1.16) –0.01 (–0.03 to 0.002) 0.0002 (–0.04 to 0.04)
December < 0.0001 0.82 (0.60 to 1.11) 1.00 (0.92 to 1.09) 1.02 (0.97 to 1.06) –0.001 (–0.02 to 0.02) 0.07 (0.03 to 0.1)
Global test 0.40 0.07 < 0.0001 < 0.0001 < 0.0001
Sex 0.00
Male –133.10 (–135.30 to 130.90) 1.00 1.00 1.00 0.00 0.00
Female 519.40 (508.90 to 530.00) 1.83 (1.62 to 2.07) 1.67 (1.61 to 1.72) 0.53 (0.52 to 0.54) –0.38 (–0.39 to 0.38) –0.31 (–0.33 to 0.29)
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Other parameter
estimates
Measures of size
Birthweight (g),
coefficient (95% CI)
Very LBW, OR
(95% CI) LBW, OR (95% CI) HBW, OR (95% CI)
Head circumference (cm),
coefficient (95% CI)
Crown-to-heel length (cm),
coefficient (95% CI)
Gestational age at delivery (weeks)
Gestational age at
delivery
–4.50 (–4.70 to 4.40) 0.33 (0.32 to 0.34) 0.359 (0.355 to 0.363) 33.13 (22.24 to 49.36) 0.28 (0.24 to 0.33) 1.10 (1.00 to 1.20)
Quadratic term gestational age at delivery 0.96 (0.96 to 0.97) –0.0026 (–0.0032 to 0.0020) –0.011 (–0.014 to 0.010)
Birthweight (g)
Birthweight 0.00279 (0.00274 to 0.00285) 0.0063 (0.0061 to 0.0064)
Quadratic term birthweight –1.51e-07 (–1.59e-07 to –1.43e-07) –4.19e-07 (–4.40e-07 to –3.98e-07)
Age (years) group
< 20 0.00 1.00 1.00 1.00 0.00 0.00
20–24 –43.70 (–48.90 to 38.40) 1.27 (0.99 to 1.63) 1.36 (1.26 to 1.46) 0.88 (0.84 to 0.92) –0.01 (–0.02 to 0.006) 0.02 (–0.01 to 0.06)
25–29 –54.90 (–60.40 to 49.40) 1.54 (1.19 to 1.99) 1.49 (1.38 to 1.60) 0.89 (0.85 to 0.93) –0.005 (–0.02 to 0.01) 0.06 (0.02 to 0.1)
30–34 –57.30 (–63.00 to 51.50) 1.49 (1.14 to 1.96) 1.68 (1.56 to 1.82) 0.90 (0.86 to 0.93) 0.03 (0.01 to 0.04) 0.10 (0.08 to 0.2)
35–39 –60.90 (–67.10 to 54.70) 1.98 (1.48 to 2.64) 1.88 (1.72 to 2.04) 0.90 (0.86 to 0.95) 0.06 (0.04 to 0.07) 0.15 (0.10 to 0.19)
≥ 40 –73.10 (–81.50 to 64.80) 2.13 (1.45 to 3.13) 2.07 (1.85 to 2.32) 0.85 (0.80 to 0.91) 0.99 (0.08 to 0.12) 0.23 (0.18 to 0.29)
Global test < 0.0001 < 0.0001 < 0.0001 < 0.0001 < 0.0001 < 0.0001
BMI (kg/m2)
BMI at booking 38.80 (37.00 to 40.70) 0.99 (0.98 to 1.01) 0.81 (0.79 to 0.83) 1.20 (1.19 to 1.22) 0.0113 (0.0106 to 0.0119) 0.0003 (–0.001 to 0.002)
Quadratic term BMI
at booking
–0.45 (–0.48 to –0.41) 1.00 (1.00 to 1.00) 1.00 (1.00 to 1.00)
Height (cm)
Height 24.00 (16.80 to 31.30) 0.97 (0.96 to 0.98) 0.79 (0.72 to 0.87) 1.14 (1.08 to 1.21) –0.04 (–0.06 to 0.02) 0.019 (0.018 to 0.021)
Quadratic term
height
–0.03 (–0.05 to 0.009) 1.00 (1.00 to 1.00) 1.00 (1.00 to 1.00) 0.0001 (0.00008 to 0.0002)
continued
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TABLE 37 Other parameter estimates for the primary and secondary outcomes using the imputed data and unadjusted for gestational age at booking and maternal smoking:
measures of size (continued )
Other parameter
estimates
Measures of size
Birthweight (g),
coefficient (95% CI)
Very LBW, OR
(95% CI) LBW, OR (95% CI) HBW, OR (95% CI)
Head circumference (cm),
coefficient (95% CI)
Crown-to-heel length (cm),
coefficient (95% CI)
Parity
0 0.00 1.00 1.00 1.00 0.00 0.00
1 116.90 (114.40 to 119.40) 0.74 (0.64 to 0.86) 0.66 (0.64 to 0.69) 1.63 (1.59 to 1.66) 0.01 (0.007 to 0.02) –0.08 (–0.10 to 0.06)
2 129.00 (125.40 to 132.60) 0.70 (0.58 to 0.86) 0.68 (0.64 to 0.71) 1.76 (1.72 to 1.81) 0.02 (0.01 to 0.03) –0.11 (–0.14 to 0.09)
3+ 117.80 (112.70 to 122.90) 0.47 (0.37 to 0.59) 0.70 (0.65 to 0.75) 1.79 (1.72 to 1.85) 0.03 (0.01 to 0.04) –0.09 (–0.10 to 0.05)
Global test < 0.0001 < 0.0001 < 0.0001 < 0.0001 < 0.0001 < 0.0001
Marital status
Married to each
other
0.00 1.00 1.00 1.00 0.00 0.00
Joint registration:
same address
–43.90 (–46.90 to 40.80) 01.26 (1.08 to 1.46) 1.35 (1.29 to 1.41) 0.87 (0.85 to 0.89) –0.01 (–0.02 to 0.005) –0.06 (–0.08 to 0.04)
Joint registration:
different address
–66.80 (–71.30 to 62.30) 1.24 (1.01 to 1.52) 1.51 (1.43 to 1.60) 0.79 (0.76 to 0.82) –0.005 (–0.02 to 0.008) –0.07 (–0.10 to 0.03)
Sole registration –97.50 (–103.20 to 91.80) 1.28 (0.99 to 1.64) 1.81 (1.69 to 1.95) 0.71 (0.67 to 0.74) –0.003 (–0.02 to 0.01) –0.10 (–0.10 to 0.07)
Global test < 0.0001 0.03 < 0.0001 < 0.0001 0.01 < 0.0001
Primary household social class
Managerial and
professional
0.00 1.00 1.00 1.00 0.00 0.00
Intermediate –6.30 (–9.80 to 2.80) 1.04 (0.86 to 1.27) 1.10 (1.04 to 1.16) 1.00 (0.98 to 1.03) –0.001 (–0.01 to 0.009) –0.02 (–0.04 to 0.005)
Working –36.50 (–39.70 to 33.20) 1.03 (0.87 to 1.23) 1.37 (1.31 to 1.44) 0.90 (0.88 to 0.92) –0.045 (–0.054 to 0.036) –0.04 (–0.07 to 0.02)
Never worked/
long-term
unemployed
–64.90 (–69.40 to 60.40) 1.02 (0.82 to 1.27) 1.64 (1.54 to 1.74) 0.80 (0.78 to 0.83) –0.05 (–0.06 to 0.04) –0.08 (–0.10 to 0.05)
Global test < 0.0001 0.90 < 0.0001 < 0.0001 < 0.0001 < 0.0001
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Other parameter
estimates
Measures of size
Birthweight (g),
coefficient (95% CI)
Very LBW, OR
(95% CI) LBW, OR (95% CI) HBW, OR (95% CI)
Head circumference (cm),
coefficient (95% CI)
Crown-to-heel length (cm),
coefficient (95% CI)
Diabetes mellitus
No 0.00 1.00 1.00 1.00 0.00 0.00
Yes 258.60 (248.80 to 268.40) 0.40 (0.28 to 0.59) 0.26 (0.22 to 0.30) 3.42 (3.21 to 3.66) –0.05 (–0.07 to 0.02) –0.02 (–0.09 to 0.04)
Income domains of the SIMD
1: most deprived 0.00 1.00 1.00 1.00 0.00 0.00
2 24.50 (20.20 to 28.70) 1.04 (0.88 to 1.23) 0.88 (0.84 to 0.93) 1.12 (1.09 to 1.15) –0.01 (–0.02 to 0.004) –0.01 (–0.10 to 0.08)
3 36.00 (31.60 to 40.40) 0.87 (0.72 to 1.05) 0.82 (0.78 to 0.87) 1.13 (1.10 to 1.16) –0.02 (–0.03 to 0.006) –0.10 (–0.30 to 0.08)
4 51.70 (47.10 to 56.30) 0.82 (0.66 to 1.00) 0.71 (0.67 to 0.76) 1.20 (1.16 to 1.23) –0.03 (–0.05 to 0.02) –0.30 (–0.40 to 0.20)
5: least deprived 59.10 (54.30 to 63.90) 0.82 (0.65 to 1.02) 0.65 (0.61 to 0.70) 1.21 (1.17 to 1.25) –0.01 (–0.03 to 0.002) –0.30 (–0.40 to 0.20)
Global test < 0.0001 0.07 < 0.0001 < 0.0001 0.0001 < 0.0001
HBW, high birthweight; LBW, low birthweight.
Blank cells indicate that terms were not included in the models.
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Appendix 12 Other parameter estimates for the
primary and secondary outcomes using the imputed
data and unadjusted for gestational age at booking
and maternal smoking: measures of stage
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TABLE 38 Other parameter estimates for the primary and secondary outcomes using the imputed data and unadjusted for gestational age at booking and maternal smoking:
measures of stage
Other parameter
estimates
Measures of stage
Gestational age at delivery
(weeks), coefficient
(95% CI)
Preterm, OR
(95% CI)
Very preterm,
OR (95% CI) z-score, coefficient (95% CI) SGA, OR (95% CI) LGA, OR (95% CI)
Months
January 0.00 1.00 1.00 0.00 1.00 1.00
February 0.03 (0.009 to 0.06) 0.96 (0.90 to 1.02) 1.04 (0.91 to 1.19) 0.01 (–0.001 to 0.02) 0.95 (0.89 to 1.01) 1.02 (0.97 to 1.07)
March 0.05 (0.02 to 0.07) 0.94 (0.88 to 0.99) 1.10 (0.97 to 1.25) 0.01 (–0.001 to 0.02) 0.97 (0.91 to 1.03) 0.99 (0.95 to 1.05)
April –0.03 (–0.06 to 0.009) 1.06 (1.00 to 1.12) 1.17 (1.03 to 1.33) 0.03 (0.02 to 0.04) 0.93 (0.87 to 0.99) 1.08 (1.03 to 1.13)
May 0.07 (0.05 to 0.10) 0.88 (0.83 to 0.93) 0.92 (0.81 to 1.05) 0.02 (0.01 to 0.03) 0.96 (0.91 to 1.03) 1.03 (0.98 to 1.08)
June 0.08 (0.05 to 0.10) 0.88 (0.83 to 0.93) 0.91 (0.79 to 1.04) 0.02 (0.01 to 0.04) 0.95 (0.89 to 1.01) 1.06 (1.01 to 1.11)
July 0.07 (0.05 to 0.10) 0.87 (0.82 to 0.93) 0.85 (0.74 to 0.97) 0.03 (0.02 to 0.04) 0.94 (0.89 to 1.01) 1.07 (1.02 to 1.12)
August 0.08 (0.06 to 0.11) 0.89 (0.84 to 0.95) 0.85 (0.75 to 0.98) 0.04 (0.03 to 0.05) 0.94 (0.88 to 1.00) 1.08 (1.02 to 1.12)
September 0.09 (0.06 to 0.11) 0.82 (0.77 to 0.87) 0.84 (0.73 to 0.96) 0.04 (0.03 to 0.05) 0.92 (0.86 to 0.98) 1.10 (1.05 to 1.16)
October 0.09 (0.06 to 0.11) 0.89 (0.84 to 0.94) 0.90 (0.79 to 1.03) 0.04 (0.03 to 0.05) 0.91 (0.85 to 0.97) 1.08 (1.03 to 1.13)
November 0.08 (0.06 to 0.10) 0.85 (0.80 to 0.90) 0.83 (0.73 to 0.96) 0.04 (0.02 to 0.05) 0.93 (0.87 to 0.99) 1.08 (1.03 to 1.13)
December 0.08 (0.06 to 0.10) 0.83 (0.78 to 0.88) 0.79 (0.69 to 0.90) 0.01 (–0.0004 to 0.02) 0.96 (0.90 to 1.02) 1.01 (0.96 to 1.06)
Global test < 0.0001 < 0.0001 < 0.0001 < 0.0001 0.30 < 0.0001
Sex
Male 0.00 1.00 1.00 0.00 1.00 1.00
Female 0.06 (0.05 to 0.07) 0.86 (0.84 to 0.88) 0.81 (0.77 to 0.86) –0.296 (–0.30 to 0.291) 1.74 (1.69 to 1.79) 0.54 (0.52 to 0.55)
Gestational age at delivery (weeks)
Gestational age at delivery –0.14 (–0.20 to 0.12)
Quadratic term gestational age at delivery 0.002 (0.001 to 0.002)
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Other parameter
estimates
Measures of stage
Gestational age at delivery
(weeks), coefficient
(95% CI)
Preterm, OR
(95% CI)
Very preterm,
OR (95% CI) z-score, coefficient (95% CI) SGA, OR (95% CI) LGA, OR (95% CI)
Age (years) group
< 20 0.00 1.00 1.00 0.00 1.00 1.00
20–24 –0.06 (–0.09 to 0.04) 1.07 (1.01 to 1.12) 1.07 (0.96 to 1.20) –0.09 (–0.10 to 0.08) 1.39 (1.32 to 1.46) 0.86 (0.81 to 0.90)
25–29 –0.12 (–0.14 to 0.10) 1.17 (1.11 to 1.24) 1.16 (1.03 to 1.30) –0.12 (–0.13 to 0.11) 1.52 (1.44 to 1.60) 0.89 (0.84 to 0.94)
30–34 –0.15 (–0.18 to 0.13) 1.27 (1.20 to 1.34) 1.25 (1.10 to 1.41) –0.12 (–0.14 to 0.11) 1.72 (1.62 to 1.82) 0.90 (0.85 to 0.95)
35–39 –0.24 (–0.25 to 0.20) 1.39 (1.30 to 1.47) 1.45 (1.27 to 1.65) –0.13 (–0.15 to 0.12) 1.96 (1.84 to 2.09) 0.92 (0.87 to 0.98)
≥ 40 –0.38 (–0.41 to 0.34) 1.53 (1.41 to 1.66) 1.56 (1.30 to 1.86) –0.16 (–0.18 to 0.14) 2.123 (1.94 to 2.33) 0.88 (0.81 to 0.94)
Global test < 0.0001 < 0.0001 < 0.0001 < 0.0001 < 0.0001 < 0.0001
BMI (kg/m2)
BMI at booking 0.08 (0.07 to 0.08) 0.91 (0.90 to 0.93) 0.91 (0.88 to 0.95) 0.086 (0.082 to 0.09) 0.82 (0.80 to 0.83) 1.23 (1.21 to 1.25)
Quadratic term
BMI at booking
–0.0011 (–0.0013 to 0.0011) 1.00 (1.00 to 1.00) 1.00 (1.00 to 1.00) –0.001 (–0.001 to 0.0009) 1.00 (1.00 to 1.00) 0.998 (0.997 to 0.998)
Height (cm)
Height 0.15 (0.12 to 0.18) 0.88 (0.82 to 0.94) 0.97 (0.96 to 0.97) 0.05 (0.04 to 0.07) 0.86 (0.80 to 0.93) 1.07 (1.06 to 1.07)
Quadratic term
height
–0.0004 (–0.0005 to 0.0003) 1.00 (1.00 to 1.00) –0.00007 (–0.0001 to 0.00002) 1.00 (1.00 to 1.00)
Parity
0 0.00 1.00 1.00 0.00 1.00 1.00
1 –0.11 (–0.12 to 0.10) 0.74 (0.72 to 0.76) 0.65 (0.60 to 0.69) 0.25 (0.24 to 0.25) 0.57 (0.55 to 0.59) 1.61 (1.58 to 1.65)
2 –0.22 (–0.23 to 0.20) 0.86 (0.82 to 0.89) 0.78 (0.72 to 0.86) 0.27 (0.26 to 0.28) 0.59 (0.56 to 0.61) 1.76 (1.71 to 1.82)
3+ –0.34 (–0.37 to 0.32) 1.10 (1.04 to 1.15) 1.02 (0.92 to 1.14) 0.25 (0.24 to 0.26) 0.63 (0.59 to 0.66) 1.77 (1.70 to 1.84)
Global test < 0.0001 < 0.0001 < 0.0001 < 0.0001 < 0.0001 < 0.0001
continued
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TABLE 38 Other parameter estimates for the primary and secondary outcomes using the imputed data and unadjusted for gestational age at booking and maternal smoking:
measures of stage (continued )
Other parameter
estimates
Measures of stage
Gestational age at delivery
(weeks), coefficient
(95% CI)
Preterm, OR
(95% CI)
Very preterm,
OR (95% CI) z-score, coefficient (95% CI) SGA, OR (95% CI) LGA, OR (95% CI)
Marital status
Married to each
other
0.00 1.00 1.00 0.00 1.00 1.00
Joint registration:
same address
0.01 (–0.001 to 0.02) 1.13 (1.09 to 1.16) 1.22 (1.14 to 1.31) –0.093 (–0.01 to 0.086) 1.37 (1.33 to 1.42) 0.87 (0.85 to 0.90)
Joint registration:
different address
–0.08 (–0.10 to 0.06) 1.29 (1.24 to 1.35) 1.67 (1.52 to 1.83) –0.14 (–0.15 to 0.13) 1.52 (1.45 to 1.59) 0.79 (0.76 to 0.83)
Sole registration –0.07 (–0.10 to 0.05) 1.34 (1.27 to 1.41) 1.62 (1.45 to 1.82) –0.21 (–0.22 to 0.20) 1.82 (1.73 to 1.92) 0.68 (0.65 to 0.72)
Global test < 0.0001 < 0.0001 < 0.0001 < 0.0001 < 0.0001 < 0.0001
Primary household social classes
Managerial and
professional
0.00 1.00 1.00 0.00 1.00 1.00
Intermediate –0.04 (–0.06 to 0.03) 1.07 (1.03 to 1.11) 1.12 (1.02 to 1.21) –0.01 (–0.02 to 0.007) 1.11 (1.07 to 1.16) 0.98 (0.96 to 1.01)
Working –0.08 (–0.10 to 0.07) 1.18 (1.14 to 1.22) 1.23 (1.14 to 1.33) –0.08 (–0.09 to 0.07) 1.38 (1.33 to 1.43) 0.89 (0.87 to 0.92)
Never worked/
long-term
unemployed
–0.17 (–0.19 to 0.15) 1.29 (1.24 to 1.35) 1.39 (1.26 to 1.53) –0.14 (–0.15 to 0.13) 1.62 (1.54 to 1.70) 0.79 (0.76 to 0.82)
Global test < 0.0001 < 0.0001 < 0.0001 < 0.0001 < 0.0001 < 0.0001
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Other parameter
estimates
Measures of stage
Gestational age at delivery
(weeks), coefficient
(95% CI)
Preterm, OR
(95% CI)
Very preterm,
OR (95% CI) z-score, coefficient (95% CI) SGA, OR (95% CI) LGA, OR (95% CI)
Diabetes mellitus
No 0.00 1.00 1.00 0.00 1.00 1.00
Yes –1.38 (–1.43 to –1.33) 3.43 (3.21 to 3.67) 2.90 (2.48 to 3.39) 0.55 (0.53 to 0.57) 0.38 (0.32 to 0.45) 3.48 (3.29 to 3.67)
Income domains of the SIMD
1: most deprived 0.00 1.00 1.00 0.00 1.00 1.00
2 0.09 (0.08 to 0.11) 0.90 (0.87 to 0.93) 0.90 (0.83 to 0.97) 0.05 (0.04 to 0.06) 0.88 (0.84 to 0.91) 1.11 (1.07 to 1.14)
3 0.12 (0.10 to 0.14) 0.86 (0.83 to 0.90) 0.87 (0.80 to 0.94) 0.08 (0.07 to 0.09) 0.80 (0.77 to 0.84) 1.10 (1.07 to 1.14)
4 0.17 (0.15 to 0.19) 0.78 (0.75 to 0.81) 0.80 (0.73 to 0.87) 0.11 (0.10 to 0.12) 0.70 (0.67 to 0.73) 1.16 (1.12 to 1.20)
5: least deprived 0.16 (0.14 to 0.18) 0.81 (0.77 to 0.84) 0.79 (0.72 to 0.87) 0.13 (0.12 to 0.14) 0.64 (0.60 to 0.67) 1.20 (1.16 to 1.24)
Global test < 0.0001 < 0.0001 < 0.0001 < 0.0001 < 0.0001 < 0.0001
Blank cells indicate that terms were not included in the models.
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Appendix 13 Other parameter estimates for the
primary and secondary outcomes using the imputed
data and unadjusted for gestational age at booking
and maternal smoking: birth outcomes
DOI: 10.3310/phr05060 PUBLIC HEALTH RESEARCH 2017 VOL. 5 NO. 6
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Leyland et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
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TABLE 39 Other parameter estimates for the primary and secondary outcomes using the imputed data and unadjusted for gestational age at booking and maternal smoking:
birth outcomes
Other covariates
Birth outcomes, OR (95% CI)
Mode of delivery
Stillbirth 5-minute Apgar score Neonatal deathElective caesarean Emergency caesarean
Months
January 1.00 1.00 1.00 1.00 1.00
February 1.05 (1.00 to 1.11) 0.97 (0.94 to 1.01) 0.83 (0.67 to 1.03) 1.03 (0.91 to 1.15) 1.03 (0.63 to 1.68)
March 1.11 (1.05 to 1.17) 1.02 (0.98 to 1.06) 0.85 (0.69 to 1.06) 1.03 (0.92 to 1.16) 0.74 (0.44 to 1.25)
April 1.11 (1.05 to 1.17) 1.00 (0.96 to 1.04) 0.97 (0.79 to 1.20) 1.00 (0.89 to 1.13) 0.57 (0.32 to 0.99)
May 1.05 (1.00 to 1.11) 1.01 (0.97 to 1.05) 0.85 (0.68 to 1.05) 1.04 (0.93 to 1.17) 1.24 (0.78 to 1.96)
June 1.09 (1.03 to 1.15) 0.99 (0.95 to 1.03) 0.84 (0.68 to 1.04) 1.01 (0.90 to 1.14) 1.03 (0.64 to 1.66)
July 1.05 (0.99 to 1.00) 0.99 (0.96 to 1.03) 0.83 (0.67 to 1.03) 1.01 (0.90 to 1.134) 1.02 (0.63 to 1.65)
August 1.07 (1.01 to 1.13) 1.01 (0.97 to 1.05) 0.76 (0.61 to 0.95) 0.97 (0.86 to 1.09) 0.81 (0.49 to 1.34)
September 1.08 (1.02 to 1.14) 1.00 (0.96 to 1.04) 0.78 (0.63 to 0.98) 0.98 (0.88 to 1.11) 0.96 (0.59 to 1.56)
October 1.06 (1.01 to 1.12) 1.02 (0.98 to 1.06) 0.85 (0.69 to 1.05) 0.99 (0.88 to 1.11) 0.98 (0.61 to 1.60)
November 1.05 (0.99 to 1.11) 1.01 (0.97 to 1.05) 0.79 (0.64 to 0.99) 0.98 (0.87 to 1.10) 0.86 (0.52 to 1.42)
December 1.10 (1.04 to 1.16) 0.96 (0.92 to 1.00) 0.77 (0.62 to 0.96) 1.02 (0.91 to 1.14) 0.75 (0.44 to 1.27)
Global test 0.006 0.06 0.30 0.90 0.30
Sex
Male 1.00 1.00 1.00 1.00 1.00
Female 1.08 (1.05 to 1.10) 0.81 (0.80 to 0.82) 1.07 (0.98 to 1.17) 0.79 (0.75 to 0.83) 0.79 (0.64 to 0.97)
Gestational age at delivery (weeks)
Gestational age at delivery 1.42 (1.19 to 1.70) 0.53 (0.45 to 0.62) 0.82 (0.77 to 0.86)
Quadratic term gestational age at delivery 0.99 (0.99 to 0.99) 1.01 (1.01 to 1.01)
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Other covariates
Birth outcomes, OR (95% CI)
Mode of delivery
Stillbirth 5-minute Apgar score Neonatal deathElective caesarean Emergency caesarean
Birthweight (g)
Birthweight 1.00 (1.00 to 1.00) 1.00 (1.00 to 1.00)
Quadratic term birthweight 1.00 (1.00 to 1.00)
Modes of delivery
Vaginal 1.00 1.00
Elective caesarean 0.61 (0.55 to 0.68) 1.32 (0.92 to 1.89)
Emergency caesarean 2.25 (2.13 to 2.38) 1.91 (1.51 to 2.43)
Global test < 0.0001 < 0.0001
Previous caesarean section
No 1.00 1.00
Yes 22.45 (21.87 to 23.05) 3.09 (3.01 to 3.17)
Age (years) group
< 20 1.00 1.00 1.00 1.00 1.00
20–24 1.62 (1.49 to 1.75) 1.38 (1.33 to 1.43) 1.10 (0.91 to 1.34) 1.02 (0.92 to 1.13) 0.91 (0.57 to 1.45)
25–29 2.14 (1.98 to 2.32) 1.82 (1.75 to 1.90) 1.06 (0.88 to 1.28) 0.98 (0.88 to 1.09) 0.97 (0.61 to 1.55)
30–34 2.73 (2.52 to 2.96) 2.29 (2.20 to 2.38) 1.02 (0.84 to 1.24) 1.03 (0.92 to 1.15) 0.89 (0.54 to 1.46)
35–39 3.49 (3.21 to 3.79) 2.72 (2.60 to 2.84) 1.24 (1.01 to 1.53) 1.06 (0.94 to 1.20) 1.01 (0.60 to 1.69)
≥ 40 4.79 (4.37 to 5.25) 3.40 (3.22 to 3.60) 1.44 (1.09 to 1.90) 1.21 (1.03 to 1.42) 0.98 (0.50 to 1.93)
Global test < 0.0001 < 0.0001 0.010 0.030 0.90
BMI (kg/m2)
BMI at booking 1.029 (1.027 to 1.03) 1.12 (1.11 to 1.14) 1.01 (0.98 to 1.04) 1.02 (1.00 to 1.04)
Quadratic term BMI at booking 1.00 (1.00 to 1.00) 1.00 (1.00 to 1.00)
continued
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TABLE 39 Other parameter estimates for the primary and secondary outcomes using the imputed data and unadjusted for gestational age at booking and maternal smoking:
birth outcomes (continued )
Other covariates
Birth outcomes, OR (95% CI)
Mode of delivery
Stillbirth 5-minute Apgar score Neonatal deathElective caesarean Emergency caesarean
Height (cm)
Height 0.84 (0.79 to 0.90) 0.82 (0.78 to 0.86) 1.00 (1.00 to 1.00) 1.02 (1.00 to 1.03)
Quadratic term height 1.00 (1.00 to 1.00) 1.00 (1.00 to 1.00)
Parity
0 1.00 1.00 1.00 1.00 1.00
1 1.06 (1.03 to 1.09) 0.234 (0.229 to 0.239) 0.78 (0.70 to 0.87) 0.87 (0.82 to 0.93) 0.81 (0.62 to 1.05)
2 0.92 (0.89 to 0.96) 0.166 (0.161 to 0.172) 0.87 (0.75 to 1.00) 0.95 (0.88 to 1.03) 1.13 (0.82 to 1.55)
3+ 0.60 (0.57 to 0.63) 0.165 (0.158 to 0.172) 0.93 (0.79 to 1.11) 1.05 (0.95 to 1.16) 0.95 (0.63 to 1.42)
Global test < 0.0001 < 0.0001 0.0002 < 0.0001 0.20
Marital status
Married to each other 1.00 1.00 1.00 1.00
Joint registration: same address 0.92 (0.90 to 0.95) 1.11 (1.09 to 1.13) 1.10 (1.03 to 1.17) 0.86 (0.78 to 1.45)
Joint registration: different address 0.94 (0.88 to 0.96) 1.14 (1.10 to 1.17) 1.14 (1.04 to 1.24) 0.68 (0.67 to 1.19)
Sole registration 0.94 (0.89 to 1.00) 1.10 (1.06 to 1.15) 1.27 (1.14 to 1.41) 0.91 (0.79 to 1.67)
Global test < 0.0001 < 0.0001 < 0.0001 0.30
Primary household social classes
Managerial and professional 1.00 1.00 1.00 1.00
Intermediate 1.00 (0.97 to 1.04) 0.99 (0.97 to 1.01) 0.99 (0.92 to 1.07) 1.06 (0.78 to 1.45)
Working 1.00 (0.97 to 1.03) 0.97 (0.95 to 0.99) 1.07 (1.00 to 1.14) 0.89 (0.67 to 1.19)
Never worked/long-term unemployed 0.96 (0.92 to 1.00) 0.94 (0.91 to 0.97) 1.13 (1.04 to 1.24) 1.15 (0.79 to 1.67)
Global test 0.10 0.002 0.01 0.40
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Other covariates
Birth outcomes, OR (95% CI)
Mode of delivery
Stillbirth 5-minute Apgar score Neonatal deathElective caesarean Emergency caesarean
Diabetes mellitus
No 1.00 1.00 1.00 1.00 1.00
Yes 2.06 (1.92 to 2.22) 1.61 (1.52 to 1.71) 0.99 (0.74 to 1.31) 1.07 (0.90 to 1.28) 0.46 (0.19 to 1.14)
Income domains of the SIMD
1: most deprived 1.00 1.00 1.00 1.00 1.00
2 0.97 (0.93 to 1.01) 0.95 (0.93 to 0.98) 0.96 (0.84 to 1.09) 1.11 (1.03 to 1.19) 0.99 (0.74 to 1.33)
3 1.01 (0.97 to 1.05) 0.90 (0.88 to 0.93) 0.97 (0.85 to 1.11) 1.20 (1.11 to 1.29) 0.88 (0.63 to 1.21)
4 1.03 (0.99 to 1.08) 0.88 (0.86 to 0.91) 0.86 (0.74 to 1.00) 1.08 (0.99 to 1.17) 1.04 (0.75 to 1.45)
5: least deprived 1.08 (1.03 to 1.12) 0.88 (0.86 to 0.91) 0.77 (0.66 to 0.90) 1.16 (1.06 to 1.26) 0.88 (0.61 to 1.27)
Global test < 0.0001 < 0.0001 0.01 0.0001 0.83
Blank cells indicate that terms were not included in the models.
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Appendix 14 Variances and standard errors for
the final models for each outcome
TABLE 40 Variances and standard errors for the final models for each outcome
Modela
Level 3 Level 2 Level 1
Data zone Mother Baby
Variance SE
% total
variance Variance SE
% total
variance Variance SE
% total
variance
Three-level models
Birthweight (g) 725.60 56.30 0.40 86659.10 519 48.10 92807.80 433.90 51.50
LBWb 0.0181 0.0078 0.50 0.348 0.036 9.50 – – 90.00
HBWb 0.008 0.0023 0.20 0.454 0.015 12.10 – – 87.70
Gestational age at
booking (weeks)
1.294 0.0301 5.50 3.39 0.926 14.30 19.004 0.0978 80.20
Booking before
25 weeksb
0.2199 0.011 5.80 0.298 0.046 7.80 – – 86.40
Gestational age at
delivery (weeks)
0.0143 0.001 0.50 1.086 0.0098 34.20 2.073 0.0092 65.30
Pretermb 0.0136 0.0042 0.40 0.538 0.032 14.00 – – 85.60
z-score 0.0033 0.0003 0.40 0.416 0.0025 48.00 0.448 0.0021 51.70
SGAb 0.0254 0.005 0.70 0.48 0.0338 12.60 – – 86.70
LGAb 0.0047 0.0027 0.10 0.5216 0.0194 13.70 – – 86.20
Head circumference
(cm)
0.011 0.00048 1.00 0.152 0.0042 14.20 0.904 0.0046 84.70
Crown-to-heel length
(cm)
0.971 0.022 18.00 0.366 0.0213 6.80 4.055 0.0233 75.20
Elective caesarean
sectionb
0.0517 0.0043 1.40 0.3233 0.0209 8.80 – – 89.80
Emergency caesarean
sectionb
0.0114 0.002 0.30 0.0863 0.0135 2.50 – – 97.10
5-minute Apgar
scoreb
0.0637 0.0165 1.80 0.208 0.0944 5.80 – – 92.40
Maternal smokingb 0.069 0.0032 1.70 0.625 0.013 15.70 – – 82.60
Two-level modelsc
Very low birthweightb 0.163 0.076 4.70 – – 95.30
Very pretermb 0.0512 0.0197 1.50 – – 98.50
Stillbirthb 0.0001 0.00 0.003 – – 99.997
Neonatal deathb 0.433 0.257 11.60 – – 88.40
HBW, high birthweight; LBW, low birthweight; SE, standard error.
a The final models are those reported in Tables 15–19 for the imputed data not adjusting for gestational age at booking
and maternal smoking.
b For multilevel logistic regression, the level 1 (baby) variance is approximated by π2/3 = 3.29 as per Snijders and Bosker.87
c For the two-level models, it was not possible to fit the mother as a level.
Note
Dashes reinforce the lack of direct estimates (with approximations used instead).
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Appendix 15 Results of the analysis for the
secondary outcomes using the imputed data:
subgroup of mothers living in the most deprived
areas (SIMD1) – maternal behaviour
TABLE 41 Subgroup of mothers living in the most deprived areas (SIMD1): maternal behaviour
Parameter
Maternal behaviour
Gestational age at booking
(weeks), coefficient (95% CI)
Booking before 25 weeks,
OR (95% CI)
Maternal smoking during this
pregnancy, OR (95% CI)
Periods
Period 1a 0.00 1.00 1.00
Period 2b –0.50 (–0.60 to 0.40) 1.04 (0.91 to 1.19) 1.03 (0.98 to 1.10)
Period 3c –1.40 (–1.60 to 1.30) 0.96 (0.81 to 1.14) 1.19 (1.09 to 1.28)
Global test 1d < 0.0001
Trend
All yearse
Interactions
Interaction 1f –0.06 (–0.08 to 0.03) 1.08(1.07 to 1.11) 0.92 (0.91 to 0.93)
Interaction 2g –0.40 (–0.50 to 0.30) 1.04 (0.93 to 1.16) 0.94 (0.90 to 0.99)
Interaction 3h –0.17 (–0.23 to 0.11) 0.85 (0.79 to 0.92) 0.96 (0.93 to 0.99)
Global test 2i < 0.0001 < 0.0001 0.02
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
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Appendix 16 Results of analysis for the
secondary outcomes using the imputed data:
subgroup of mothers living in the most deprived
areas (SIMD1) – measures of size
TABLE 42 Subgroup of mothers living in the most deprived areas (SIMD1): measures of size
Parameter
Measures of size
Very LBW,
OR (95% CI)
LBW, OR
(95% CI)
HBW, OR
(95% CI)
Head circumference (cm),
coefficient (95% CI)
Crown-to-heel length
(cm), coefficient (95% CI)
Periods
Period 1a 1.00 1.00 1.00 0.00 0.00
Period 2b 0.91
(0.60 to 1.38)
1.07
(0.96 to 1.20)
0.93
(0.86 to 0.995)
–0.02
(–0.05 to 0.005)
0.04
(–0.04 to 0.1)
Period 3c 0.97
(0.54 to 1.74)
1.23
(1.05 to 1.44)
0.91
(0.82 to 1.01)
–0.10
(–0.14 to 0.06)
0.40
(0.20 to 0.60)
Global test 1d 0.90 0.02 0.10
Trend
All yearse 1.00
(0.91 to 1.09)
0.95
(0.93 to 0.98)
1.02
(1.01 to 1.04)
Interactions
Interaction 1f 0.01
(0.005 to 0.02)
0.06
(0.04 to 0.07)
Interaction 2
g
–0.03
(–0.05 to 0.005)
0.05
(–0.01 to 0.1)
Interaction 3h –0.03
(–0.05 to 0.01)
0.001
(–0.04 to 0.05)
Global test 2i 0.30 0.04 0.60 < 0.0001 0.08
HBW, high birthweight; LBW, low birthweight.
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
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Appendix 17 Results of analysis for the
secondary outcomes using the imputed data:
subgroup of mothers living in the most deprived
areas (SIMD1) – measures of stage
TABLE 43 Subgroup of mothers living in the most deprived areas (SIMD1): measures of stage
Parameter
Measures of stage
Gestational age at
delivery (weeks),
coefficient (95% CI)
Preterm, OR
(95% CI)
Very
preterm, OR
(95% CI)
z-score,
coefficient
(95% CI)
SGA, OR
(95% CI)
LGA, OR
(95% CI)
Periods
Period 1a 0.00 1.00 1.00 0.00 1.00 1.00
Period 2b –0.04
(–0.08 to 0.0007)
1.01
(0.92 to 1.12)
1.05
(0.85 to 1.31)
–0.03
(–0.05 to 0.01)
1.07
(0.98 to 1.17)
0.93
(0.86 to 1.01)
Period 3c –0.19
(–0.24, -0.13)
1.23
(1.08 to 1.39)
1.34
(0.95 to 1.88)
–0.05
(–0.08 to 0.03)
1.19
(1.05 to 1.34)
0.92
(0.83 to 1.04)
Global test 1d 0.0006 0.02 0.20
Trend
All yearse 0.015
(0.011 to 0.019)
0.94
(0.93 to 0.96)
0.99
(0.97 to 1.02)
Interactions
Interaction 1f 0.03
(0.02 to 0.04)
0.95
(0.93 to 0.97)
0.92
(0.88 to 0.96)
Interaction 2g 0.17
(0.13 to 0.20)
0.76
(0.70 to 0.82)
0.60
(0.51 to 0.72)
Interaction 3h 0.05
(0.03 to 0.08)
0.87
(0.82 to 0.92)
0.80
(0.71 to 0.90)
Global test 2i < 0.0001 < 0.0001 < 0.0001 0.02 0.03 0.20
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
DOI: 10.3310/phr05060 PUBLIC HEALTH RESEARCH 2017 VOL. 5 NO. 6
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Leyland et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
129

Appendix 18 Results of analysis for the
secondary outcomes using the imputed data:
subgroup of mothers living in the most deprived
areas (SIMD1) – birth outcomes
TABLE 44 Subgroup of mothers living in the most deprived areas (SIMD1): birth outcomes
Parameter
Mode of delivery Other birth outcomes
Elective
caesarean,
OR (95% CI)
Emergency
caesarean,
OR (95% CI)
Stillbirth,
OR (95% CI)
5-minute
Apgar score,
OR (95% CI)
Neonatal
death,
OR (95% CI)
Periods
Period 1a 1.00 1.00 1.00 1.00 1.00
Period 2b 1.00
(0.91 to 1.09)
1.10
(1.03 to 1.18)
0.79
(0.58 to 1.09)
1.02
(0.85 to 1.23)
1.54
(0.72 to 3.28)
Period 3c 0.98
(0.86 to 1.11)
1.17
(1.07 to 1.29)
0.58
(0.37 to 0.91)
1.01
(0.78 to 1.30)
1.32
(0.45 to 3.92)
Global test 1d 0.90 0.05 0.90 0.40
Trend
All yearse 1.06
(1.04 to 1.08)
1.03
(0.96 to 1.10)
1.00
(0.96 to 1.04)
0.94
(0.80 to 1.10)
Interactions
Interaction 1f 0.99
(0.97 to 1.00)
Interaction 2g 1.00
(0.95 to 1.05)
Interaction 3h 1.01
(0.97 to 1.04)
Global test 2i 0.30 0.50 0.01 0.10 0.07
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
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Appendix 19 Results of analysis for the
secondary outcomes using the imputed data:
subgroup of mothers living in SIMD2 areas –
maternal behaviour
TABLE 45 Subgroup of mothers living in SIMD2 areas: maternal behaviour
Parameter
Maternal behaviour
Gestational age at booking
(weeks), coefficient (95% CI)
Booking before 25 weeks,
OR (95% CI)
Maternal smoking during this
pregnancy, OR (95% CI)
Periods
Period 1a 0.00 1.00 1.00
Period 2b –0.32 (–0.45 to 0.19) 1.15 (0.98 to 1.35) 0.96 (0.90 to 1.04)
Period 3c –1.10 (–1.30 to 0.90) 1.37 (0.94 to 1.98) 1.10 (1.00 to 1.21)
Global test 1d
Trend
All yearse
Interactions
Interaction 1f –0.15 (–0.18 to 0.12) 1.09 (1.06 to 1.12) 0.93 (0.91 to 0.94)
Interaction 2g –0.53 (–0.64 to 0.43) 1.19 (1.14 to 1.36) 0.95 (0.90 to 1.00)
Interaction 3h –0.27 (–0.33 to 0.20) 0.91 (0.83 to 0.99) 0.98 (0.94 to 1.02)
Global test 2i < 0.0001 0.0006 0.03
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
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Appendix 20 Results of analysis for the
secondary outcomes using the imputed data:
subgroup of mothers living in SIMD2 areas –
measures of size
TABLE 46 Subgroup of mothers living in SIMD2 areas: measures of size
Parameter
Measures of size
Very LBW,
OR (95% CI)
LBW, OR
(95% CI)
HBW, OR
(95% CI)
Head circumference (cm),
coefficient (95% CI)
Crown-to-heel length
(cm), coefficient (95% CI)
Periods
Period 1a 1.00 1.00 1.00 0.00 0.00
Period 2b 0.73
(0.44 to 1.21)
1.04
(0.90 to 1.20)
1.01
(0.94 to 1.09)
–0.04
(–0.07 to 0.006)
0.03
(–0.05 to 0.10)
Period 3c 0.95
(0.47 to 1.90)
1.01
(0.83 to 1.24)
0.95
(0.85 to 1.06)
–0.12
(–0.16 to 0.08)
0.10
(0.03 to 0.2)
Global test 1d 0.20 0.80 0.20
Trend
All yearse 0.99
(0.89 to 1.10)
0.98
(0.95 to 1.01)
1.01
(0.99 to 1.03)
Interactions
Interaction 1f 0.008
(0.001 to 0.01)
0.04
(0.02 to 0.05)
Interaction 2
g
–0.02
(–0.04 to 0.005)
0.07
(0.009 to 0.10)
Interaction 3h –0.02
(–0.04 to 0.006)
0.02
(–0.02 to 0.06)
Global test 2i 0.90 0.50 0.80 0.0006 0.40
HBW, high birthweight; LBW, low birthweight.
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
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Appendix 21 Results of analysis for the
secondary outcomes using the imputed data:
subgroup of mothers living in SIMD2 areas –
measures of stage
TABLE 47 Subgroup of mothers living in SIMD2 areas: measures of stage
Parameter
Measures of stage
Gestational
age at delivery
(weeks),
coefficient
(95% CI)
Preterm, OR
(95% CI)
Very
preterm, OR
(95% CI)
z-score,
coefficient
(95% CI)
SGA, OR
(95% CI)
LGA, OR
(95% CI)
Periods
Period 1a 0.00 1.00 1.00 0.00 1.00 1.00
Period 2b –0.04
(–0.09 to 0.001)
1.05
(0.94 to 1.19)
1.02
(0.78 to 1.33)
–0.004
(–0.02 to 0.02)
0.98
(0.88 to 1.09)
0.97
(0.89 to 1.06)
Period 3c –0.16
(–0.22 to 0.10)
1.23
(1.05 to 1.43)
1.34
(0.95 to 1.88)
–0.02
(–0.05 to 0.009)
0.94
(0.80 to 1.09)
0.92
(0.82 to 1.04)
Global test 1d 0.20 0.60 0.30
Trend
All yearse 0.009
(0.005 to 0.01)
0.98
(0.96 to 1.00)
1.01
(0.99 to 1.02)
Interactions
Interaction 1f 0.02
(0.01 to 0.03)
0.96
(0.94 to 0.98)
0.95
(0.90 to 1.00)
Interaction 2
g
0.16
(0.12 to 0.19)
0.72
(0.66 to 0.79)
0.57
(0.46 to 0.70)
Interaction 3h 0.04
(0.02 to 0.07)
0.89
(0.83 to 0.95)
0.68
(0.59 to 0.78)
Global test 2i < 0.0001 < 0.0001 < 0.0001 0.40 0.60 0.90
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
DOI: 10.3310/phr05060 PUBLIC HEALTH RESEARCH 2017 VOL. 5 NO. 6
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Leyland et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
137

Appendix 22 Results of analysis for the
secondary outcomes using the imputed data:
subgroup of mothers living in SIMD2 areas –
birth outcomes
TABLE 48 Subgroup of mothers living in SIMD2 areas: birth outcomes
Parameter
Other birth outcomes, OR (95% CI)
Mode of delivery
Stillbirth
5-minute
Apgar score
Neonatal
death
Elective
caesarean
Emergency
caesarean
Periods IGLS algorithm
failed to
convergePeriod 1
a 1.00 1.00 1.00 1.00
Period 2b 1.03
(0.93 to 1.13)
1.08
(1.00 to 1.17)
1.20
(0.81 to 1.77)
0.86
(0.70 to 1.05)
Period 3c 1.08
(0.94 to 1.24)
1.18
(1.07 to 1.31)
1.11
(0.64 to 1.93)
0.81
(0.61 to 1.07)
Global test 1d 0.50 0.60 0.30
Trend
All yearse 1.05
(1.02 to 1.07)
0.92
(0.85 to 1.00)
1.02
(0.98 to 1.06)
Interactions
Interaction 1f 0.98
(0.97 to 1.00)
Interaction 2g 1.02
(0.96 to 1.09)
Interaction 3h 1.01
(0.97 to 1.06)
Global test 2i 0.10 0.20 0.09 0.70
IGLS, iterative generalised least squares.
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
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Appendix 23 Results of analysis for the
secondary outcomes using the imputed data:
subgroup of mothers living in SIMD3 areas –
maternal behaviour
TABLE 49 Subgroup of mothers living in SIMD3 areas: maternal behaviour
Parameter
Maternal behaviour
Gestational age at booking
(weeks), coefficient (95% CI)
Booking before 25 weeks,
OR (95% CI)
Maternal smoking during this
pregnancy, OR (95% CI)
Periods
Period 1a 0.00 1.00 1.00
Period 2b –0.34 (–0.48 to 0.20) 1.24 (1.06 to 1.45) 1.10 (1.01 to 1.20)
Period 3c –1.03 (–1.20 to 0.84) 1.03 (0.84 to 1.25) 1.24 (1.10 to 1.38)
Global test 1d
Trend
All yearse
Interactions
Interaction 1f –0.19 (–0.22 to 0.17) 1.09 (1.06 to 1.12) 0.91 (0.89 to 0.92)
Interaction 2g –0.57 (–0.68 to 0.46) 1.13 (0.98 to 1.30) 0.91 (0.85 to 0.97)
Interaction 3h –0.17 (–0.25 to 0.10) 0.89 (0.80 to 0.97) 0.97 (0.92 to 1.02)
Global test 2i < 0.0001 0.0002 0.04
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
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Appendix 24 Results of analysis for the
secondary outcomes using the imputed data:
subgroup of mothers living in SIMD3 areas –
measures of size
TABLE 50 Subgroup of mothers living in SIMD3 areas: measures of size
Parameter
Measures of size
Very LBW,
OR (95% CI)
LBW, OR
(95% CI)
HBW, OR
(95% CI)
Head circumference (cm),
coefficient (95% CI)
Crown-to-heel length
(cm), coefficient (95% CI)
Periods
Period 1a 1.00 1.00 1.00 0.00 0.00
Period 2b 0.89
(0.50 to 1.57)
1.05
(0.90 to 1.24)
0.97
(0.89 to 1.05)
–0.06
(–0.10 to 0.03)
0.08
(0.003 to 0.20)
Period 3c 0.72
(0.32 to 1.60)
1.12
(0.90 to 1.40)
0.98
(0.87 to 1.09)
–0.10
(–0.20 to 0.08)
0.30
(0.20 to 0.40)
Global test 1d 0.7 0.6 0.7
Trend
All yearse 1.01
(0.89 to 1.15)
0.97
(0.94 to 1.00)
1.01
(0.99 to 1.02)
Interactions
Interaction 1f 0.008
(0.002 to 0.01)
0.009
(–0.007 to 0.03)
Interaction 2
g
–0.03
(–0.05 to 0.001)
0.08
(0.02 to 0.10)
Interaction 3h –0.03
(–0.05 to 0.01)
0.08
(0.03 to 0.10)
Global test 2i 0.30 0.90 0.90 0.0001 0.002
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
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Appendix 25 Results of analysis for the
secondary outcomes using the imputed data:
subgroup of mothers living in SIMD3 areas –
measures of stage
TABLE 51 Subgroup of mothers living in SIMD3 areas: measures of stage
Parameter
Measures of stage
Gestational
age at delivery
(weeks),
coefficient
(95% CI)
Preterm, OR
(95% CI)
Very
preterm, OR
(95% CI)
z-score,
coefficient
(95% CI)
SGA, OR
(95% CI)
LGA, OR
(95% CI)
Periods
Period 1a 0.00 1.00 1.00 0.00 1.00 1.00
Period 2b –0.04
(–0.08 to 0.01)
1.03
(0.90 to 1.17)
1.15
(0.85 to 1.56)
–0.006
(–0.03 to 0.02)
1.00
(0.89 to 1.13)
0.99
(0.90 to 1.08)
Period 3c –0.17
(–0.24 to –0.11)
1.30
(1.10 to 1.54)
1.73
(1.18 to 2.54)
–0.006
(–0.03 to 0.03)
1.00
(0.85 to 1.19)
1.02
(0.90 to 1.15)
Global test 1d 0.70 0.90 0.70
Trend
All yearse 0.005
(0.0006 to 0.01)
0.97
(0.95 to 1.00)
1.00
(0.98 to 1.02)
Interactions
Interaction 1f 0.03
(0.02 to 0.04)
0.96
(0.93 to 0.98)
0.91
(0.86 to 0.97)
Interaction 2
g
0.16
(0.12 to 0.19)
0.72
(0.65 to 0.80)
0.57
(0.45 to 0.72)
Interaction 3h 0.07
(0.05 to 0.10)
0.84
(0.78 to 0.90)
0.66
(0.56 to 0.77)
Global test 2i < 0.0001 < 0.0001 < 0.0001 0.90 0.50 0.60
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
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Appendix 26 Results of analysis for the
secondary outcomes using the imputed data:
subgroup of mothers living in SIMD3 areas –
birth outcomes
TABLE 52 Subgroup of mothers living in SIMD3 areas: birth outcomes
Parameter
Mode of delivery
Stillbirth,
OR (95% CI)
5-minute
Apgar score,
OR (95% CI)
Neonatal death,
OR (95% CI)
Elective
caesarean,
OR (95% CI)
Emergency
caesarean,
OR (95% CI)
Periods IGLS algorithm
failed to
convergePeriod 1
a 1.00 1.00 1.00 1.00
Period 2b 0.99
(0.90 to 1.10)
1.05
(0.97 to 1.14)
1.11
(0.74 to 1.66)
0.86
(0.70 to 1.07)
Period 3c 1.05
(0.92 to 1.21)
1.18
(1.06 to 1.31)
0.77
(0.43 to 1.38)
0.80
(0.60 to 1.07)
Global test 1d 0.40 0.10
Trend
All yearse 1.05
(1.03 to 1.07)
1.01
(0.92 to 1.10)
1.01
(0.96 to 1.05)
Interactions
Interaction 1f 0.98
(0.96 to 1.00)
Interaction 2g 1.04
(0.97 to 1.10)
Interaction 3h 1.00
(0.96 to 1.04)
Global test 2i 0.60 0.30 0.90 0.80
IGLS, iterative generalised least squares.
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
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Appendix 27 Results of analysis for the
secondary outcomes using the imputed data:
subgroup of mothers living in SIMD4 areas –
maternal behaviour
TABLE 53 Subgroup of mothers living in SIMD4 areas: maternal behaviour
Parameter
Maternal behaviour
Gestational age at booking
(weeks), coefficient (95% CI)
Booking before 25 weeks,
OR (95% CI)
Maternal smoking during this
pregnancy, OR (95% CI)
Periods
Period 1a 0.00 1.00 1.00
Period 2b –0.24 (–0.39 to –0.10) 1.09 (0.92 to 1.29) 0.99 (0.89 to 1.10)
Period 3c –0.86 (–1.04 to –0.67) 0.85 (0.68 to 1.05) 1.13 (0.99 to 1.29)
Global test 1d
Trend
All yearse
Interactions
Interaction 1f –0.22 (–0.25 to –0.19) 1.12 (1.09 to 1.16) 0.92 (0.90 to 0.94)
Interaction 2g –0.62 (–0.73 to –0.50) 1.11 (0.96 to 1.29) 0.91 (0.84 to 0.99)
Interaction 3h –0.26 (–0.33 to –0.18) 0.87 (0.78 to 0.96) 1.05 (0.99 to 1.12)
Global test 2i < 0.0001 < 0.0001 < 0.0001
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
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Appendix 28 Results of analysis for the
secondary outcomes using the imputed data:
subgroup of mothers living in SIMD4 areas –
measures of size
TABLE 54 Subgroup of mothers living in SIMD4 areas: measures of size
Parameter
Measures of size
Very LBW,
OR (95% CI)
LBW, OR
(95% CI)
HBW, OR
(95% CI)
Head circumference (cm),
coefficient (95% CI)
Crown-to-heel length
(cm), coefficient (95% CI)
Periods
Period 1a 1.00 1.00 1.00 0.00 0.00
Period 2b 1.07
(0.54 to 2.13)
0.87
(0.72 to 1.04)
0.98
(0.91 to 1.06)
–0.04
(–0.08 to –0.01)
0.02
(–0.06 to 0.09)
Period 3c 1.23
(0.47 to 3.20)
0.79
(0.61 to 1.02)
0.99
(0.88 to 1.10)
–0.11
(–0.15 to –0.06)
0.20
(0.1 to 0.30)
Global test 1d 0.90 0.20 0.90
Trend
All yearse 0.94
(0.81 to 1.09)
1.03
(0.99 to 1.08)
1.00
(0.98 to 1.02)
Interactions
Interaction 1f 0.005
(–0.002 to 0.01)
0.02
(0.007 to 0.04)
Interaction 2
g
–0.04
(–0.06 to –0.01)
0.09
(0.03 to 0.20)
Interaction 3h –0.04
(–0.05 to –0.02)
0.07
(0.03 to 0.10)
Global test 2i 0.90 0.50 0.10 < 0.0001 0.0007
HBW, high birthweight; LBW, low birthweight.
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
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Appendix 29 Results of analysis for the
secondary outcomes using the imputed data:
subgroup of mothers living in SIMD4 areas –
measures of stage
TABLE 55 Subgroup of mothers living in SIMD4 areas: measures of stage
Parameter
Measures of stage
Gestational
age at delivery
(weeks),
coefficient
95% CI
Preterm, OR
(95% CI)
Very
preterm, OR
(95% CI)
z-score,
coefficient
(95% CI)
SGA, OR
(95% CI)
LGA, OR
(95% CI)
Periods
Period 1a 0.00 1.00 1.00 0.00 1.00 1.00
Period 2b –0.01
(–0.06 to 0.03)
0.97
(0.84 to 1.11)
1.35
(0.97 to 1.88)
0.008
(–0.01 to 0.03)
0.91
(0.80 to 1.05)
1.02
(0.93 to 1.11)
Period 3c –0.10
(–0.20 to –0.05)
1.07
(0.89 to 1.28)
1.56
(1.02 to 2.40)
0.01
(–0.02 to 0.04)
0.83
(0.69 to 1.01)
0.98
(0.87 to 1.11)
Global test 1d 0.70 0.20 0.70
Trend
All yearse 0.002
(–0.003 to 0.006)
1.00
(0.97 to 1.03)
0.99
(0.98 to 1.01)
Interactions
Interaction 1f 0.02
(0.007 to 0.03)
0.98
(0.95 to 1.00)
0.91
(0.86 to 0.978)
Interaction 2
g
0.14
(0.11 to 0.18)
0.69
(0.62 to 0.78)
0.71
(0.55 to 0.91)
Interaction 3h 0.05
(0.03 to 0.08)
0.82
(0.76 to 0.89)
0.66
(0.55 to 0.79)
Global test 2i < 0.0001 < 0.0001 0.001 0.20 0.30
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
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Appendix 30 Results of analysis for the
secondary outcomes using the imputed data:
subgroup of mothers living in SIMD4 areas –
birth outcomes
TABLE 56 Subgroup of mothers living in SIMD4 areas: birth outcomes
Parameter
Birth outcomes
Mode of delivery
Stillbirth,
OR (95% CI)
5-minute
Apgar score,
OR (95% CI)
Neonatal
death, OR
(95% CI)
Elective
caesarean,
OR (95% CI)
Emergency
caesarean,
OR (95% CI)
Periods IGLS algorithm
failed to
convergePeriod 1
a 1.00 1.00 1.00 1.00
Period 2b 1.00
(0.91 to 1.11)
1.02
(0.93 to 1.10)
1.17
(0.73 to 1.90)
0.92
(0.73 to 1.16)
Period 3c 1.03
(0.89 to 1.18)
1.09
(0.98 to 1.22)
1.55
(0.80 to 3.00)
0.96
(0.70 to 1.33)
Global test 1d 0.90 0.40 0.70
Trend
All yearse 0.91
(0.83 to 1.01)
0.99
(0.94 to 1.04)
Interactions
1.06
(1.04 to 1.08)
Interaction 1f 0.99
(0.97 to 1.01)
Interaction 2g 1.01
(0.95 to 1.08)
Interaction 3h 0.99
(0.94 to 1.04)
Global test 2i 0.40 0.80 0.60 0.20
IGLS, iterative generalised least squares.
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
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Appendix 31 Results of analysis for the
secondary outcomes using the imputed data:
subgroup of mothers living in the least deprived
areas – maternal behaviour
TABLE 57 Subgroup of mothers living in the least deprived areas: maternal behaviour
Parameter
Maternal behaviour
Gestational age at booking
(weeks), coefficient (95% CI)
Booking before 25 weeks,
OR (95% CI)
Maternal smoking during this
pregnancy, OR (95% CI)
Periods
Period 1a 0.00 1.00 1.00
Period 2b –0.20 (–0.40 to 0.10) 1.02 (0.85 to 1.22) 0.98 (0.86 to 1.11)
Period 3c –1.00 (–1.10 to 0.80) 0.76 (0.61 to 0.96) 1.16 (0.98 to 1.37)
Global test 1d
Trend
All yearse
Interactions
Interaction 1f –0.13 (–0.16 to 0.10) 1.10 (1.06 to 1.13) 0.91 (0.89 to 0.94)
Interaction 2g –0.80 (–0.90 to 0.70) 1.12 (0.96 to 1.31) 0.81 (0.73 to 0.90)
Interaction 3h –0.16 (–0.24 to 0.08) 0.88 (0.80 to 0.97) 1.05 (0.97 to 1.13)
Global test 2i < 0.0001 0.0003 0.0001
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
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Appendix 32 Results of analysis for the
secondary outcomes using the imputed data:
subgroup of mothers living in the least deprived
areas – measures of size
TABLE 58 Subgroup of mothers living in the least deprived areas: measures of size
Parameter
Measures of size
Very LBW, OR
(95% CI)
LBW, OR
(95% CI)
HBW, OR
(95% CI)
Head circumference (cm),
coefficient (95% CI)
Crown-to-heel length
(cm), coefficient (95% CI)
Periods
Period 1a 1.00 1.00 1.00 0.00 0.00
Period 2b 0.68
(0.33 to 1.37)
1.01
(0.83 to 1.24)
1.00
(0.92 to 1.09)
–0.04
(–0.08 to 0.01)
0.20
(0.10 to 0.30)
Period 3c 0.97
(0.37 to 2.55)
0.99
(0.75 to 1.30)
0.99
(0.88 to 1.10)
–0.09
(–0.10 to 0.04)
0.40
(0.30 to 0.50)
Global test 1d 0.30 0.90 0.90
Trend
All yearse 1.04
(0.89 to 1.20)
1.00
(0.96 to 1.05)
1.00
(0.98 to 1.02)
Interactions
Interaction 1f 0.004
(–0.003 to 0.01)
–0.01
(–0.03 to 0.006)
Interaction 2
g
–0.009
(–0.03 to 0.02)
0.09
(0.03 to 0.20)
Interaction 3h –0.05
(–0.07 to 0.03)
0.03
(–0.01 to 0.08)
Global test 2i 0.30 0.90 0.04 < 0.0001 0.002
HBW, high birthweight; LBW, low birthweight.
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
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Appendix 33 Results of analysis for the
secondary outcomes using the imputed data:
subgroup of mothers living in the least deprived
areas – measures of stage
TABLE 59 Subgroup of mothers living in the least deprived areas: measures of stage
Parameter
Measures of stage
Gestational age
at delivery
(weeks),
coefficient
(95% CI)
Preterm, OR
(95% CI)
Very
preterm, OR
(95% CI)
z-score,
coefficient
(95% CI)
SGA, OR
(95% CI)
LGA, OR
(95% CI)
Periods
Period 1a 0.00 1.00 1.00 0.00 1.00 1.00
Period 2b 0.10
(0.02 to 0.20)
1.03
(0.89 to 1.19)
1.07
(0.77 to 1.49)
0.001
(–0.02 to 0.02)
1.04
(0.90 to 1.22)
1.06
(0.96 to 1.16)
Period 3c –0.20
(–0.30 to 0.10)
1.25
(1.04 to 1.51)
1.11
(0.72 to 1.72)
–0.0007
(–0.03 to 0.03)
1.06
(0.86 to 1.32)
1.08
(0.95 to 1.22)
Global test 1d 0.90 0.80 0.40
Trend
All yearse 0.0004
(–0.004 to 0.005)
0.99
(0.96 to 1.02)
0.98
(0.96 to 1.00)
Interactions
Interaction 1f 0.03
(0.02 to 0.04)
0.96
(0.93 to 0.99)
0.96
(0.90 to 1.03)
Interaction 2
g
0.11
(0.07 to 0.15)
0.76
(0.67 to 0.85)
0.70
(0.54 to 0.91)
Interaction 3h 0.05
(0.02 to 0.08)
0.85
(0.78 to 0.92)
0.65
(0.53 to 0.80)
Global test 2i 0.0001 < 0.0001 0.0002 0.30 0.50 0.040
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
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Appendix 34 Results of analysis for the
secondary outcomes using the imputed data:
subgroup of mothers living in the least deprived
areas – birth outcomes
TABLE 60 Subgroup of mothers living in the least deprived areas: birth outcomes
Parameter
Birth outcomes, OR (95% CI)
Mode of delivery
Stillbirth
5-minute
Apgar score Neonatal death
Elective
caesarean
Emergency
caesarean
Periods
Period 1a 1.00 1.00 1.00 1.00
Period 2b 1.02
(0.93 to 1.13)
1.05
(0.96 to 1.15)
1.00
(0.59 to 1.69)
0.91
(0.72 to 1.15)
Period 3c 1.23
(1.07 to 1.41)
1.23
(1.10 to 1.38)
1.32
(0.65 to 2.67)
0.84
(0.60 to 1.16)
Global test 1d 0.0002 0.50 0.60
Trend
IGLS algorithm
failed to converge
All yearse 1.05
(1.03 to 1.07)
0.97
(0.87 to 1.08)
1.02
(0.97 to 1.07)
Interactions
Interaction 1f 0.98
(0.95 to 0.99)
Interaction 2
g
1.03
(0.96 to 1.10)
Interaction 3h 0.98
(0.94 to 1.03)
Global test 2i 0.90 0.30 0.80 0.01
IGLS, iterative generalised least squares.
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
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Appendix 35 Results of analysis for the
secondary outcomes using the imputed data:
subgroup of mothers with diabetes mellitus
(before or during pregnancy) – maternal behaviour
TABLE 61 Subgroup of mothers with diabetes mellitus (before or during pregnancy): maternal behaviour
Parameter
Maternal behaviour
Gestational age at booking
(weeks), coefficient (95% CI)
Booking before 25 weeks,
OR (95% CI)
Maternal smoking during this
pregnancy, OR (95% CI)
Periods
Period 1a 0.00 1.00
Period 2b –0.10 (–0.70 to 0.50) 1.23 (0.88 to 1.73)
Period 3c –0.60 (–1.40 to 0.10) 1.30 (0.81 to 2.08)
Global test 1d
Trend
IGLS algorithm failed to
converge
All yearse
Interactions
Interaction 1f –0.10 (–0.30 to 0.02) 0.91 (0.84 to 0.98)
Interaction 2
g
–0.30 (–0.70 to 0.10) 0.93 (0.75 to 1.17)
Interaction 3h –0.20 (–0.40 to 0.03) 0.99 (0.86 to 1.13)
Global test 2i 0.70 0.60
IGLS, iterative generalised least squares.
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
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Appendix 36 Results of analysis for the
secondary outcomes using the imputed data:
subgroup of mothers with diabetes mellitus
(before or during pregnancy) – measures of size
TABLE 62 Subgroup of mothers with diabetes mellitus (before or during pregnancy): measures of size
Parameter
Measures of size
Very LBW,
OR (95% CI)
LBW, OR
(95% CI)
HBW, OR
(95% CI)
Head circumference (cm),
coefficient (95% CI)
Crown-to-heel length
(cm), coefficient (95% CI)
Periods
Period 1a 1.00 1.00 0.00 0.00
Period 2b 0.98
(0.55 to 1.76)
0.82
(0.64 to 1.04)
–0.02
(–0.14 to 0.11)
0.10
(–0.30 to 0.50)
Period 3c 0.81
(0.36 to 1.86)
0.64
(0.46 to 0.90)
–0.02
(–0.20 to 0.20)
0.10
(–0.40 to 0.70)
Global test 1d 0.70 0.03
Trend IGLS algorithm failed to converge
All yearse 0.99
(0.87 to 1.12)
0.97
(0.92 to 1.03)
Interactions
Interaction 1f 0.005
(–0.03 to 0.04)
0.002
(–0.08 to 0.09)
Interaction 2
g
0.02
(–0.08 to 0.10)
0.20
(–0.10 to 0.40)
Interaction 3h 0.004
(–0.05 to 0.06)
0.04
(–0.10 to 0.20)
Global test 2i 0.20 0.0005 0.90 0.50
IGLS, iterative generalised least squares.
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
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Appendix 37 Results of analysis for the
secondary outcomes using the imputed data:
subgroup of mothers with diabetes mellitus
(before or during pregnancy) – measures of stage
TABLE 63 Subgroup of mothers with diabetes mellitus (before or during pregnancy): measures of stage
Parameter
Measures of stage
Gestational
age at delivery
(weeks),
coefficient
(95% CI)
Preterm, OR
(95% CI)
Very
preterm,
OR (95% CI)
z-score,
coefficient
(95% CI)
SGA, OR
(95% CI)
LGA, OR
(95% CI)
Periods
Period 1a 0.00 1.00 0.00 1.00 1.00
Period 2b –0.04
(–0.30 to 0.20)
1.14
(0.84 to 1.54)
–0.40
(–0.60 to 0.10)
1.14
(0.54 to 2.39)
1.07
(0.86 to 1.33)
Period 3c –0.07
(–0.40 to 0.20)
1.00
(0.67 to 1.50)
–0.20
(–0.50 to 0.10)
0.78
(0.26 to 2.36)
0.85
(0.62 to 1.16)
Global test 1d < 0.0001 0.03 0.40 0.03
Trend
IGLS algorithm
failed to
converge
All yearse –0.02
(–0.04 to 0.004)
1.07
(0.90 to 1.28)
0.95
(0.91 to 0.999)
Interactions
Interaction 1f 0.04
(–0.01 to 0.09)
0.95
(0.89 to 1.01)
Interaction 2g 0.08
(–0.09 to 0.20)
0.87
(0.70 to 1.07)
Interaction 3h 0.10
(0.02 to 0.20)
0.78
(0.68 to 0.89)
Global test 2i 0.40 0.03 0.0001 0.10 0.002
IGLS, iterative generalised least squares.
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
DOI: 10.3310/phr05060 PUBLIC HEALTH RESEARCH 2017 VOL. 5 NO. 6
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Leyland et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
169

Appendix 38 Results of analysis for the
secondary outcomes using the imputed data:
subgroup of mothers with diabetes mellitus
(before or during pregnancy) – birth outcomes
TABLE 64 Subgroup of mothers with diabetes mellitus (before or during pregnancy): birth outcomes
Parameter
Birth outcomes, OR (95% CI)
Mode of delivery
Stillbirth
5-minute Apgar
score Neonatal death
Elective
caesarean
Emergency
caesarean
Periods
Period 1a 1.00 1.00 1.00 1.00
Period 2b 0.96 (0.73 to 1.26) 0.92 (0.54 to 1.59) 2.35 (0.72 to 7.69) 0.87 (0.44 to 1.71)
Period 3c 1.08 (0.73 to 1.58) 1.08 (0.73 to 1.58) 4.57 (0.89 to 23.52) 0.51 (0.18 to 1.41)
Global test 1d 0.50 0.20 0.20
Trend
IGLS algorithm
failed to converge
All yearse 1.00 (0.95 to 1.07) 0.76 (0.59 to 0.97) 1.10 (0.93 to 1.29)
Interactions
Interaction 1f 0.96 (0.90 to 1.02)
Interaction 2g 0.87 (0.72 to 1.04)
Interaction 3h 0.99 (0.89 to 1.10)
Global test 2i 0.40 0.50 0.70 0.90
IGLS, iterative generalised least squares.
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
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Appendix 39 Results of analysis for the
secondary outcomes using the imputed data:
subgroup of obese mothers (BMI ≥ 35 kg/m2) –
maternal behaviour
TABLE 65 Subgroup of obese mothers (BMI ≥ 35 kg/m2): maternal behaviour
Parameter
Maternal behaviour
Gestational age at booking
(weeks), coefficient (95% CI)
Booking before 25 weeks,
OR (95% CI)
Maternal smoking during this
pregnancy, OR (95% CI)
Periods
Period 1a 0.00 1.00 1.00
Period 2b –0.70 (–0.90 to 0.40) 1.35 (1.05 to 1.72) 1.00 (0.88 to 1.14)
Period 3c –1.50 (–1.90 to 1.10) 1.11 (0.81 to 1.52) 1.18 (0.99 to 1.41)
Global test 1d
Trend
All yearse
Interactions
Interaction 1f –0.10 (–0.20 to 0.09) 1.08 (1.03 to 1.13) 0.94 (0.92 to 0.97)
Interaction 2g –0.70 (–0.90 to 0.50) 1.09 (0.88 to 1.35) 0.92 (0.83 to 1.03)
Interaction 3h –0.10 (–0.30 to 0.02) 0.92 (0.80 to 1.06) 0.96 (0.90 to 1.02)
Global test 2i < 0.0001 0.10 0.80
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
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Appendix 40 Results of analysis for the
secondary outcomes using the imputed data:
subgroup of obese mothers (BMI ≥ 35 kg/m2) –
measures of size
TABLE 66 Subgroup of obese mothers (BMI ≥ 35 kg/m2): measures of size
Parameter
Measures of size
Very LBW,
OR (95% CI)
LBW, OR
(95% CI)
HBW, OR
(95% CI)
Head circumference (cm),
coefficient (95% CI)
Crown-to-heel length
(cm), coefficient (95% CI)
Periods
Period 1a 1.00 1.00 1.00 0.00 0.00
Period 2b 0.63
(0.23 to 1.70)
1.10
(0.82 to 1.48)
0.92
(0.82 to 1.03)
–0.02
(–0.08 to 0.03)
0.20
(0.03 to 0.30)
Period 3c 0.73
(0.18 to 2.91)
1.32
(0.87 to 1.99)
0.80
(0.67 to 0.94)
–0.10
(–0.20 to 0.03)
0.40
(0.20 to 0.60)
Global test 1d 0.60 0.30 0.01
Trend
All yearse 1.09
(0.87 to 1.37)
0.99
(0.93 to 1.06)
1.01
(0.98 to 1.03)
Interactions
Interaction 1f 0.01
(0.001 to 0.02)
–0.01
(–0.04 to 0.02)
Interaction 2
g
0.003
(–0.04 to 0.04)
0.06
(–0.05 to 0.2)
Interaction 3h –0.02
(–0.05 to 0.005)
0.04
(–0.03 to 0.1)
Global test 2i 0.90 0.30 0.20 0.01 0.20
HBW, high birthweight; LBW, low birthweight.
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
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Appendix 41 Results of analysis for the
secondary outcomes using the imputed data:
subgroup of obese mothers (BMI ≥ 35 kg/m2) –
measures of stage
TABLE 67 Subgroup of obese mothers (BMI ≥ 35 kg/m2): measures of stage
Parameter
Measures of stage
Gestational age
at delivery
(weeks),
coefficient
(95% CI)
Preterm, OR
(95% CI)
Very preterm,
OR (95% CI)
z-score,
coefficient
(95% CI)
SGA, OR
(95% CI)
LGA, OR
(95% CI)
Periods
Period 1a 0.00 1.00 1.00 0.00 1.00 1.00
Period 2b –0.03
(–0.1 to 0.05)
1.01
(0.82 to 1.23)
1.27
(0.82 to 1.97)
–0.03
(–0.07 to 0.01)
1.16
(0.91 to 1.50)
0.94
(0.84 to 1.06)
Period 3c –0.20
(–0.30 to 0.05)
1.26
(0.97 to 1.64)
1.59
(0.90 to 2.83)
–0.09
(–0.20 to 0.03)
1.41
(1.00 to 2.00)
0.85
(0.72 to 1.01)
Global test 1d 0.004 0.10 0.10
Trend
All yearse 0.002
(–0.007 to 0.01)
0.96
(0.91 to 1.01)
0.99
(0.97 to 1.02)
Interactions
Interaction 1f 0.02
(–0.002 to 0.04)
0.96
(0.92 to 1.00)
0.93
(0.85 to 1.01)
Interaction 2
g
0.10
(0.06 to 0.20)
0.75
(0.64 to 0.87)
0.79
(0.57 to 1.09)
Interaction 3h 0.06
(0.02 to 0.10)
0.84
(0.76 to 0.92)
0.69
(0.55 to 0.85)
Global test 2i 0.001 0.0006 0.04 0.006 0.40 0.05
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
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Appendix 42 Results of analysis for the
secondary outcomes using the imputed data:
subgroup of obese mothers (BMI ≥ 35 kg/m2) –
birth outcomes
TABLE 68 Subgroup of obese mothers (BMI ≥ 35 kg/m2): birth outcomes
Parameter
Birth outcomes, OR (95% CI)
Mode of delivery
Stillbirth
5-minute Apgar
score Neonatal death
Elective
caesarean
Emergency
caesarean
Periods
Period 1a 1.00 1.00 1.00
Period 2b 1.01 (0.88 to 1.17) 1.11 (0.98 to 1.25) 0.85 (0.61 to 1.20)
Period 3c 1.12 (0.92 to 1.38) 1.21 (1.02 to 1.44) 0.70 (0.43 to 1.13)
Global test 1d 0.20 0.30
Trend
IGLS algorithm
failed to converge
IGLS algorithm failed
to converge
All yearse 1.05 (1.02 to 1.08) 1.03 (0.96 to 1.12)
Interactions
Interaction 1f 0.97 (0.95 to 1.00)
Interaction 2g 1.03 (0.94 to 1.12)
Interaction 3h 0.99 (0.93 to 1.05)
Global test 2i 0.90 0.50 0.70
IGLS, iterative generalised least squares.
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
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Appendix 43 Results of analysis for the
secondary outcomes using the imputed data:
subgroup of lone mothers – maternal behaviour
TABLE 69 Subgroup of lone mothers: maternal behaviour
Parameter
Maternal behaviour
Gestational age at booking
(weeks), coefficient (95% CI)
Booking before 25 weeks,
OR (95% CI)
Maternal smoking during this
pregnancy, OR (95% CI)
Periods
Period 1a 0.00 1.00 1.00
Period 2b –0.40 (–0.70 to –0.06) 0.97 (0.79 to 1.19) 1.03 (0.92 to 1.14)
Period 3c –1.20 (–1.60 to –0.70) 0.89 (0.68 to 1.16) 1.18 (1.02 to 1.37)
Global test 1d
Trend
All yearse
Interactions
Interaction 1f –0.17 (–0.23 to –0.11) 1.09 (1.05 to 1.13) 0.94 (0.92 to 0.96)
Interaction 2
g
–0.50 (–0.70 to –0.20) 0.97 (0.82 to 1.14) 0.92 (0.85 to 1.01)
Interaction 3h –0.20 (–0.40 to –0.02) 0.94 (0.83 to 1.07) 0.98 (0.91 to 1.04)
Global test 2i 0.10 0.049 0.50
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
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Appendix 44 Results of analysis for the
secondary outcomes using the imputed data:
subgroup of lone mothers – measures of size
TABLE 70 Subgroup of lone mothers: measures of size
Parameter
Measures of size
Very LBW,
OR (95% CI)
LBW, OR
(95% CI)
HBW, OR
(95% CI)
Head circumference
(cm), coefficient
(95% CI)
Crown-to-heel
length (cm),
coefficient (95% CI)
Periods
Period 1a 1.00 1.00 1.00 0.00 0.00
Period 2b 0.94
(0.39 to 2.25)
1.15
(0.91 to 1.44)
0.98
(0.83 to 1.16)
–0.04
(–0.10 to 0.02)
0.03
(–0.10 to 0.20)
Period 3c 0.75
(0.22 to 2.58)
1.13
(0.82 to 1.55)
0.81
(0.64 to 1.02)
–0.09
(–0.2 to –0.007)
0.20
(–0.02 to 0.4)
Global test 1d 0.90 0.50 0.03
Trend
All yearse 1.10
(0.91 to 1.33)
0.96
(0.91 to 1.00)
1.03
(1.00 to 1.07)
Interactions
Interaction 1f 0.01
(–0.002 to 0.02)
0.03
(–0.009 to 0.06)
Interaction 2
g
–0.007
(–0.06 to 0.04)
0.09
( –0.03 to 0.20)
Interaction 3h –0.01
(–0.05 to 0.03)
0.20
(0.07 to 0.30)
Global test 2i 0.50 0.70 0.90 0.50 0.02
HBW, high birthweight; LBW, low birthweight.
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
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Appendix 45 Results of analysis for the
secondary outcomes using the imputed data:
subgroup of lone mothers – measures of stage
TABLE 71 Subgroup of lone mothers: measures of stage
Parameter
Measures of stage
Gestational
age at delivery
(weeks),
coefficient
(95% CI)
Preterm, OR
(95% CI)
Very preterm,
OR (95% CI)
z-score,
coefficient
(95% CI)
SGA, OR
(95% CI)
LGA, OR
(95% CI)
Periods
Period 1a 0.00 1.00 1.00 0.00 1.00 1.00
Period 2b –0.10
(–0.20 to 0.008)
1.16
(0.95 to 1.41)
0.92
(0.60 to 1.43)
–0.01
(–0.05 to 0.03)
1.12
(0.94 to 1.33)
0.91
(0.75 to 1.10)
Period 3c –0.30
(–0.40 to 0.20)
1.44
(1.11 to 1.87)
1.51
(0.88 to 2.59)
–0.06
(–0.1 to 0.003)
1.17
(0.92 to 1.49)
0.74
(0.56 to 0.96)
Global test 1d 0.06 0.40 0.047
Trend
All yearse 0.01
(0.003 to 0.02)
0.95
(0.92 to 0.98)
1.02
(0.98 to 1.07)
Interactions
Interaction 1f 0.04
(0.02 to 0.06)
0.94
(0.90 to 0.97)
0.91
(0.84 to 0.99)
Interaction 2g 0.10
(0.07 to 0.20)
0.80
(0.68 to 0.94)
0.55
(0.38 to 0.79)
Interaction 3h 0.09
(0.03 to 0.10)
0.77
(0.68 to 0.86)
0.65
(0.51 to 0.84)
Global test 2i 0.02 0.002 0.002 0.70 0.60 0.50
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
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Appendix 46 Results of analysis for the
secondary outcomes using the imputed data:
subgroup of lone mothers – birth outcomes
TABLE 72 Subgroup of lone mothers: birth outcomes
Parameter
Birth outcomes, OR (95% CI)
Mode of delivery
Stillbirth
5-minute
Apgar score Neonatal death
Elective
caesarean
Emergency
caesarean
Periods
Period 1a 1.00 1.00 1.00
Period 2b 0.94
(0.76 to 1.17)
1.11
(0.95 to 1.29)
1.09
(0.76 to 1.56)
Period 3c 0.97
(0.72 to 1.31)
1.20
(0.98 to 1.47)
1.06
(0.64 to 1.74)
Global test 1d 0.80 0.90
Trend
IGLS algorithm
failed to converge
IGLS algorithm
failed to converge
IGLS algorithm
failed to converge
All yearse 1.07
(1.02 to 1.12)
1.01
(0.94 to 1.09)
Interactions
Interaction 1f 0.99
(0.96 to 1.02)
Interaction 2g 0.90
(0.80 to 1.02)
Interaction 3h 0.96
(0.88 to 1.05)
Global test 2i 0.90 0.30 0.90
IGLS, iterative generalised least squares.
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
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Appendix 47 Results of analysis for the
secondary outcomes using the imputed data:
subgroup of mothers living in households where
the head is in the group of working-class
people – maternal behaviour
TABLE 73 Subgroup of mothers living in households where the head is in the group of working-class people:
maternal behaviour
Parameter
Maternal behaviour
Gestational age at booking
(weeks), coefficient (95% CI)
Booking before 25 weeks,
OR (95% CI)
Maternal smoking during this
pregnancy, OR (95% CI)
Periods
Period 1a 0.00 1.00 1.00
Period 2b –0.50 (–0.60 to 0.40) 1.19 (1.04 to 1.35) 1.03 (0.97 to 1.09)
Period 3c –1.26 (–1.39 to 1.12) 1.00 (0.85 to 1.18) 1.17 (1.09 to 1.26)
Global test 1d
Trend
All yearse
Interactions
Interaction 1f –0.13 (–0.15 to 0.11) 1.09 (1.06 to 1.11) 0.92 (0.91 to 0.93)
Interaction 2g –0.60 (–0.70 to 0.50) 1.12 (1.00 to 1.25) 0.91 (0.87 to 0.95)
Interaction 3h –0.24 (–0.29 to 0.19) 0.87 (0.80 to 0.94) 0.98 (0.95 to 1.01)
Global test 2i < 0.0001 < 0.0001 0.0007
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
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Appendix 48 Results of analysis for the
secondary outcomes using the imputed data:
subgroup of mothers living in households where
the head is in the group of working-class
people – measures of size
TABLE 74 Subgroup of mothers living in households where the head is in the group of working-class people:
measures of size
Parameter
Measures of size
Very LBW,
OR (95% CI)
LBW, OR
(95% CI)
HBW, OR
(95% CI)
Head circumference (cm),
coefficient (95% CI)
Crown-to-heel length
(cm), coefficient (95% CI)
Periods
Period 1a 1.00 1.00 1.00 0.00 0.00
Period 2b 0.76
(0.51 to 1.14)
1.04
(0.93 to 1.16)
0.94
(0.89 to 1.00)
–0.05
(–0.07 to 0.03)
0.03
(–0.02 to 0.10)
Period 3c 0.92
(0.53 to 1.60)
1.10
(0.95 to 1.28)
0.92
(0.84 to 1.00)
–0.11
(–0.14 to 0.08)
0.20
(0.10 to 0.30)
Global test 1d 0.20 0.40 0.10
Trend
All yearse 1.00
(0.92 to 1.09)
0.97
(0.95 to 0.99)
1.02
(1.01 to 1.03)
Interactions
Interaction 1f 0.008
(0.003 to 0.01)
0.02
(0.01 to 0.04)
Interaction 2
g
–0.03
(–0.05 to 0.01)
0.08
(0.03 to 0.10)
Interaction 3h –0.03
(–0.04 to 0.01)
0.05
(0.01 to 0.08)
Global test 2i 0.50 0.90 0.20 < 0.0001 0.03
HBW, high birthweight; LBW, low birthweight.
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
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Appendix 49 Results of analysis for the
secondary outcomes using the imputed data:
subgroup of mothers living in households where
the head is in the group of working-class
people – measures of stage
TABLE 75 Subgroup of mothers living in households where the head is in the group of working-class people:
measures of stage
Parameter
Measures of stage
Gestational age
at delivery
(weeks),
coefficient
(95% CI)
Preterm, OR
(95% CI)
Very preterm,
OR (95% CI)
z-score,
coefficient
(95% CI)
SGA, OR
(95% CI)
LGA, OR
(95% CI)
Periods
Period 1a 0.00 1.00 1.00 0.00 1.00 1.00
Period 2b –0.04
(–0.07 to 0.0007)
1.05
(0.96 to 1.15)
1.14
(0.92 to 1.40)
–0.01
(–0.03 to 0.002)
1.02
(0.94 to 1.11)
0.95
(0.89 to 1.01)
Period 3c –0.18
(–0.23 to 0.13)
1.31
(1.16 to 1.47)
1.55
(1.19 to 2.03)
–0.03
(–0.05 to 0.008)
1.06
(0.94 to 1.19)
0.92
(0.83 to 1.00)
Global test 1d 0.02 0.60 0.20
Trend
All yearse 0.011
(0.008 to 0.014)
0.96
(0.94 to 0.98)
1.01
(0.99 to 1.02)
Interactions
Interaction 1f 0.037
(0.020 to 0.030)
0.95
(0.93 to 0.96)
0.92
(0.89 to 0.96)
Interaction 2
g
0.16
(0.13 to 0.19)
0.72
(0.67 to 0.78)
0.60
(0.51 to 0.71)
Interaction 3h 0.08
(0.06 to 0.10)
0.85
(0.81 to 0.89)
0.67
(0.59 to 0.75)
Global test 2i < 0.0001 < 0.0001 < 0.0001 0.50 0.80 0.40
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
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Appendix 50 Results of analysis for the
secondary outcomes using the imputed data:
subgroup of mothers living in households where
the head is in the group of working-class
people – birth outcomes
TABLE 76 Subgroup of mothers living in households where the head is in the group of working-class people:
birth outcomes
Parameter
Birth outcomes, OR (95% CI)
Mode of delivery
Stillbirth 5-minute Apgar score Neonatal death
Elective
caesarean
Emergency
caesarean
Periods
Period 1a 1.00 1.00 1.00 1.00
Period 2b 0.98 (0.91 to 1.06) 1.02 (0.96 to 1.08) 0.91 (0.77 to 1.06) 1.33 (0.66 to 2.68)
Period 3c 1.03 (0.92 to 1.14) 1.09 (1.01 to 1.19) 0.83 (0.67 to 1.03) 0.87 (0.32 to 2.39)
Global test 1d 0.30 0.20 0.30
Trend IGLS algorithm failed to converge
All yearse 1.07 (1.05 to 1.08) 1.01 (0.97 to 1.04) 0.96 (0.83 to 1.12)
Interactions
Interaction 1f 0.99 (0.98 to 1.00)
Interaction 2
g
1.00 (0.95 to 1.05)
Interaction 3h 0.99 (0.96 to 1.02)
Global test 2i 0.30 0.90 0.50 0.70
IGLS, iterative generalised least squares.
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
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Appendix 51 Results of analysis for the
secondary outcomes using the imputed data:
subgroup of mothers living in households where the
head is in the group of people who have never
worked – maternal behaviour
TABLE 77 Subgroup of mothers living in households where the head is in the group of people who have never
worked: maternal behaviour
Parameter
Maternal behaviour
Gestational age at booking
(weeks), coefficient (95% CI)
Booking before 25 weeks,
OR (95% CI)
Maternal smoking during this
pregnancy, OR (95% CI)
Periods
Period 1a 0.00 1.00 1.00
Period 2b –0.30 (–0.50 to 0.10) 1.03 (0.90 to 1.19) 1.06 (0.99 to 1.14)
Period 3c –1.10 (–1.40 to 0.90) 0.95 (0.79 to 1.14) 1.25 (1.14 to 1.38)
Global test 1d
Trend
All yearse
Interactions
Interaction 1f –0.15 (–0.19 to 0.11) 1.08 (1.05 to 1.11) 0.93 (0.91 to 0.94)
Interaction 2g –0.50 (–0.60 to 0.30) 1.05 (0.93 to 1.19) 0.96 (0.91 to 1.01)
Interaction 3h –0.20 (–0.30 to 0.10) 0.85 (0.78 to 0.92) 0.97 (0.94 to 1.01)
Global test 2i 0.0001 < 0.0001 0.05
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
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Appendix 52 Results of analysis for the
secondary outcomes using the imputed data:
subgroup of mothers living in households where the
head is in the group of people who have never
worked – measures of size
TABLE 78 Subgroup of mothers living in households where the head is in the group of people who have never
worked: measures of size
Parameter
Measures of size
Very LBW,
OR (95% CI)
LBW, OR
(95% CI)
HBW, OR
(95% CI)
Head circumference (cm),
coefficient (95% CI)
Crown-to-heel length
(cm), coefficient (95% CI)
Periods
Period 1a 1.00 1.00 1.00 0.00 0.00
Period 2b 0.80
(0.47 to 1.36)
1.02
(0.89 to 1.18)
1.03
(0.93 to 1.13)
–0.02
(–0.06 to 0.01)
0.06
(–0.04 to 0.10)
Period 3c 0.67
(0.32 to 1.40)
1.12
(0.92 to 1.36)
1.05
(0.92 to 1.21)
–0.10
(–0.15 to 0.06)
0.20
(0.03 to 0.30)
Global test 1d 0.60 0.40 0.70
Trend
All yearse 1.06
(0.95 to 1.19)
0.97
(0.94 to 1.00)
1.00
(0.98 to 1.02)
Interactions
Interaction 1f 0.008
(0.0008 to 0.02)
0.04
(0.02 to 0.06)
Interaction 2
g
–0.03
(–0.05 to 0.001)
0.08
(0.008 to 0.10)
Interaction 3h –0.03
(–0.05 to 0.01)
0.05
(–0.003 to 0.10)
Global test 2i 0.80 0.01 0.40 0.0001 0.60
HBW, high birthweight; LBW, low birthweight.
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
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Appendix 53 Results of analysis for the
secondary outcomes using the imputed data:
subgroup of mothers living in households where the
head is in the group of people who have never
worked – measures of stage
TABLE 79 Subgroup of mothers living in households where the head is in the group of people who have never
worked: measures of stage
Parameter
Measures of stage
Gestational
age at delivery
(weeks),
coefficient
(95% CI)
Preterm, OR
(95% CI)
Very preterm,
OR (95% CI)
z-score,
coefficient
(95% CI)
SGA, OR
(95% CI)
LGA, OR
(95% CI)
Periods
Period 1a 0.00 1.00 1.00 0.00 1.00 1.00
Period 2b –0.05
(–0.10 to 0.006)
1.10
(0.97 to 1.25)
1.22
(0.93 to 1.59)
–0.005
(–0.03 to 0.02)
1.02
(0.91 to 1.14)
0.95
(0.85 to 1.06)
Period 3c –0.20
(–0.28 to 0.12)
1.33
(1.13 to 1.56)
1.58
(1.12 to 2.24)
–0.03
(–0.06 to 0.009)
1.07
(0.92 to 1.24)
1.01
(0.86 to 1.18)
Global test 1d 0.20 0.30
Trend
All yearse 0.008
(0.002 to 0.01)
0.97
(0.95 to 0.99)
0.99
(0.96 to 1.01)
Interactions
Interaction 1f 0.03
(0.02 to 0.04)
0.95
(0.92 to 0.97)
0.91
(0.87 to 0.96)
Interaction 2
g
0.17
(0.13 to 0.22)
0.75
(0.68 to 0.83)
0.68
(0.56 to 0.84)
Interaction 3h 0.06
(0.03 to 0.10)
0.83
(0.78 to 0.89)
0.77
(0.67 to 0.89)
Global test 2i < 0.0001 < 0.0001 0.004 0.30 0.60 0.30
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
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Appendix 54 Results of analysis for the
secondary outcomes using the imputed data:
subgroup of mothers living in households where the
head is in the group of people who have never
worked – birth outcomes
TABLE 80 Subgroup of mothers living in households where the head is in the group of people who have never
worked: birth outcomes
Parameter
Birth outcomes, OR (95% CI)
Mode of delivery
Stillbirth
5-minute Apgar
score Neonatal death
Elective
caesarean
Emergency
caesarean
Periods
Period 1a 1.00 1.00 1.00
Period 2b 1.01 (0.89 to 1.15) 1.12 (1.01 to 1.24) 1.03 (0.82 to 1.30)
Period 3c 1.01 (0.84 to 1.21) 1.24 (1.09 to 1.42) 1.05 (0.77 to 1.44)
Global test 1d 0.90 0.90
Trend
IGLS algorithm
failed to converge
IGLS algorithm
failed to converge
All yearse 1.05 (1.02 to 1.08) 0.99 (0.94 to 1.04)
Interactions
Interaction 1f 0.98 (0.96 to 1.00)
Interaction 2g 1.02 (0.94 to 1.10)
Interaction 3h 1.02 (0.97 to 1.07)
Global test 2i 0.10 0.30 0.30
IGLS, iterative generalised least squares.
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
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Appendix 55 Results of analysis for the
secondary outcomes using the imputed data:
subgroup of teen mothers (< 20 years old) –
maternal behaviour
TABLE 81 Subgroup of teen mothers (< 20 years old): maternal behaviour
Parameter
Maternal behaviour
Gestational age at booking
(weeks), coefficient (95% CI)
Booking before 25 weeks,
OR (95% CI)
Maternal smoking during this
pregnancy, OR (95% CI)
Periods
Period 1a 0.00 1.00 1.00
Period 2b –0.50 (–0.80 to 0.20) 1.08 (0.89 to 1.33) 0.92 (0.84 to 1.02)
Period 3c –1.30 (–1.60 to 0.90) 0.97 (0.75 to 1.27) 0.94 (0.82 to 1.07)
Global test 1d
Trend
All yearse
Interactions
Interaction 1f –0.16 (–0.22 to 0.11) 1.07 (1.03 to 1.12) 0.97 (0.95 to 0.99)
Interaction 2g –0.60 (–0.82 to 0.38) 1.07 (0.90 to 1.27) 1.00 (0.92 to 1.08)
Interaction 3h –0.30 (–0.51 to 0.18) 0.88 (0.77 to 1.01) 1.02 (0.96 to 1.08)
Global test 2i < 0.0001 0.03 0.30
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
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Appendix 56 Results of analysis for the
secondary outcomes using the imputed data:
subgroup of teen mothers (< 20 years old) –
measures of size
TABLE 82 Subgroup of teen mothers (< 20 years old): measures of size
Parameter
Measures of size
Very LBW, OR
(95% CI)
LBW, OR
(95% CI) HBW, OR (95% CI)
Head circumference
(cm), coefficient
(95% CI)
Crown-to-heel
length (cm),
coefficient (95% CI)
Periods
Period 1a 1.00 0.00 0.00
Period 2b 1.05
(0.84 to 1.33)
–0.01
(–0.07 to 0.04)
0.05
(–0.09 to 0.20)
Period 3c 1.45
(1.06 to 1.99)
–0.10
(–0.20 to 0.03)
0.10
(–0.08 to 0.30)
Global test 1d 0.01
Trend
IGLS algorithm
failed to converge
IGLS algorithm
failed to converge
All yearse 0.93
(0.89 to 0.98)
Interactions
Interaction 1f 0.002
(–0.008 to 0.01)
0.04
(0.02 to 0.07)
Interaction 2
g
–0.02
(–0.06 to 0.02)
0.05
(–0.06 to 0.20)
Interaction 3h –0.03
(–0.06 to 0.007)
0.05
(–0.04 to 0.10)
Global test 2i 0.20 0.20 0.90
HBW, high birthweight; IGLS, iterative generalised least squares; LBW, low birthweight.
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
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Appendix 57 Results of analysis for the
secondary outcomes using the imputed data:
subgroup of teen mothers (< 20 years old) –
measures of stage
TABLE 83 Subgroup of teen mothers (< 20 years old): measures of stage
Parameter
Measures of stage
Gestational age
at delivery
(weeks),
coefficient
(95% CI)
Preterm, OR
(95% CI)
Very preterm, OR
(95% CI)
z-score,
coefficient
(95% CI)
SGA, OR
(95% CI)
LGA, OR
(95% CI)
Periods
Period 1a 0.00 1.00 0.00 1.00 1.00
Period 2b –0.09
(–0.20 to 0.0006)
1.07
(0.89 to 1.29)
–0.006
(–0.04 to 0.03)
1.09
(0.92 to 1.29)
0.92
(0.77 to 1.10)
Period 3c –1.30
(–1.60 to 1.10)
1.33
(1.04 to 1.69)
–0.03
(–0.08 to 0.02)
1.26
(1.01 to 1.59)
1.03
(0.80 to 1.32)
Global test 1d 0.30 0.10 0.30
Trend
IGLS algorithm
failed to converge
All yearse 0.01
(0.004 to 0.02)
0.94
(0.91 to 0.97)
1.01
(0.97 to 1.05)
Interactions
Interaction 1f 0.05
(0.03 to 0.07)
0.93
(0.90 to 0.97)
Interaction 2g 0.20
(0.09 to 0.20)
0.72
(0.62 to 0.84)
Interaction 3h 0.03
(0.09 to 0.20)
0.86
(0.77 to 0.97)
Global test 2i 0.005 0.004 0.20 0.70 0.10
IGLS, iterative generalised least squares.
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
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Appendix 58 Results of analysis for the
secondary outcomes using the imputed data:
subgroup of teen mothers (< 20 years old) –
birth outcomes
TABLE 84 Subgroup of teen mothers (< 20 years old): birth outcomes
Parameter
Birth outcomes, OR (95% CI)
Mode of delivery
Stillbirth
5-minute Apgar
score Neonatal death
Elective
caesarean
Emergency
caesarean
Periods
Period 1a 1.00 1.00 1.00
Period 2b 1.03 (0.77 to 1.38) 1.09 (0.95 to 1.25) 1.07 (0.56 to 2.05)
Period 3c 1.33 (0.89 to 1.98) 0.95 (0.76 to 1.20) 1.12 (0.45 to 2.77)
Global test 1d 0.20 0.90
Trend
IGLS algorithm
failed to converge
IGLS algorithm
failed to converge
All yearse 0.99 (0.93 to 1.05) 0.94 (0.83 to 1.08)
Interactions
Interaction 1f 0.99 (0.96 to 1.02)
Interaction 2g 1.00 (0.89 to 1.11)
Interaction 3h 1.07 (0.98 to 1.17)
Global test 2i 0.20 0.20 0.20
IGLS, iterative generalised least squares.
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
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Appendix 59 Results of analysis for the
secondary outcomes using the imputed data:
subgroup of non-white mothers – maternal behaviour
TABLE 85 Subgroup of non-white mothers: maternal behaviour
Parameter
Maternal behaviour
Gestational age at booking
(weeks), coefficient (95% CI)
Booking before 25 weeks,
OR (95% CI)
Maternal smoking during this
pregnancy, OR (95% CI)
Periods
Period 1a 0.00 1.00 1.00
Period 2b –0.70 (–1.10 to 0.20) 1.10 (0.82 to 1.48) 0.82 (0.54 to 1.25)
Period 3c –1.70 (–2.40 to 1.00) 1.20 (0.79 to 1.84) 1.15 (0.62 to 2.11)
Global test 1d
Trend
All yearse
Interactions
Interaction 1f –0.02 (–0.10 to 0.10) 1.00 (0.93 to 1.08) 0.90 (0.81 to 0.99)
Interaction 2
g
–0.70 (–1.04 to 0.50) 1.11 (0.92 to 1.34) 0.97 (0.70 to 1.34)
Interaction 3h –0.10 (–0.30 to 0.04) 0.88 (0.78 to 0.99) 1.09 (0.91 to 1.31)
Global test 2i < 0.0001 0.07 0.20
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
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Appendix 60 Results of analysis for the
secondary outcomes using the imputed data:
subgroup of non-white mothers – measures of size
TABLE 86 Subgroup of non-white mothers: measures of size
Parameter
Measures of size
Very LBW, OR
(95% CI)
LBW, OR
(95% CI)
HBW, OR
(95% CI)
Head circumference
(cm), coefficient
(95% CI)
Crown-to-heel
length (cm),
coefficient (95% CI)
Periods
Period 1a 1.00 1.00 0.00 0.00
Period 2b 0.93
(0.66 to 1.30)
0.97
(0.76 to 1.24)
–0.06
(–0.10 to 0.03)
0.20
(–0.04 to 0.40)
Period 3c 1.28
(0.79 to 2.07)
1.04
(0.72 to 1.49)
–0.20
(–0.30 to 0.05)
0.40
(0.03 to 0.70)
Global test 1d 0.05 0.70
Trend
All yearse IGLS algorithm
failed to converge
0.94
(0.87 to 1.01)
1.00
(0.94 to 1.06)
Interactions
Interaction 1f 0.03
(0.004 to 0.05)
0.0006
(–0.05 to 0.06)
Interaction 2
g
–0.02
(–0.07 to 0.04)
0.06
(–0.08 to 0.20)
Interaction 3h –0.03
(–0.06 to 0.003)
0.03
(–0.06 to 0.10)
Global test 2i 0.80 0.90 0.02 0.70
HBW, high birthweight; IGLS, iterative generalised least squares; LBW, low birthweight.
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
DOI: 10.3310/phr05060 PUBLIC HEALTH RESEARCH 2017 VOL. 5 NO. 6
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Leyland et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
215

Appendix 61 Results of analysis for the
secondary outcomes using the imputed data:
subgroup of non-white mothers – measures of stage
TABLE 87 Subgroup of non-white mothers: measures of stage
Parameter
Measures of stage
Gestational
age at delivery
(weeks),
coefficient
(95% CI)
Preterm, OR
(95% CI)
Very preterm, OR
(95% CI)
z-score,
coefficient
(95% CI)
SGA, OR
(95% CI)
LGA, OR
(95% CI)
Periods
Period 1a 0.00 1.00 0.00 1.00 1.00
Period 2b –0.04
(–0.20 to 0.08)
1.05
(0.75 to 1.46)
–0.02
(–0.07 to 0.03)
1.30
(1.01 to 1.67)
1.07
(0.81 to 1.40)
Period 3c –0.20
(–0.30 to 0.02)
1.23
(0.77 to 1.96)
–0.05
(–0.10 to 0.03)
1.45
(1.01 to 2.08)
0.97
(0.65 to 1.45)
Global test 1d 0.30 0.10 0.50
Trend
IGLS algorithm
failed to converge
All yearse 0.02
(0.004 to 0.03)
0.90
(0.85 to 0.96)
1.01
(0.94 to 1.08)
Interactions
Interaction 1f 0.04
(0.008 to 0.07)
0.93
(0.86 to 1.01)
Interaction 2
g
0.20
(0.10 to 0.30)
0.72
(0.58 to 0.89)
Interaction 3h 0.06
(0.01 to 0.10)
0.91
(0.80 to 1.04)
Global test 2i 0.0002 0.08 0.30 0.60 0.80
IGLS, iterative generalised least squares.
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
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Appendix 62 Results of analysis for the
secondary outcomes using the imputed data:
subgroup of non-white mothers – birth outcomes
TABLE 88 Subgroup of non-white mothers: birth outcomes
Parameter
Birth outcomes, OR (95% CI)
Mode of delivery
Stillbirth
5-minute Apgar
score Neonatal death
Elective
caesarean
Emergency
caesarean
Periods
Period 1a 1.00 1.00
Period 2b 1.02 (0.78 to 1.31) 1.05 (0.86 to 1.29)
Period 3c 1.10 (0.76 to 1.60) 0.94 (0.70 to 1.26)
Global test 1d 0.70
Trend
IGLS algorithm
failed to converge
IGLS algorithm
failed to converge
IGLS algorithm
failed to converge
All yearse 1.09 (1.02 to 1.16)
Interactions
Interaction 1f 1.00 (0.95 to 1.06)
Interaction 2g 0.90 (0.80 to 1.02)
Interaction 3h 1.10 (1.01 to 1.19)
Global test 2i 0.80 0.02
IGLS, iterative generalised least squares.
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
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Appendix 63 Results of the main analysis for the
secondary outcomes adjusted for ethnicity and using
the complete cases: maternal behaviour
TABLE 89 Secondary outcomes adjusted for ethnicity and using the complete cases: maternal behaviour
Parameter
Maternal behaviour
Gestational age at booking
(weeks), coefficient (95% CI)
Booking before 25 weeks,
OR (95% CI)
Maternal smoking during this
pregnancy, OR (95% CI)
Periods
Period 1a 0.00 1.00 1.00
Period 2b –1.07 (–1.20 to 1.00) 1.36 (1.17 to 1.58) 0.94 (0.88 to 1.01)
Period 3c –2.40 (–2.60 to 2.30) 1.56 (1.25 to 1.94) 1.15 (0.62 to 2.11)
Global test 1d
Trend
All yearse
Interactions
Interaction 1f 0.02 (–0.01 to 0.05) 1.01 (0.97 to 1.05) 0.97 (0.95 to 0.99)
Interaction 2
g
–1.00 (–1.02 to 0.90) 1.24 (1.13 to 1.37) 0.96 (0.92 to 1.00)
Interaction 3h –0.31 (–0.35 to 0.27) 0.96 (0.91 to 1.02) 1.01 (0.98 to 1.03)
Global test 2i < 0.0001 < 0.0001 0.20
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
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Appendix 64 Results of the main analysis for
the primary and secondary outcomes adjusted
for ethnicity and using the complete cases:
measures of size
TABLE 90 Primary and secondary outcomes adjusted for ethnicity and using the complete cases: measures of size
Parameter
Birthweight
(g), coefficient
(95% CI)
Measures of size
Very LBW,
OR (95% CI)
LBW, OR
(95% CI)
HBW, OR
(95% CI)
Head circumference
(cm), coefficient
(95% CI)
Crown-to-heel
length (cm),
coefficient (95% CI)
Periods
Period 1a 0.00 1.00 1.00 1.00 0.00 0.00
Period 2b –12.80
(–20.90 to –4.60)
1.34
(0.83 to 2.17)
1.12
(0.98 to 1.28)
0.95
(0.89 to 1.02)
–0.01
(–0.04 to 0.02)
0.16
(0.09 to 0.23)
Period 3c –16.50
(–28.60 to 4.50)
1.89
(0.94 to 3.81)
1.23
(1.01 to 1.49)
0.94
(0.85 to 1.04)
–0.08
(–0.10 to 0.04)
0.30
(0.20 to 0.40)
Global test 1d 0.009 0.20 0.05
Trend
All yearse 5.90
(3.80 to 8.00)
0.88
(0.78 to 0.99)
0.95
(0.92 to 0.99)
1.01
(0.99 to 1.03)
Interactions
Interaction 1f 0.003
(–0.005 to 0.01)
0.01
(–0.009 to 0.03)
Interaction 2g –0.01
(–0.03 to 0.004)
0.11
(0.07 to 0.15)
Interaction 3h –0.07
(–0.08 to 0.06)
0.03
(0.01 to 0.05)
Global test 2i 0.30 0.70 0.07 0.30 < 0.0001 0.0001
HBW, high birthweight; LBW, low birthweight.
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
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Appendix 65 Results of the main analysis for the
secondary outcomes adjusted for ethnicity and using
the complete cases: measures of stage
TABLE 91 Secondary outcomes adjusted for ethnicity and using the complete cases: measures of stage
Parameter
Measures of stage
Gestational
age at delivery
(weeks),
coefficient
(95% CI)
Preterm, OR
(95% CI)
Very preterm,
OR (95% CI)
z-score,
coefficient
(95% CI)
SGA, OR
(95% CI)
LGA, OR
(95% CI)
Periods
Period 1a 0.00 1.00 1.00 0.00 1.00 1.00
Period 2b –0.03
(–0.06 to 0.005)
1.03
(0.91 to 1.16)
1.11
(0.84 to 1.47)
–0.03
(–0.05 to 0.01)
1.09
(0.98 to 1.20)
0.97
(0.90 to 1.04)
Period 3c –0.14
(–0.18 to 0.11)
1.26
(1.06 to 1.51)
1.54
(1.03 to 2.31)
–0.04
(–0.06 to 0.01)
1.16
(1.00 to 1.34)
0.96
(0.86 to 1.08)
Global test 1d 0.009 0.20 0.70
Trend
All yearse 0.01
(0.008 to 0.02)
0.95
(0.92 to 0.97)
1.00
(0.98 to 1.02)
Interactions
Interaction 1f 0.018
(0.012 to 0.024)
0.96
(0.93 to 0.99)
0.93
(0.87 to 1.00)
Interaction 2g 0.14
(0.13 to 0.16)
0.70
(0.65 to 0.75)
0.57
(0.49 to 0.66)
Interaction 3h 0.04
(0.02 to 0.05)
0.86
(0.83 to 0.89)
0.71
(0.65 to 0.77)
Global test 2i < 0.0001 < 0.0001 < 0.0001 0.10 0.80 0.70
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
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Appendix 66 Results of the main analysis for the
secondary outcomes adjusted for ethnicity and using
the complete cases: birth outcomes
TABLE 92 Secondary outcomes adjusted for ethnicity and using the complete cases: birth outcomes
Parameter
Birth outcomes
Mode of delivery
Stillbirth,
OR (95% CI)
5-minute
Apgar score,
OR (95% CI)
Neonatal
death, OR
(95% CI)
Elective
caesarean,
OR (95% CI)
Emergency
caesarean,
OR (95% CI)
Periods
Period 1a 1.00 1.00 1.00 1.00 1.00
Period 2b 1.03
(0.96 to 1.12)
1.00
(0.93 to 1.08)
0.91
(0.69 to 1.21)
0.86
(0.72 to 1.03)
2.84
(1.26 to 6.38)
Period 3c 1.03
(0.92 to 1.15)
1.12
(1.05 to 1.19)
0.80
(0.53 to 1.20)
0.79
(0.61 to 1.03)
2.74
(0.85 to 8.86)
Global test 1d 0.60 0.50 0.20 0.002
Trend
All yearse 1.06
(1.03 to 1.08)
0.92
(0.86 to 0.99)
1.02
(0.97 to 1.07)
0.78
(0.64 to 0.94)
Interactions
Interaction 1f 1.00
(0.98 to 1.02)
Interaction 2g 0.94
(0.91 to 0.99)
Interaction 3h 1.00
(0.98 to 1.03)
Global test 2i 0.50 0.90 0.50 0.60 0.03
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
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Appendix 67 Results of analysis for the secondary
outcomes using the imputed data: subgroup of
nulliparous mothers – maternal behaviour
TABLE 93 Subgroup of nulliparous mothers: maternal behaviour
Parameter
Maternal behaviour
Gestational age at booking
(weeks), coefficient (95% CI)
Booking before 25 weeks,
OR (95% CI)
Maternal smoking during this
pregnancy, OR (95% CI)
Periods
Period 1a 0.00 1.00 1.00
Period 2b –0.33 (–0.43 to 0.23) 1.08 (0.98 to 1.19) 1.01 (0.90 to 1.13)
Period 3c –1.01 (–1.14 to 0.88) 0.87 (0.77 to 0.98) 1.17 (1.10 to 1.25)
Global test 1d
Trend
All yearse
Interactions
Interaction 1f –0.15 (–0.17 to 0.13) 1.09 (1.07 to 1.11) 0.92 (0.91 to 0.93)
Interaction 2
g
–0.53 (–0.60 to 0.45) 1.03 (0.95 to 1.11) 0.92 (0.88 to 0.96)
Interaction 3h –0.19 (–0.24 to 0.14) 0.87 (0.82 to 0.92) 1.02 (0.99 to 1.05)
Global test 2i < 0.0001 < 0.0001 < 0.0001
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
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Appendix 68 Results of analysis for the primary
and secondary outcomes using the imputed data:
subgroup of nulliparous mothers – measures of size
TABLE 94 Subgroup of nulliparous mothers: measures of size
Parameter
Birthweight
(g), coefficient
(95% CI)
Measures of size
Very LBW,
OR (95% CI)
LBW, OR
(95% CI)
HBW, OR
(95% CI)
Head circumference
(cm), coefficient
(95% CI)
Crown-to-heel
length (cm),
coefficient (95% CI)
Periods
Period 1a 0.00 1.00 1.00 1.00 0.00 0.00
Period 2b –0.20
(–6.80 to 6.40)
0.74
(0.54 to 1.03)
0.98
(0.90 to 1.08)
0.98
(0.90 to 1.08)
–0.05
(–0.07 to 0.03)
0.07
(0.02 to 0.10)
Period 3c 1.30
(–7.90 to 10.60)
0.74
(0.47 to 1.16)
1.00
(0.88 to 1.13)
1.00
(0.88 to 1.13)
–0.12
(–0.14 to 0.09)
0.20
(0.10 to 0.30)
Global test 1d 0.90 0.20 0.90 0.90
Trend
All yearse 1.92
(0.50 to 3.34)
1.04
(0.97 to 1.12)
0.99
(0.97 to 1.01)
0.99
(0.97 to 1.01)
Interactions
Interaction 1f 0.004
(–0.0004 to 0.008)
0.03
(0.02 to 0.04)
Interaction 2
g
–0.03
(–0.05 to 0.01)
0.06
(0.02 to 0.10)
Interaction 3h –0.04
(–0.05 to 0.02)
0.07
(0.04 to 0.09)
Global test 2i 0.90 0.90 0.20 0.20 < 0.0001 0.02
HBW, high birthweight; LBW, low birthweight.
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
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Appendix 69 Results of analysis for the
secondary outcomes using the imputed data:
subgroup of nulliparous mothers – measures of stage
TABLE 95 Subgroup of nulliparous mothers: measures of stage
Parameter
Measures of stage
Gestational
age at delivery
(weeks),
coefficient
(95% CI)
Preterm, OR
(95% CI)
Very preterm,
OR (95% CI)
z-score,
coefficient
(95% CI)
SGA, OR
(95% CI)
LGA, OR
(95% CI)
Periods
Period 1a 0.00 1.00 1.00 0.00 1.00 1.00
Period 2b –0.07
(–0.10 to 0.04)
1.02
(0.94 to 1.10)
1.11
(0.93 to 1.31)
–0.002
(–0.02 to 0.01)
0.96
(0.90 to 1.03)
0.98
(0.92 to 1.04)
Period 3c –0.24
(–0.29 to 0.20)
1.23
(1.11 to 1.35)
1.56
(1.25 to 1.94)
–0.001
(–0.02 to 0.02)
0.98
(0.90 to 1.08)
1.00
(0.91 to 1.09)
Global test 1d 0.90 0.30 0.60
Trend
All yearse 0.005
(0.001 to 0.008)
0.98
(0.97 to 0.99)
1.00
(0.98 to 1.01)
Interactions
Interaction 1f 0.04
(0.03 to 0.05)
0.96
(0.94 to 0.97)
0.92
(0.89 to 0.96)
Interaction 2g 0.17
(0.15 to 0.20)
0.72
(0.68 to 0.77)
0.60
(0.52 to 0.68)
Interaction 3h 0.06
(0.04 to 0.08)
0.86
(0.82 to 0.90)
0.73
(0.67 to 0.80)
Global test 2i < 0.0001 < 0.0001 < 0.0001 0.90 0.50 0.20
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
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Appendix 70 Results of analysis for the
secondary outcomes using the imputed data:
subgroup of nulliparous mothers – birth outcomes
TABLE 96 Subgroup of nulliparous mothers: birth outcomes
Parameter
Birth outcomes
Mode of delivery
Stillbirth
OR (95% CI)
5-minute
Apgar score
OR (95% CI)
Neonatal death
OR (95% CI)
Elective
caesarean OR
(95% CI)
Emergency
caesarean
OR (95% CI)
Periods
Period 1a 1.00 1.00 1.00 1.00
Period 2b 1.20
(1.11 to 1.30)
1.00
(0.95 to 1.04)
1.01
(0.79 to 1.30)
0.87
(0.77 to 0.99)
Period 3c 1.38
(1.24 to 1.1.54)
1.06
(1.00 to 1.12)
1.01
(0.71 to 1.44)
0.81
(0.68 to 0.97)
Global test 1d < 0.0001 0.90 0.06
Trend
IGLS algorithm
failed to converge
All yearse 0.97
(0.95 to 0.98)
0.98
(0.93 to 1.03)
1.03
(1.00 to 1.06)
Interactions
Interaction 1f 1.01
(1.00 to 1.02)
Interaction 2g 1.05
(1.01 to 1.08)
Interaction 3h 1.02
(1.00 to 1.04)
Global test 2i 0.20 0.10 0.10 0.60
IGLS, iterative generalised least squares.
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
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Appendix 71 Impact of restricting the
pre-intervention period to the period after
the smoking ban: maternal behaviour
TABLE 97 Impact of restricting the pre-intervention period to the period after the smoking ban:
maternal behaviour
Parameter
Maternal behaviour
Gestational age at booking
(weeks), coefficient (95% CI)
Booking before 25 weeks,
OR (95% CI)
Maternal smoking during this
pregnancy, OR (95% CI)
Periods
Period 1a 0.00 1.00 1.00
Period 2b –0.17 (–0.28 to 0.06) 1.05 (0.92 to 1.20) 1.01 (0.95 to 1.08)
Period 3c –0.80 (–1.00 to 0.60) 0.84 (0.67 to 1.06) 1.16 (1.03 to 1.30)
Global test 1d
Trend
All yearse
Interactions
Interaction 1f –0.22 (–0.27 to 0.18) 1.11 (1.06 to 1.17) 0.92 (0.90 to 0.94)
Interaction 2g –0.58 (–0.64 to 0.55) 1.11 (1.05 to 1.18) 0.92 (0.90 to 0.95)
Interaction 3h –0.21 (–0.24 to 0.18) 0.88 (0.84 to 0.91) 0.99 (0.97 to 1.01)
Global test 2i < 0.0001 < 0.0001 < 0.0001
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
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Appendix 72 Impact of restricting the
pre-intervention period to the period after
the smoking ban: measures of size
TABLE 98 Impact of restricting the pre-intervention period to the period after the smoking ban: measures of size
Parameter
Birthweight
(g), coefficient
(95% CI)
Measures of size
Very LBW,
OR (95% CI)
LBW, OR
(95% CI)
HBW, OR
(95% CI)
Head circumference,
coefficient (95% CI)
Crown-to-heel
length, coefficient
(95% CI)
Periods
Period 1a 0.00 1.00 1.00 1.00 0.00 0.00
Period 2b –0.80
(–6.10 to 4.50)
0.93
(0.69 to 1.25)
1.06
(0.98 to 1.15)
0.99
(0.95 to 1.03)
0.008
(–0.02 to 0.03)
0.09
(0.03 to 0.20)
Period 3c –0.10
(–9.50 to 9.30)
1.09
(0.65 to 1.82)
1.16
(1.00 to 1.34)
1.00
(0.93 to 1.08)
–0.02
(–0.06 to 0.03)
0.30
(0.20 to 0.40)
Global test 1d 0.90 0.40 0.10 0.80
Trend
All yearse 2.40
(0.40 to 4.40)
0.96
(0.86 to 1.07)
0.96
(0.93 to 0.99)
1.00
(0.98 to 1.01)
Interactions
Interaction 1f –0.01
(–0.02 to 0.004)
0.009
(–0.02 to 0.03)
Interaction 2
g
–0.03
(–0.04 to 0.01)
0.07
(0.05 to 0.1)
Interaction 3h –0.034
(–0.042 to 0.026)
0.04
(0.02 to 0.06)
Global test 2i 0.30 0.50 0.07 0.70 0.007 0.001
HBW, high birthweight; LBW, low birthweight.
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
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Appendix 73 Impact of restricting the
pre-intervention period to the period after
the smoking ban: measures of stage
TABLE 99 Impact of restricting the pre-intervention period to the period after the smoking ban: measures of stage
Parameter
Measures of stage
Gestational
age at delivery
(weeks),
coefficient
(95% CI)
Preterm, OR
(95% CI)
Very preterm,
OR (95% CI)
z-score,
coefficient
(95% CI)
SGA, OR
(95% CI)
LGA, OR
(95% CI)
Periods
Period 1a 0.00 1.00 1.00 0.00 1.00 1.00
Period 2b –0.40
(–0.44 to 0.36)
1.81
(1.64 to 2.01)
3.80
(2.96 to 4.87)
–0.003
(–0.01 to 0.009)
1.01
(0.94 to 1.07)
1.00
(0.95 to 1.05)
Period 3c –0.87
(–0.94 to 0.80)
3.69
(3.10 to 4.40)
15.27
(10.03 to 23.25)
–0.002
(–0.02 to 0.02)
1.01
(0.91 to 1.13)
1.01
(0.93 to 1.10)
Global test 1d 0.80 0.90 0.80
Trend
All yearse 0.004
(0.0006 to 0.009)
0.97
(0.95 to 0.997)
0.99
(0.97 to 1.01)
Interactions
Interaction 1f 0.19
(0.18 to 0.21)
0.74
(0.71 to 0.77)
0.54
(0.49 to 0.59)
Interaction 2
g
0.17
(0.15 to 0.18)
0.72
(0.69 to 0.75)
0.59
(0.53 to 0.65)
Interaction 3h 0.06
(0.05 to 0.07)
0.85
(0.83 to 0.88)
0.70
(0.65 to 0.74)
Global test 2i < 0.0001 < 0.0001 < 0.0001 0.20 0.30 0.30
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
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Appendix 74 Impact of restricting the
pre-intervention period to the period after
the smoking ban: birth outcomes
TABLE 100 Impact of restricting the pre-intervention period to the period after the smoking ban: birth outcomes
Imputed
Birth outcomes
Mode of delivery
Stillbirth,
OR (95% CI)
5-minute
Apgar score,
OR (95% CI)
Neonatal
death, OR
(95% CI)
Elective
caesarean,
OR (95% CI)
Emergency
caesarean,
OR (95% CI)
Periods
Period 1a 1.00 1.00 1.00 1.00 1.00
Period 2b 1.06
(1.01 to 1.12)
1.12
(1.05 to 1.19)
1.08
(0.86 to 1.35)
0.94
(0.84 to 1.05)
2.08
(1.26 to 3.44)
Period 3c 1.19
(1.09 to 1.31)
1.28
(1.14 to 1.44)
1.08
(0.73 to 1.60)
0.93
(0.76 to 1.14)
2.08
(0.86 to 5.04)
Global test 1d 0.0001 0.70 0.50 0.004
Trend
All yearse 1.03
(1.01 to 1.05)
0.93
(0.86 to 1.01)
0.99
(0.95 to 1.04)
0.84
(0.69 to 1.01)
Interactions
Interaction 1f 0.96
(0.94 to 0.99)
Interaction 2g 1.02
(0.99 to 1.05)
Interaction 3h 1.00
(0.98 to 1.02)
Global test 2i 0.04 0.005 0.30 0.80 0.10
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
DOI: 10.3310/phr05060 PUBLIC HEALTH RESEARCH 2017 VOL. 5 NO. 6
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Leyland et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
243

Appendix 75 Impact of moving the real Health in
Pregnancy grant period: restriction to 18 months
TABLE 101 Impact of moving the real HiP grant period: restriction to 18 months
Imputed
Birthweight
(g), coefficient
95% CI
Booking status
Measures of stage,
OR (95% CI)
Other birth
outcomes,
OR (95% CI)
Gestational
age at booking
(weeks),
coefficient
(95% CI)
Booking before
25 weeks, OR
(95% CI) Preterm
Very
preterm
Neonatal
death
Periods
Period 1a 0.00 0.00 1.00 1.00 1.00 1.00
Period 2b –1.80
(–6.10 to 2.50)
–0.25
(–0.32 to 0.17)
1.12
(1.03 to 1.22)
0.90
(0.84 to 0.96)
0.93
(0.80 to 1.08)
1.98
(1.31 to 2.98)
Period 3c –5.10
(–10.70 to 0.50)
–1.07
(–1.20 to 1.00)
0.90
(0.82 to 0.98)
1.17
(1.09 to 1.25)
1.34
(1.15 to 1.57)
1.90
(1.09 to 3.29)
Global test 1d 0.20 0.005
Trend
All yearse 3.30
(2.40 to 4.20)
0.89
(0.82 to 0.97)
Interactions
Interaction 1f –0.14
(–0.15 to 0.13)
1.09
(1.08 to 1.11)
0.96
(0.95 to 0.97)
0.93
(0.91 to 0.96)
Interaction 2
g
–0.47
(–0.54 to 0.39)
1.13
(1.04 to 1.24)
0.68
(0.64 to 0.72)
0.57
(0.49 to 0.65)
Interaction 3h –0.28
(–0.31 to 0.26)
0.92
(0.89 to 0.95)
0.88
(0.86 to 0.90)
0.75
(0.71 to 0.79)
Global test 2i 0.20 < 0.0001 < 0.0001 < 0.0001 < 0.0001 0.04
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
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Appendix 76 Impact of moving the real Health in
Pregnancy grant period: extension to 30 months
TABLE 102 Impact of moving the real HiP grant period: extension to 30 months
Imputed
Birthweight
(g), coefficient
(95% CI)
Booking status
Measures of stage,
OR (95% CI)
Other birth
outcomes,
OR (95% CI)
Gestational
age at booking
(weeks),
coefficient
(95% CI)
Booking before
25 weeks,
OR (95% CI) Preterm
Very
preterm
Neonatal
death
Periods
Period 1a 0.00 0.00 1.00 1.00 1.00 1.00
Period 2b –3.00
(–7.40 to 1.30)
–0.37
(–0.44 to –0.31)
1.10
(1.03 to 1.17)
1.10
(1.04 to 1.16)
1.28
(1.14 to 1.44)
1.76
(1.16 to 2.66)
Period 3c –7.20
(–13.60 to 0.90)
–1.15
(–1.24 to 1.06)
0.92
(0.84 to 1.02)
1.30
(1.21 to 1.39)
1.30
(1.21 to 1.39)
1.26
(0.68 to 2.34)
Global test 1d 0.06 0.001
Trend
All yearse 3.50
(2.6 to 4.4)
0.93
(0.85 to 1.01)
Interactions
Interaction 1f –0.14
(–0.15 to 0.13)
1.09
(1.08 to 1.11)
0.96
(0.95 to 0.97)
0.93
(0.91 to 0.96)
Interaction 2
g
–0.62
(–0.66 to 0.59)
1.11
(1.06 to 1.16)
0.83
(0.81 to 0.86)
0.78
(0.73 to 0.84)
Interaction 3h –0.10
(–0.20 to 0.09)
0.86
(0.82 to 0.91)
0.77
(0.74 to 0.80)
0.59
(0.54 to 0.65)
Global test 2i 0.70 < 0.0001 < 0.0001 < 0.0001 < 0.0001 0.20
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
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Appendix 77 Impact of moving the real Health
in Pregnancy grant period: exclusion of births that
occurred during the 2009 swine flu outbreak
TABLE 103 Impact of moving the real HiP grant period: exclusion of births that occurred during the 2009 swine
flu outbreak
Imputed
Birthweight
(g), coefficient
95% CI
Booking status
Measures of stage,
OR (95% CI)
Other birth
outcomes,
OR (95% CI)
Gestational
age at booking
(weeks),
coefficient
(95% CI)
Booking before
25 weeks, OR
(95% CI) Preterm
Very
preterm
Neonatal
death
Periods
Period 1a 0.00 0.00 1.00 1.00 1.00 1.00
Period 2b –4.40
(–9.00 to 0.20)
–0.36
(–0.43 to 0.30)
1.09
(1.02 to 1.17)
1.07
(1.01 to 1.13)
1.19
(1.04 to 1.34)
1.97
(1.27 to 3.06)
Period 3c –6.40
(–12.50 to 0.30)
–1.10
(–1.20 to 1.00)
0.90
(0.83 to 1.00)
1.22
(1.14 to 1.31)
1.46
(1.24 to 1.71)
1.56
(0.86 to 2.84)
Global test 1d 0.10 0.003
Trend
All yearse 3.40
(2.40 to 4.30)
0.91
(0.83 to 0.99)
Interactions
Interaction 1f –0.14
(–0.15 to 0.13)
1.09
(1.08 to 1.11)
0.96
(0.95 to 0.97)
0.93
(0.91 to 0.95)
Interaction 2
g
–0.54
(–0.60 to 0.48)
1.13
(1.04 to 1.22)
0.62
(0.59 to 0.65)
0.45
(0.40 to 0.51)
Interaction 3h –0.21
(–0.24 to 0.17)
0.88
(0.84 to 0.91)
0.86
(0.83 to 0.88)
0.71
(0.66 to 0.76)
Global test 2i 0.30 < 0.0001 < 0.0001 < 0.0001 < 0.0001 0.09
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
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Appendix 78 Impact of moving the start of the
intervention period to one year before the real Health in
Pregnancy grant period: 24-month intervention period
TABLE 104 Impact of moving the start of the intervention period to 1 year before the real HiP grant period:
24-month intervention period
Imputed
Birthweight
(g), coefficient
(95% CI)
Booking status
Measures of stage,
OR (95% CI)
Birth outcome,
OR (95% CI)
Gestational
age at booking
(weeks),
coefficient
(95% CI)
Booking before
25 weeks, OR
(95% CI) Preterm
Very
preterm
Neonatal
death
Periods
Period 1a 0.00 0.00 1.00 1.00 1.00 1.00
Period 2b 2.20
(–2.10 to 6.50)
–0.20
(–0.30 to 0.07)
1.23
(1.09 to 1.38)
0.88
(0.80 to 0.97)
0.82
(0.66 to 1.01)
1.85
(1.22 to 2.81)
Period 3c –1.70
(–8.30 to 5.00)
–1.23
(–1.35 to 1.11)
0.99
(0.88 to 1.12)
1.41
(1.27 to 1.56)
1.91
(1.52 to 2.41)
2.11
(1.10 to 4.03)
Global test 1d 0.07 0.02
Trend
All yearse 2.8
(1.80 to 3.9)
0.88
(0.79 to 0.97)
Interactions
Interaction 1f –0.11
(–0.13 to 0.10)
1.08
(1.06 to 1.10)
0.93
(0.92 to 0.95)
0.89
(0.86 to 0.92)
Interaction 2g –0.16
(–0.21 to 0.11)
1.15
(1.09 to 1.22)
0.72
(0.69 to 0.75)
0.57
(0.52 to 0.63)
Interaction 3h –0.37
(–0.39 to 0.35)
0.94
(0.92 to 0.97)
0.92
(0.90 to 0.93)
0.82
(0.79 to 0.85)
Global test 2i 0.90 < 0.0001 < 0.0001 < 0.0001 < 0.0001 0.10
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
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Appendix 79 Impact of moving the start of the
intervention period to 1 year before the real Health in
Pregnancy grant period: 18-month intervention period
TABLE 105 Impact of moving the start of the intervention period to 1 year before the real HiP grant period:
18-month intervention period
Imputed
Birthweight
(g), coefficient
(95% CI)
Booking status
Measures of stage,
OR (95% CI)
Birth outcome,
OR (95% CI)
Gestational
age at booking
(weeks),
coefficient
(95% CI)
Booking before
25 weeks,
OR (95% CI) Preterm Very preterm Neonatal death
Periods
Period 1a 0.00 0.00 1.00 1.00 1.00 1.00
Period 2b 3.10
(–1.10 to 7.30)
–0.030
(–0.20 to 0.10)
1.17
(1.00 to 1.38)
0.79
(0.70 to 0.90)
0.67
(0.50 to 0.88)
1.88
(1.25 to 2.83)
Period 3c –1.50
(–7.40 to 4.40)
–1.20
(–1.30 to 1.10)
0.99
(0.88 to 1.12)
1.37
(1.24 to 1.51)
1.81
(1.44 to 2.28)
2.78
(1.56 to 4.95)
Global test 1d 0.03 0.002
Trend
All yearse 2.80
(1.90 to 3.80)
0.84
(0.77 to 0.92)
Interactions
Interaction 1f –0.12
(–0.13 to 0.10)
1.08
(1.06 to 1.10)
0.94
(0.92 to 0.95)
0.89
(0.86 to 0.92)
Interaction 2g –0.07
(–0.10 to 0.002)
1.12
(1.03 to 1.22)
0.71
(0.67 to 0.75)
0.54
(0.47 to 0.63)
Interaction 3h –0.43
(–0.45 to 0.42)
0.96
(0.94 to 0.98)
0.92
(0.91 to 0.94)
0.85
(0.82 to 0.88)
Global test 2i 0.50 < 0.0001 < 0.0001 < 0.0001 < 0.0001 0.30
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
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Appendix 80 Impact of moving the start of the
intervention period to 1 year before the real Health in
Pregnancy grant period: 30-month intervention period
TABLE 106 Impact of moving the start of the intervention period to 1 year before the real HiP grant period:
30-month intervention period
Imputed
Birthweight
(g), coefficient
(95% CI)
Booking status
Measures of stage,
OR (95% CI)
Birth outcome,
OR (95% CI)
Gestational
age at booking
(weeks),
coefficient
(95% CI)
Booking before
25 weeks, OR
(95% CI) Preterm Very preterm Neonatal death
Periods
Period 1a 0.00 0.00 1.00 1.00 1.00 1.00
Period 2b 2.50
(–2.00 to 6.90)
–0.30
(–0.40 to 0.20)
1.21
(1.09 to 1.34)
1.05
(0.97 to 1.14)
1.20
(0.99 to 1.43)
1.97
(1.28 to 3.05)
Period 3c 0.20
(–6.90 to 7.30)
–1.20
(–1.40 to 1.10)
1.00
(0.88 to 1.13)
1.41
(1.28 to 1.56)
1.90
(1.51 to 2.40)
2.43
(1.22 to 4.86)
Global test 1d 0.2 0.009
Trend
All yearse 2.60
(1.50 to 3.70)
0.86
(0.78 to 0.96)
Interactions
Interaction 1f –0.12
(–0.13 to 010)
1.08
(1.06 to 1.10)
0.94
(0.92 to 0.95)
0.89
(0.86 to 0.92)
Interaction 2g –0.24
(–0.28 to 0.20)
1.14
(1.09 to 1.19)
0.81
(0.78 to 0.83)
0.72
(0.68 to 0.78)
Interaction 3h –0.28
(–0.30 to 0.26)
0.92
(0.89 to 0.95)
0.87
(0.85 to 0.89)
0.75
(0.71 to 0.79)
Global test 2i 0.60 < 0.0001 < 0.0001 < 0.0001 < 0.0001 0.05
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
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Appendix 81 Impact of moving the start of the
intervention period to 6 months before the real
Health in Pregnancy grant period: 24-month
intervention period
TABLE 107 Impact of moving the start of the intervention period to 6 months before the real HiP grant period:
24-month intervention period
Imputed
Birthweight
(g), coefficient
(95% CI)
Booking status
Measures of stage,
OR (95% CI)
Birth outcome,
OR (95% CI)
Gestational
age at booking
(weeks),
coefficient
(95% CI)
Booking before
25 weeks, OR
(95% CI) Preterm Very preterm Neonatal death
Periods
Period 1a 0.00 0.00 1.00 1.00 1.00 1.00
Period 2b 0.09
(–4.20 to 4.40)
–0.24
(–0.32 to 0.16)
1.16
(1.06 to 1.27)
0.88
(0.82 to 0.94)
0.87
(0.74 to 1.02)
1.64
(1.08 to 2.49)
Period 3c –3.10
(–9.50 to 3.30)
–0.60
(–0.70 to 0.40)
0.96
(0.87 to 1.07)
1.22
(1.12 to 1.32)
1.49
(1.24 to 1.80)
1.73
(0.94 to 3.20)
Global test 1d 0.30 0.07
Trend
All yearse 3.04
(2.00 to 4.00)
0.90
(0.82 to 0.99)
Interactions
Interaction 1f –0.13
(–0.15 to 0.12)
1.08
(1.07 to 1.10)
0.96
(0.94 to 0.97)
0.92
(0.90 to 0.95)
Interaction 2
g
–0.31
(–0.35 to 0.26)
1.10
(1.04 to 1.17)
0.70
(0.67 to 0.73)
0.56
(0.51 to 0.62)
Interaction 3h –0.28
(–0.31 to 0.26)
0.92
(0.89 to 0.95)
0.87
(0.85 to 0.89)
0.74
(0.70 to 0.78)
Global test 2i 0.60 < 0.0001 < 0.0001 < 0.0001 < 0.0001 0.02
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
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Appendix 82 Impact of moving the start of the
intervention period to 6 months before the real
Health in Pregnancy grant period: 18-month
intervention period
TABLE 108 Impact of moving the start of the intervention period to 6 months before the real HiP grant period:
18-month intervention period
Imputed
Birthweight
(g), coefficient
(95% CI)
Booking status
Measures of stage,
OR (95% CI)
Birth outcome,
OR (95% CI)
Gestational
age at booking
(weeks),
coefficient
(95% CI)
Booking before
25 weeks, OR
(95% CI) Preterm Very preterm Neonatal death
Periods
Period 1a 0.00 0.00 1.00 1.00 1.00 1.00
Period 2b 0.50
(–3.80 to 4.80)
–0.10
(–0.20 to 0.01)
1.15
(1.03 to 1.29)
0.64
(0.59 to 0.70)
0.47
(0.38 to 0.58)
1.60
(1.07 to 2.40)
Period 3c –3.70
(–9.40 to 2.10)
–1.10
(–1.20 to 1.00)
0.95
(0.86 to 1.06)
1.20
(1.11 to 1.31)
1.47
(1.22 to 1.77)
1.60
(0.91 to 2.80)
Global test 1d 0.10 0.08
Trend
All yearse 3.10
(2.20 to 4.10)
0.91
(0.83 to 1.00)
Interactions
Interaction 1f –0.13
(–0.15 to 0.12)
1.08
(1.07 to 1.10)
0.95
(0.94 to 0.97)
0.92
(0.89 to 0.95)
Interaction 2
g
–0.22
(–0.29 to 0.15)
1.10
(1.01 to 1.19)
0.55
(0.52 to 0.59)
0.37
(0.32 to 0.42)
Interaction 3h –0.38
(–0.40 to 0.36)
0.94
(0.92 to 0.97)
0.92
(0.90 to 0.94)
0.82
(0.79 to 0.86)
Global test 2i 0.90 < 0.0001 < 0.0001 < 0.0001 < 0.0001 0.05
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
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Appendix 83 Impact of moving the start of the
intervention period to 6 months before the real
Health in Pregnancy grant period: 30-month
intervention period
TABLE 109 Impact of moving the start of the intervention period to 6 months before the real HiP grant period:
30-month intervention period
Imputed
Birthweight
(g), coefficient
(95% CI)
Booking status
Measures of stage,
OR (95% CI)
Birth outcome,
OR (95% CI)
Gestational
age at booking
(weeks),
coefficient
(95% CI)
Booking before
25 weeks, OR
(95% CI) Preterm Very preterm Neonatal death
Periods
Period 1a 0.00 0.00 1.00 1.00 1.00 1.00
Period 2b 0.03
(–4.40 to 4.50)
–0.37
(–0.44 to 0.30)
1.15
(1.06 to 1.24)
1.00
(0.94 to 1.06)
1.06
(0.92 to 1.23)
1.50
(0.98 to 2.28)
Period 3c –1.90
(–8.60 to 4.80)
–1.10
(–1.20 to 1.05)
0.98
(0.88 to 1.08)
1.25
(1.15 to 1.36)
1.58
(1.31 to 1.90)
1.27
(0.67 to 2.43)
Global test 1d 0.60
Trend
All yearse 2.90
(1.80 to 3.90)
0.94
(0.85 to 1.03)
Interactions
Interaction 1f –0.14
(–0.15 to 0.12)
1.08
(1.07 to 1.10)
0.96
(0.94 to 0.97)
0.92
(0.90 to 0.95)
Interaction 2
g
–0.44
(–0.48 to 0.41)
1.09
(1.04 to 1.14)
0.76
(0.74 to 0.78)
0.64
(0.60 to 0.69)
Interaction 3h –0.21
(–0.24 to 0.18)
0.88
(0.84 to 0.91)
0.86
(0.84 to 0.89)
0.71
(0.66 to 0.76)
Global test 2i 0.30 < 0.0001 < 0.0001 < 0.0001 < 0.0001 0.04
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
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Appendix 84 Impact of moving the start of the
intervention period to 6 months after the real Health
in Pregnancy grant period: 24-month intervention
period
TABLE 110 Impact of moving the start of the intervention period to 6 months after the real HiP grant period:
24-month intervention period
Imputed
Birthweight
(g), coefficient
(95% CI)
Booking status
Measures of stage,
OR (95% CI)
Birth outcome,
OR (95% CI)
Gestational
age at booking
(weeks),
coefficient
(95% CI)
Booking before
25 weeks, OR
(95% CI) Preterm Very preterm Neonatal death
Periods
Period 1a 0.00 0.00 1.00 1.00 1.00 1.00
Period 2b –4.70
(–8.80 to 0.50)
–0.39
(–0.45 to 0.33)
1.09
(1.020 to 1.17)
1.14
(1.09 to 1.20)
1.34
(1.20 to 1.48)
1.43
(0.97 to 2.11)
Period 3c –8.20
(–13.90 to 2.60)
–1.20
(–1.30 to 1.10)
0.90
(0.82 to 0.98)
1.25
(1.18 to 1.33)
1.49
(1.30 to 1.72)
0.91
(0.53 to 1.58)
Global test 1d 0.02 0.007
Trend
All yearse 3.70
(2.80 to 4.50)
0.97
(0.90 to 1.05)
Interactions
Interaction 1f –0.14
(–0.15 to 0.12)
1.10
(1.08 to 1.11)
0.97
(0.96 to 0.98)
0.95
(0.93 to 0.97)
Interaction 2
g
–0.65
(–0.70 to 0.60)
1.08
(1.02 to 1.15)
0.73
(0.70 to 0.76)
0.63
(0.58 to 0.70)
Interaction 3h –0.10
(–0.20 to 0.09)
0.86
(0.82 to 0.91)
0.75
(0.72 to 0.78)
0.56
(0.51 to 0.61)
Global test 2i 0.80 < 0.0001 < 0.0001 < 0.0001 < 0.0001 0.10
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
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Appendix 85 Impact of moving the start of the
intervention period to 6 months after the real Health
in Pregnancy grant period: 18-month intervention
period
TABLE 111 Impact of moving the start of the intervention period to 6 months after the real HiP grant period:
18-month intervention period
Imputed
Birthweight
(g), coefficient
(95% CI)
Booking status
Measures of stage,
OR (95% CI)
Birth outcome,
OR (95% CI)
Gestational
age at booking
(weeks),
coefficient
(95% CI)
Booking before
25 weeks, OR
(95% CI) Preterm Very preterm Neonatal death
Periods
Period 1a 0.00 0.00 1.00 1.00 1.00 1.00
Period 2b –4.50
(–8.80 to 0.30)
–0.36
(–0.42 to 0.31)
1.08
(1.01 to 1.16)
1.04
(0.99 to 1.09)
1.09
(0.98 to 1.23)
1.51
(1.02 to 2.23)
Period 3c –5.80
(–11.10 to 0.60)
–1.14
(–1.21 to 1.07)
0.89
(0.82 to 0.96)
1.16
(1.09 to 1.23)
1.31
(1.15 to 1.51)
1.09
(0.66 to 1.81)
Global test 1d 0.06 0.03
Trend
All yearse 3.40
(2.60 to 4.30)
0.96
(0.88 to 1.03)
Interactions
Interaction 1f –0.14
(–0.15 to 0.12)
1.10
(1.08 to 1.11)
0.97
(0.96 to 0.98)
0.95
(0.93 to 0.97)
Interaction 2
g
–0.60
(–0.70 to 0.50)
1.06
(0.98 to 1.16)
0.56
(0.53 to 0.60)
0.40
(0.35 to 0.45)
Interaction 3h –0.21
(–0.24 to 0.18)
0.88
(0.84 to 0.91)
0.86
(0.84 to 0.89)
0.71
(0.66 to 0.76)
Global test 2i 0.40 < 0.0001 < 0.0001 < 0.0001 < 0.0001 0.04
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
DOI: 10.3310/phr05060 PUBLIC HEALTH RESEARCH 2017 VOL. 5 NO. 6
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Leyland et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
265

Appendix 86 Impact of moving the start of the
intervention period to 6 months after the real Health
in Pregnancy grant period: 30-month intervention
period
TABLE 112 Impact of moving the start of the intervention period to 6 months after the real HiP grant period:
30-month intervention period
Imputed
Birthweight
(g), coefficient
(95% CI)
Booking status
Measures of stage,
OR (95% CI)
Birth outcome,
OR (95% CI)
Gestational
age at booking
(weeks),
coefficient
(95% CI)
Booking before
25 weeks, OR
(95% CI) Preterm Very preterm Neonatal death
Periods
Period 1a 0.00 0.00 1.00 1.00 1.00 1.00
Period 2b –4.90
(–9.10 to 0.70)
–0.40
(–0.50 to 0.30)
1.090
(1.02 to 1.17)
1.19
(1.13 to 1.25)
1.42
(1.28 to 1.57)
1.36
(0.92 to 2.01)
Period 3c –6.40
(–12.30 to 0.50)
–1.30
(–1.40 to 1.20)
0.93
(0.84 to 1.02)
1.34
(1.25 to 1.44)
1.66
(1.42 to 1.94)
0.72
(0.40 to 1.29)
Global test 1d 0.06 0.001
Trend
All yearse 3.50
(2.60 to 4.30)
0.98
(0.91 to 1.06)
Interactions
Interaction 1f –0.14
(–0.15 to 0.12)
1.10
(1.08 to 1.11)
0.97
(0.96 to 0.98)
0.95
(0.93 to 0.97)
Interaction 2
g
–0.59
(–0.62 to 0.55)
1.05
(1.01 to 1.10)
0.78
(0.75 to 0.80)
0.69
(0.64 to 0.74)
Interaction 3h –0.02
(–0.08 to 0.04)
0.82
(0.76 to 0.89)
0.74
(0.70 to 0.79)
0.56
(0.50 to 0.64)
Global test 2i 0.60 < 0.0001 < 0.0001 < 0.0001 < 0.0001 0.50
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
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Appendix 87 Impact of moving the start of the
intervention period to 1 year after the real Health in
Pregnancy grant period: 24-month intervention period
TABLE 113 Impact of moving the start of the intervention period to 1 year after the real HiP grant period:
24-month intervention period
Imputed
Birthweight
(g), coefficient
(95% CI)
Booking status
Measures of stage,
OR (95% CI)
Birth outcome,
OR (95% CI)
Gestational
age at booking
(weeks),
coefficient
(95% CI)
Booking before
25 weeks, OR
(95% CI) Preterm Very preterm Neonatal death
Periods
Period 1a 0.00 0.00 1.00 1.00 1.00 1.00
Period 2b –4.20
(–8.20 to 0.10)
–0.46
(–0.52 to 0.40)
1.06
(0.99 to 1.14)
1.30
(1.23 to 1.36)
1.69
(1.51 to 1.88)
1.04
(0.72 to 1.50)
Period 3c –4.60
(–1.00 to 0.80)
–1.26
(–1.33 to 1.18)
0.89
(0.81 to 0.97)
1.35
(1.27 to 1.44)
1.68
(1.46 to 1.94)
0.50
(0.29 to 0.85)
Global test 1d 0.10 0.002
Trend
All yearse 3.30
(2.50 to 4.00)
1.02
(0.95 to 1.10)
Interactions
Interaction 1f –0.14
(–0.15 to 0.13)
1.10
(1.09 to 1.12)
0.966
(0.958 to 0.974)
0.95
(0.93 to 0.96)
Interaction 2g –0.51
(–0.56 to 0.47)
1.05
(0.99 to 1.12)
0.75
(0.72 to 0.78)
0.62
(0.57 to 0.69)
Interaction 3h –0.01
(–0.07 to 0.05)
0.82
(0.76 to 0.89)
0.74
(0.69 to 0.78)
0.55
(0.48 to 0.63)
Global test 2i 0.60 < 0.0001 < 0.0001 < 0.0001 < 0.0001 0.60
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
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Appendix 88 Impact of moving the start of the
intervention period to 1 year after the real Health in
Pregnancy grant period: 18-month intervention period
TABLE 114 Impact of moving the start of the intervention period to 1 year after the real HiP grant period:
18-month intervention period
Imputed
Birthweight
(g), coefficient
(95% CI)
Booking status
Measures of stage,
OR (95% CI)
Birth outcome,
OR (95% CI)
Gestational
age at booking
(weeks),
coefficient
(95% CI)
Booking before
25 weeks, OR
(95% CI) Preterm Very preterm Neonatal death
Periods
Period 1a 0.00 0.00 1.00 1.00 1.00 1.00
Period 2b –3.70
(–7.90 to 0.50)
–0.40
(–0.46 to 0.33)
1.04
(0.97 to 1.13)
1.22
(1.16 to 1.29)
1.52
(1.35 to 1.70)
1.11
(0.76 to 1.62)
Period 3c –6.50
(–11.40 to 1.50)
–1.16
(–1.22 to 1.09)
0.86
(0.80 to 0.93)
1.23
(1.16 to 1.30)
1.42
(1.26 to 1.61)
0.69
(0.43 to 1.12)
Global test 1d 0.04 0.04
Trend
All yearse 3.40
(2.70 to 4.20)
1.01
(0.94 to 1.08)
Interactions
Interaction 1f –0.14
(–0.15 to 0.13)
1.10
(1.09 to 1.12)
0.966
(0.958 to 0.975)
0.95
(0.93 to 0.96)
Interaction 2g –0.63
(–0.70 to 0.56)
1.10
(1.01 to 1.21)
0.72
(0.68 to 0.77)
0.61
(0.53 to 0.70)
Interaction 3h –0.13
(–0.17 to 0.08)
0.86
(0.82 to 0.91)
0.77
(0.74 to 0.80)
0.60
(0.54 to 0.65)
Global test 2i 0.30 < 0.0001 < 0.0001 < 0.0001 < 0.0001 0.08
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
DOI: 10.3310/phr05060 PUBLIC HEALTH RESEARCH 2017 VOL. 5 NO. 6
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Leyland et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
271

Appendix 89 Impact of moving the start of the
intervention period to 1 year after the real Health in
Pregnancy grant period: 30-month intervention period
TABLE 115 Impact of moving the start of the intervention period to 1 year after the real HiP grant period:
30-month intervention period
Imputed
Birthweight
(g), coefficient
(95% CI)
Booking status
Measures of stage,
OR (95% CI)
Birth outcome,
OR (95% CI)
Gestational
age at booking
(weeks),
coefficient
(95% CI)
Booking before
25 weeks, OR
(95% CI) Preterm Very preterm Neonatal death
Periods
Period 1a 0.00 0.00 1.00 1.00 1.00 1.00
Period 2b –4.40
(–8.40 to 0.30)
–0.45
(–0.50 to 0.39)
1.07
(0.99 to 1.14)
1.23
(1.17 to 1.29)
1.57
(1.41 to 1.75)
1.01
(0.69 to 1.47)
Period 3c –5.60
(–11.40 to 0.20)
–1.10
(–1.20 to 1.03)
0.83
(0.73 to 0.95)
1.81
(1.66 to 1.98)
2.57
(2.14 to 3.09)
0.60
(0.34 to 1.07)
Global test 1d 0.09 0.06
Trend
All yearse 3.30
(2.60 to 4.10)
1.01
(0.94 to 1.08)
Interactions
Interaction 1f –0.14
(–0.15 to 0.13)
1.10
(1.09 to 1.12)
0.966
(0.958 to
0.974)
0.95
(0.93 to 0.96)
Interaction 2
g
–0.55
(–0.58 to 0.51)
1.04
(0.99 to 1.08)
0.85
(0.83 to 0.88)
0.75
(0.70 to 0.81)
Interaction 3h –0.13
(–0.23 to 0.035)
0.88
(0.77 to 0.99)
0.55
(0.50 to 0.59)
0.36
(0.30 to 0.43)
Global test 2i 0.90 < 0.0001 0.0001 < 0.0001 < 0.0001 0.10
a Pre-intervention period.
b Intervention HiP grant.
c Post-intervention period.
d Global test for the periods in which the interactions were not significant.
e Trend over the study period 2004–13.
f Trend pre intervention.
g Trend during the HiP grant period.
h Trend post intervention.
i Global test for the interactions.
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Appendix 90 STrengthening the Reporting of
OBservational studies in Epidemiology statement for
reporting of observational studies
TABLE 116 STrengthening the Reporting of OBservational studies in Epidemiology statement for reporting of
observational studies
Section Item number Recommendation
Title and abstract 1 (a) Indicate the study’s design with a commonly used term in the title or the
abstract (Abstract)
(b) Provide in the abstract an informative and balanced summary of what was
done and what was found (Abstract)
Introduction
Background/rationale 2 Explain the scientific background and rationale for the investigation being
reported (Background, The intervention, Rationale for the study)
Objectives 3 State specific objectives, including any prespecified hypotheses (Research
objectives)
Methods
Study design 4 Present key elements of study design early in the paper (Research design)
Setting 5 Describe the setting, locations, and relevant dates, including periods of
recruitment, exposure, follow-up and data collection (Study population including
definitions of subgroups)
Participants 6 (a) Cohort study: give the eligibility criteria, and the sources and methods of
selection of participants. Describe methods of follow-up (N/A); case–control
study: give the eligibility criteria, and the sources and methods of case
ascertainment and control selection. Give the rationale for the choice of cases
and controls (N/A); cross-sectional study: give the eligibility criteria, and the
sources and methods of selection of participants (Research design, Study
population including definitions of subgroups)
(b) Cohort study: for matched studies, give matching criteria and number of
exposed and unexposed (N/A); case–control study; for matched studies, give
matching criteria and the number of controls per case (N/A)
Variables 7 Clearly define all outcomes, exposures, predictors, potential confounders, and
effect modifiers. Give diagnostic criteria, if applicable (Table 4)
Data sources/
measurement
8a For each variable of interest, give sources of data and details of methods of
assessment (measurement). Describe comparability of assessment methods if
there is more than one group (Study population including definitions of
subgroups)
Bias 9 Describe any efforts to address potential sources of bias (Imputation Methods;
Strengthening the inference)
Study size 10 Explain how the study size was arrived at (Power calculation)
Quantitative variables 11 Explain how quantitative variables were handled in the analyses. If applicable,
describe which groupings were chosen and why (Table 4)
Statistical methods 12 (a) Describe all statistical methods, including those used to control for
confounding (Statistical analysis, Economic analysis, Strengthening the inference,
Models fitted and interpretation; Table 4)
(b) Describe any methods used to examine subgroups and interactions
(Study population including definitions of subgroups)
continued
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TABLE 116 STrengthening the Reporting of OBservational studies in Epidemiology statement for reporting of
observational studies (continued )
Section Item number Recommendation
(c) Explain how missing data were addressed (Imputation methods)
(d) Cohort study: if applicable, explain how loss to follow-up was addressed
(N/A); case–control study: if applicable, explain how matching of cases and
controls was addressed (N/A); cross-sectional study: if applicable, describe
analytical methods taking account of sampling strategy (Statistical analysis)
(e) Describe any sensitivity analyses (Strengthening the inference)
Results
Participants 13a (a) Report numbers of individuals at each stage of study (e.g. numbers potentially
eligible, examined for eligibility, confirmed eligible, included in the study,
completing follow-up and analysed) (Numbers of observations used in analyses;
Figure 1, Tables 2 and 3)
(b) Give reasons for non-participation at each stage (Figure 1)
(c) Consider use of a flow diagram (Figure 1)
Descriptive data 14a (a) Give characteristics of study participants (e.g. demographic, clinical, social)
and information on exposures and potential confounders (Table 14)
(b) Indicate number of participants with missing data for each variable of interest
(Tables 12–14)
(c) Cohort study: summarise follow-up time (e.g. average and total amount) (N/A)
Outcome data 15a Cohort study: report numbers of outcome events or summary measures over
time (Tables 10–13)
Case–control study: report numbers in each exposure category, or summary
measures of exposure (N/A)
Cross-sectional study: report numbers of outcome events or summary measures
(N/A)
Main results 16 (a) Give unadjusted estimates and, if applicable, confounder-adjusted estimates
and their precision (e.g. 95% CI). Make clear which confounders were adjusted
for and why they were included (Results for the main analysis; Tables 15–23)
(b) Report category boundaries when continuous variables were categorised
(Tables 10–14)
(c) If relevant, consider translating estimates of relative risk into absolute risk for
a meaningful time period (N/A)
Other analyses 17 Report other analyses done [e.g. analyses of subgroups and interactions (Results
of the subgroup analysis, Tables 24–25, Appendices 15–66) and sensitivity
analyses (Results of sensitivity analysis; Appendices 67–89; Figures 3–8)]
Discussion
Key results 18 Summarise key results with reference to study objectives (Principal findings)
Limitations 19 Discuss limitations of the study, taking into account sources of potential bias or
imprecision. Discuss both direction and magnitude of any potential bias
(Strengths and weaknesses)
Interpretation 20 Give a cautious overall interpretation of results considering objectives, limitations,
multiplicity of analyses, results from similar studies, and other relevant evidence
(Interpretation)
Generalisability 21 Discuss the generalisability (external validity) of the study results (Robustness and
generalisability)
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TABLE 116 STrengthening the Reporting of OBservational studies in Epidemiology statement for reporting of
observational studies (continued )
Section Item number Recommendation
Other information
Funding 22 Give the source of funding and the role of the funders for the present study and,
if applicable, for the original study on which the present article is based
(Abstract)
a Give information separately for cases and controls in case–control studies and, if applicable, for exposed and unexposed
groups in cohort and cross-sectional studies.
Note
An explanation and elaboration article discusses each checklist item and gives the methodological background and
published examples of transparent reporting. The STrengthening the Reporting of OBservational studies in Epidemiology
(STROBE) checklist is best used in conjunction with this article (freely available on the websites of PLOS Medicine at
www.plosmedicine.org/ and Annals of Internal Medicine at www.annals.org/, and Epidemiology at www.epidem.com/).
Information on the STROBE initiative is available at www.strobe-statement.org.
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